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Programmed cell death (PCD) is an important process in the development of 
multicellular organisms. Apoptosis, a form of PCD characterized morphologically by 
chromatin condensation, membrane blebbing, and cytoplasm compaction, and 
molecularly by the activation of caspase proteases, has been extensively investigated. 
Studies in C. elegans, Drosophila, mice, and the developing chick have revealed, 
however, that developmental PCD also occurs through other mechanisms, 
morphologically and molecularly distinct from apoptosis. One prominent cell death 
program, linker cell-type death (LCD), is morphologically conserved, and independent of 
the key genes that drive apoptosis. Instead, LCD functions, in part, through the stress-
related protein HSF-1, and subsequent upregulation of members of the ubiquitin 
proteasome system. How exactly HSF-1 is post-translationally regulated to either 
commit to cell survival or cell death is not currently known. Using a protein interaction 
screen and classical genetic studies, I propose that the homeodomain protein kinase 
HPK-1 is required to activate the heat shock function of HSF-1, thereby indirectly 
inhibiting its cell death role. I hypothesize that PQN-41C, a polyglutamine protein 
necessary for linker cell death, binds HPK-1 to limit its HSF-1 interactions, and pushes 
the cell towards death. 
Downstream of cell death, the linker cell must be phagocytosed and degraded by 
engulfing cells. This process does not rely on canonical apoptotic factors, so I carried 
out a forward genetic screen to identify genes involved in corpse degradation. I 
discovered a key protein network involved in linker cell corpse engulfment and 
degradation and revealed that two small GTPases, RAB-35 and ARF-6, and their 
regulators ensure timely phagocytosis and phagosome maturation. I also determined 
that the caspase CED-3 and its upstream regulator CED-4 are required not for cell 
death, but for proper cell corpse removal. This new role of caspase in cell corpse 
disposal offers an alternative function for the role of caspases in cell death, and 
suggests how apoptotic and non-apoptotic forms of cell death may work together to 
remove cells during animal development. 
iii
To Luka and Elias: 
“Think and wonder, 
wonder and think.” 
iv 
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1. Introduction
1.1. Programmed cell death
The term Programmed Cell Death (PCD) was first coined to describe cell 
elimination that occurs at precise locations and times during development [1], although 
cell death as a phenomenon had been described as early as the 1885 [2]. This process 
is key for sculpting tissues and organs, for removing excess or unnecessary cells, 
and for tissue homeostasis. The reproducible and consistent patterns of cell death in 
developing animals led to the idea that specific genes are driving the phenomenon. 
Indeed, genes promoting apoptosis, a form of PCD characterized by chromatin 
condensation, membrane blebbing, and cytoplasm compaction [3,4] (Figure 1-1), 
were initially isolated in Caenorhabditis elegans [5]. The discovery that the C. elegans 
caspase gene ced-3 is required for developmental apoptosis, and the subsequent 
realization that caspase homologs in Drosophila and in vertebrates also promote 
apoptosis, demonstrated that underlying the stereotypical morphological signature 
is a conserved molecular program [6,7]. In species as diverged as C. elegans and 
the mouse, apoptosis is mediated by caspase proteases, activated by a conserved 
scaffolding protein called CED-4 in C. elegans and APAF1 in mice. Bcl-2 family proteins 
act upstream of CED-4/APAF1 to control its activation. This occurs by direct binding in 
C. elegans [8], or through release of mitochondrial cytochrome C, which oligomerizes 
APAF1 in mammals [9].
1.2. A brief introduction to developmental apoptosis in C. elegans and 
Drosophila
In C. elegans, a BH3-only-like protein, EGL-1, inhibits CED-9, a Bcl-2-
like protein [10] (Figure 1-2a). This removes the inhibition that CED-9 places on 
CED-4, an APAF1 homolog [11]. Activated CED-4 cleaves CED-3, a caspase, into 
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its functional form [5]. Later, molecular apoptosis was confirmed and expanded in 
Drosophila melanogaster and in mouse [12,13]. 
In Drosophila, apoptotic stimuli gather Inhibitor of Apoptosis Proteins (IAP) 
antagonists, including Reaper, Hid, Grim, to the mitochondria, to inhibit the IAP, 
Diap1 [13-16]. IAPs were found to negatively inhibit caspases in Drosophila and other 
organisms [17,18] (Figure 1-2b). Inhibition of IAPs allows for the APAF1-like protein Ark 
to activate the Caspase-9-like protein Dronc [19-21]. Downstream of Dronc, caspases 
DrICE and Dcp1 promote apoptosis [22,23].
1.3. A brief introduction to developmental apoptosis in mammals and 
evidence of alternative cell death pathways
In mammals, the core components of the apoptosis pathway combine aspects of 
the pathways from worms and flies, with molecular paradigms upstream of mitochondria 
similar to C. elegans, and those downstream of the mitochondria similar to Drosophila 
(Figure 1-2c). For example, BH3-only proteins inhibit Bcl-2 family members upon 
activation by an apoptotic stimulus [24], similar to C. elegans. This lifts the negative 
inhibition that Bcl-2 family members place on Bax and Bak at the mitochondria [25], 
allowing these proteins to form pores on the outer mitochondrial membrane and 
release cytochrome C [26,27]. Blocking Bax and Bak is thought to inhibit all forms of 
intrinsic apoptosis [28]. Additionally, this also releases IAP-binding partners to promote 
apoptosis [29,30], similar to Drosophila. Cytochrome C release leads to the activation 
Figure 1-1. Morphology of an apoptotic corpse. 
In apoptosis, chromatin is highly condensed and darkly 
staining, but the nuclear envelope remains round 
(C. elegans cell, courtesy of Yun Lu).
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of the apoptosome containing multimeric APAF1, which activates the initiator caspase, 
caspase-9; this in turn activates the executioner caspases, caspases -3 and -7 [30,31]. 
Although initial reports of mice harboring knockout mutations in caspase genes, 
in Apaf1, or in both Bax and Bak suggested that these genes play important roles in 
vertebrate developmental cell death [13,32-36], breeding mutants onto different genetic 
backgrounds revealed that homozygous knockout mice were not only born, but could 
survive to adulthood, often exhibiting only minor defects [36-39]. For example, while 
initial reports suggested that mice defective in Apaf1 exhibit inappropriate webbing 
between the digits of the pentadactyl limb, later analysis revealed only a delay in 
the process, with complete culling of the webbing within two days [34,35]. Mutations 
in Caspase-3 or Caspase-9 do not affect this process [33,40]. Furthermore, while 
persistence of small webs are observed in Bax; Bak double mutants, this surviving 
tissue is a small fraction of what survives in Bmp mutants, in which cell death is 
indirectly blocked [41,42]. 
Similarly, early studies of Caspase-3 mutants revealed mice with apparent skull 
Figure 1-2. Core components of the apoptosis pathway are conserved in worms, 
flies, and mammals. 
Figure adapted from [46].
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Figure 1 | The core of the apoptotic machinery is conserved.  Functional homologues of apoptotic proteins in 
Caenorhabditis elegans, Drosophila melanogasterand mammals show the evolutionary conservation of the apoptotic 
pathway.a | InC. elegans, EGL-1 (which is a BH3-only protein homologue) binds to and inhibits CED-9 (a BCL-2-family 
homologue), resulting in the release of CED-4 (a homologue of apoptotic protease-activating factor 1 (APAF1)) from the 
CED-9–CED-4 complex. This enables cells to be eliminated by CED-3 (which is a caspase). b | InD. melanogaster, inhibitor of 
apoptosis protein (IAP) antagonists Reaper, Head involution defective (Hid) and Grim (which are known as the RHG 
proteins) mediate the degradation of Death-associated IAP 1 (Diap1), thereby liberating the executioner caspases Ice and 
Death caspase 1 (Dcp1). In addition, this enables Death regulator Nedd2-like caspase (Dronc), which is a caspase 9 
homologue, to interact with Ark (an APAF1 homologue) and form the apoptosome that eciently activates the executioner 
caspases. The protein p35 is a specic inhibitor of executioner caspases, and the activation of the apoptosome may be 
regulated by the BCL-2 family members Debcl and Buy (hence depicted by a dashed line and question mark). 
c | In mammals, the crucial decision as to whether a cell commits to apoptosis is regulated by an interplay between the 
anti-apoptotic BCL-2 subfamily of proteins and the pro-apoptotic BH3-only subfamily. During apoptosis, BH3-only proteins 
facilitate a BAX (BCL-2-associated X protein) - and BAK (BCL-2 antagonist/killer)-dependent release of cytochromec
from mitochondria; cytochromec binds to APAF1 and gives rise to the apoptosome. In parallel, IAP antagonists such as 
second mitochondria-derived activator of caspase (SMAC), HTRA2 and apoptosis-related protein in the TGF-β signalling 
pathway (ARTS) translocate from mitochondria and release caspases from negative regulation by IAPs. In particular, 
caspase 9 is liberated from X-linked IAP (XIAP) and activated by the apoptosome, which stimulates the 
executioner caspases 3 and 7. Homologous proteins are depicted in the same colours in the three panels.
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fractures and protruding brain tissue, suggesting a vast excess of neurons in the brain, 
consistent with the observation that in some brain regions up to 80% of cells that are 
originally produced are thought to undergo PCD [13,43]. Subsequent examination, 
however, revealed no increase in neuronal cell number [44]. Rather, defects in the 
sutures that bind skull bones together appear to be the cause of skull disruption [45], 
and oozing of brain tissue is likely a consequence of the release of intracranial pressure 
to which the brain is normally subjected.
Although the absence of massive cell survival in Caspase-3 or Caspase-9 
mutants could be explained by redundant activities of these enzymes, as the mouse 
harbors 13 caspase genes [46], only a single Apaf1 gene is found in the murine genome 
[34]. Furthermore, studies of Bax; Bak double mutants suggest that developmental 
apoptosis is nearly entirely abrogated, yet some animals still develop normally to 
adulthood [36]. Thus, an alternative explanation may be the existence of caspase-
independent non-apoptotic processes. Cells dying with non-apoptotic features during 
animal development have been extensively described [47], yet little is known about 
the underlying molecular effectors of these alternative death programs, or their in vivo 
relevance.
1.4. Non-apoptotic developmental cell death
While most developmental cell death in Drosophila and C. elegans proceeds via 
apoptosis, these organisms also provide highly amenable settings for non-apoptotic 
pathway discoveries. 
1.4.1. Germ cell death in Drosophila males
Pre-meiotic male germ cells undergo stochastic PCD in the adult fly testes, and 
dying cells display some apoptotic features, including cytoplasmic compaction and 
chromatin condensation [48] (Figure 1-3a). Dying germ cells are also TUNEL-positive, 
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suggesting chromosomal DNA fragmentation. Surprisingly, these wild-type cells are 
not stained with an antibody against cleaved Caspase-3, which binds the executioner 
caspases Drice and Dcp-1 [48]. Furthermore, cells still die when these caspases are 
knocked down, suggesting that germ cell death is non-apoptotic. Correspondingly, 
unlike apoptotic cells, mitochondria of dying wild-type germ cells appear deformed and 
swollen [48].
Although germ cell death does not employ executioner caspases, it does require 
an APAF1-independent function of the initiator caspase Dronc [48]. Mutations in the 
Apaf1 homolog, ark, in fact, increase cell death, perhaps because more Dronc is now 
available to induce non-apoptotic death [48,49]. Mutations in dronc result in a 40%-60% 
decrease in death. This defect is specific, as lesions in the initiator caspases strica 
and dredd have no effect. The mechanism of Dronc action here is not fully understood. 

















Figure 1-3. Germ cell death in Drosophila males.
(a) In adult males, germ cell death occurs within the testes (green). (b) Dronc, a 
Caspase-9-like protease, functions in an apoptosome-independent fashion to perhaps 
trigger lysosome membrane permeabilization (LMP), allowing the release of the 
protease CathepsinD and the nuclease DNaseII. At the mitochondria, Bcl-2 family 
members Debcl and Buffy function on the outer membrane, and the Parkinson-related 
protein Pink1 functions within. ROS may trigger release of the serine protease HtrA2/
Omi and the nuclease EndoG [48].
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required for efficient demise, and an increase in reactive oxygen species (ROS), and 
acidification of the cytoplasm occur [48]. ROS and Dronc may promote lysosome 
membrane permeabilization, allowing release of cathepsinD and DNaseII into the 
cytosol [48] (Figure 1-3b). The release of DNaseII may explain TUNEL staining in the 
absence of cleaved Caspase-3.
Yacobi-Sharon and colleagues discovered that the mitochondrial protease HtrA2/
Omi plays an important role in germ cell death [48]. Drosophila carrying deletions of 
either one or both htrA2/omi copies are viable, but exhibit male sterility associated with 
a decrease in germ cell death. htrA2/omi encodes a multi-domain protein containing 
a mitochondrial targeting sequence, an IAP-binding motif (IBM), a serine protease 
domain, and a protein-interaction domain. Structure-function analysis revealed that 
the catalytic domain, but not the IBM, is crucial for death [48]. Remarkably, htrA2/omi 
lesions in humans are associated with Parkinson’s disease [48], and mutations in the 
Parkinson’s disease- and mitochondrial-associated gene pink1 also cause a decrease 
in Drosophila germ cell death. Overexpression of a cytosolic version of HtrA2/Omi 
promotes caspase-independent cell death in mammalian cells [51], accompanied by 
morphological similarities to Drosophila germ-cell death, although nuclear changes 
are not evident [48,51]. Roles for mitochondria in Drosophila germ cell death are 
also supported by the findings that the Bcl-2 family proteins Debcl and Buffy, and the 
mitochondrial nuclease EndoG, promote death [48] (Figure 1-3b).
Additionally, GCD does not function completely independent of caspases, but it 
provides a good model for how both caspase-dependent and independent mechanisms 
can work together to kill cells. Aspects of GCD may be conserved in some mammalian 
necrotic pathways. For example, in immortalized mouse embryonic fibroblasts (MEFs), 
introduction of tumor necrosis factor (TNF) can induce a non-apoptotic cell death 
program that does not utilize executioner caspases [52]. Instead, like GCD, lysosomes 
and caspase-9, but not APAF1, are required [52]. The upstream signaling and some 
7
molecular components of TNF-induced cell death differ from GCD, but the similarities 
are striking nonetheless. In addition, LMP, like that observed in GCD, is important for 
mammary gland epithelial cell death after weaning [53].
In rodents, male germ cells also undergo stochastic cell death that may be 
caspase independent [54,55]. Mutations in the pro-apoptotic gene Bax do not block 
these deaths, suggesting possible involvement of non-apoptotic programs [56,57]. 
Furthermore, mutations in the testes-specific serine protease inhibitor spink2 result in 
increased germ cell death in male mice [55]. These observations provide circumstantial 
evidence that conserved pathways may control stochastic germ cell death in males 
across species.
1.4.2. Nurse cell death in Drosophila females
In the Drosophila ovary, 15 nurse cells provide a developing oocyte with proteins, 
mRNA, and organelles [58] (Figure 1-4a). After extruding their cytoplasmic contents 
into the oocyte, nurse-cell remnants die. Dying wild-type cells exhibit chromatin 
condensation, but also autophagosomes, ruptured lysosomes, and larger vacuolar 
structures [59,60]. Dying cells stain with acidification markers, autophagic markers, and 
TUNEL [59-62], raising the possibility that more than one cell death program is involved.
Whether caspases promote nurse cell death is debated. Some studies report no 
activated caspases in dying cells [63,64], whereas others report immunoreactivity using 
an activated Caspase-3 antibody [61,62]. Mutants in Drosophila inducers of apoptosis 
(hid, reaper, grim) do not exhibit nurse cell survival, suggesting a caspase-independent 
process [65,66], and some studies suggest that overexpression of the caspase 
inhibitors diap1 or p35 also does not perturb nurse cell death [62,63]. However, other 
studies suggest that such overexpression weakly blocks death [67].
Genetic studies demonstrate that nurse cell death still proceeds in dronc, dredd, 
strica, dcp-1, or drice caspase single mutants [23,67,68]. However, dredd; strica or 
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dcp-1; drice double mutants exhibit weak survival, suggesting that caspases may be 
relevant, but functionally redundant [67]. Congruently, mutants in Apaf1/ark, which 
functions upstream of initiator caspases, also exhibit weak nurse cell death defects [66].
In developing nurse cells in vitro, the Caspase-3-inhibitor Z-DEVD-FMK blocks 
DNA fragmentation but not chromatin condensation [69]. While mutations in inhibitor 
of caspase-activated DNase (ICAD) cause a decrease in cleaved DNA, as assessed 
by a PCR assay, nurse cells still clear their DNA efficiently [70]. In another study, 
however, mutants in dICAD displayed weak nuclear persistence, similar to Apaf1/ark 
mutants [66]. Together, these data suggest that caspases may play some role in nurse 
cell death.
The role of autophagy in nurse cell death is also unclear. Despite the presence 
of autophagosomes, autophagy-related protein levels are not increased in dying 



















Figure 1-4. Nurse cell death in Drosophila females. 
(a) In the female adult fly, nurse cell death occurs within the ovaries (purple). (b) The 
surrounding follicle cells may induce nurse cell death, using the engulfment receptors 
Draper and Ced-12 via phagoptosis. Downstream events may lead to lysosome 
membrane permeabilization (LMP) and the release of the lysosomal fusion protein 
Spinster and the nuclease DNaseII. Caspases and autophagy may be minimally 
involved.
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the autophagy genes atg1 and atg13 [61]. This defect, however, is not fully penetrant, 
suggesting other processes are probably involved [61]. atg7; dcp-1 double mutants 
exhibit similar defects to atg7 single mutants [71], indicating that these other pathways 
may be caspase independent.
Lysosomes may play important roles in nurse cell death and removal 
(Figure 1-4b). Mutants in the lysosomal nuclease DNaseII and the lysosomal trafficking 
protein deep orange/Vps18 exhibit persisting nurse cell nuclei [60,71], as do mutants 
in the lysosomal fusion protein Spinster and the lysosomal protease CathepsinD [60]. 
While Deep Orange is required in the engulfing follicle cells, DNaseII and Spinster 
appear to function cell autonomously [60]. Thus, lysosomes may have multiple activities 
in nurse cell death, although these results are complicated by the fact that some of 
these mutants perturb cytoplasm transfer to the oocyte, which may delay or impede 
death [59].
Recent research raises the possibility that the primary nurse-cell-death 
mechanism may be phagoptosis (primary phagocytosis), such that death of nurse cells 
is non-autonomously promoted by surrounding follicle cells [72]. Consistently, mutants 
in the engulfment genes draper and ced-12 display nurse cell survival, and Draper is 
required for nurse cell acidification [72]. Furthermore, ablation of surrounding follicle 
cells strongly inhibits nurse cell death, although cytoplasm transfer is also blocked, 
complicating interpretation of the persistent nuclei phenotype [72]. However, it is 
possible that nurse cell death may be an example of assisted suicide.
1.4.3. Salivary gland cell death in Drosophila larvae
Drosophila salivary glands are larva-specific structures that are rapidly degraded 
after puparium formation [73,74] (Figure 1-5a). Dying wild-type cells exhibit apoptotic 
features, but also an abundance of autophagosomes, and nuclear separation from 
the cytoplasm [75,76]. Both autophagy and caspase genes are induced during 
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salivary gland cell death [77,78], although the precise contribution of each is not fully 
understood. Caspases may be dispensable for cell death. Loss-of-function mutants 
in dronc or drice caspase genes or in Apaf1/ark do not strongly perturb salivary gland 
death and degradation [74,79]. While expression of the caspase inhibitor p35 halts DNA 
fragmentation and nuclear lamin cleavage [75,76], it does not result in intact cells [78]. 
Instead, fragments appear to persist inappropriately [74], suggesting a cell degradation 
role for caspases.
Autophagy is induced prior to salivary gland cell death, and in the absence of the 
autophagy-related gene atg18, salivary glands are not properly degraded, exhibiting 
vacuolated cell fragments [74] (Figure 1-5b). These findings provide in vivo evidence 
for a role of autophagy in degrading dying cells [74]. Combining autophagy and 
caspase inhibition blocks gland degradation further, but not cell death, suggesting these 
pathways function in parallel [74]. Cell death can be inhibited by overexpression of the 
PI3K active subunit Dp110 and p35, suggesting involvement of a PI3K target [74].













Cell Death and Degradation
Engulfment 
gene
Figure 1-5. Salivary gland cell death in Drosophila larvae. 
(a) After puparium formation, large larval salivary glands (blue) die and degrade before 
the adult fly hatches. (b) The engulfment gene Draper is required cell-autonomously 
within the salivary glands to drive cell death, and may lead to downstream activation of 
autophagy genes like Atg18. Caspases may work in parallel.
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cells is not well understood. The engulfment gene draper is required to induce 
autophagy cell-autonomously in the salivary gland cells, and not for engulfment [76,80], 
suggesting an unexpected and intimate connection between engulfment and 
degradation genes. Such a connection had been described for nurse cell death (see 
above) [72]. In C. elegans, engulfment genes also appear important in some contexts 
for promoting nuclease activation for cell degradation [81].
1.4.4. Linker cell death in C. elegans
The C. elegans male-specific linker cell leads gonad elongation. During the L4 
larva-to-adult transition, the cell dies, allowing gonad-cloaca fusion for sperm release 
and male fertility (Figure 1-6a). The dying linker cell is engulfed by its neighboring 
U.l/rp cells [82]. Morphologically, wild-type linker cell death is non-apoptotic: chromatin 
is not condensed, the nuclear envelope becomes crenellated, and mitochondria and 
endoplasmic reticulum swell [82] (Figure 1-7). Death proceeds even when all four 
C. elegans caspase genes are inactivated, and mutations in other core apoptotic genes 
also fail to prevent death [82,83]. Thus, linker cell death represents the first example 
of a non-apoptotic caspase-independent cell death process required for development. 
The morphology of dying linker cells is frequently seen in vertebrate development, and 
we have termed this appearance linker cell-type death (LCD). Importantly, although 
invaginated membranes are often artifacts of EM fixation, this is not the case for linker 
cell nuclear crenellation, as this feature is detected in the living animal under light 
microscopy. In vertebrate settings, LCD ultrastructural features are distinguished from 
EM artifacts or natural variability as they are seen only at specific developmental times, 
and accompany only populations of dying cells and not their neighbors (see below).
Work in the lab revealed multiple control pathways promoting linker cell death. 
This death must be tightly regulated, as premature demise blocks gonad elongation, 
resulting in sterility [84]. Two opposing Wnt pathways control death onset (Figure 1-6b). 
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Figure 1-6. The linker cell dies independent of caspases. 
(a) The linker cell (green) is a male-specific cell that leads the elongation of the 
developing gonad. Once it reaches its destination, it dies, and is engulfed by the U.l/
rp cells (purple), allowing fusion of the gonad with the cloaca. (b) Multiple regulatory 
pathways are required to ensure the linker cell dies at the proper place and time. These 
pathways include two antagonistic Wnt pathways (blue), the developmental timing 
protein LIN-29 (red), Sarm/TIR-1, the MAPKK SEK-1, and the polyglutamine protein 
PQN-41 (green), and the nuclear hormone receptor NHR-67 (purple). These pathways 
converge on the heat shock factor HSF-1, which acts in parallel with the SET-16 histone 
methyltransferase complex (orange). The pro-death function of HSF-1 competes with 
its pro-survival function. HSF-1 may transcriptionally upregulate the E2 ubiquitin-
conjugating enzyme LET-70 (purple). The transfer of ubiquitin from the E1 UBA-1, 
through LET-70, to an E3 complex may confer substrate specificity leading, perhaps to 

































































One pathway, consisting of the Wnt ligand LIN-44, secreted by some tail cells, the 
Frizzled receptors MIG-1 and CFZ-2, the Nemo-like kinase LIT-1, and the β-catenin 
WRM-1, all acting in the linker cell, appears to block linker cell death, and may 
prevent premature death [85]. The LIN-44/Wnt pathway is inhibited by a second Wnt 
pathway, consisting of EGL-20/Wnt, secreted by the engulfing cells, and LIN-17/
Frizzled and MOM-5/Frizzled, acting within the linker cell with MIG-5/Disheveled and 
BAR-1/β-catenin, which promotes death [85]. Two transcription factors, NOB-1/Hox and 
the EOR-1/-2/PLZF complex, likely control the EGL-20/Wnt pathway [86].
In parallel, TIR-1, the C. elegans ortholog of the human Sarm protein, activates 
the MAPKK protein SEK-1 to promote linker cell death [87]. SEK-1 may promote 
expression of the polyglutamine-repeat protein PQN-41. PQN-41 expression is induced 
in the linker cell at the onset of death, and a GFP-tagged version forms puncta within 
the linker cell [87]. How exactly PQN-41 promotes cell death is currently unknown.
The zinc finger protein LIN-29, a component of a developmental timing 
program [88], also promotes death, as does the nuclear hormone receptor NHR-67 [86]. 
These genes appear to act independently of and in parallel to the Wnt and MAPKK 
pathways [86], and ensure that the linker cell is dying in the correct place at the right 
time.
Linker cell death can be restored to mutants carrying lesions in the upstream 
control pathways by a gain-of-function mutation in HSF-1, a highly conserved 
transcriptional regulator of the heat-shock and other stress responses. HSF-1 loss-
Control of Nonapoptotic Developmental
Cell Death in Caenorhabditis elegans
by a Polyglutamine-Repeat Protein
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Death is a vital developmental cell fate. In Caenorhabditis elegans, programmed death of the
linker cell, which leads gonadal elongation, proceeds independently of caspases and apoptotic effectors.
To identify genes promoting linker-cell death, we performed a genome-wide RNA interference
screen. We show that linker-cell death requires the gene pqn-41, encoding an endogenous
polyglutamine-repeat protein. pqn-41 functions cell-autonomously and is expressed at the onset of
linker-cell death. pqn-41 expression is controlled by the mitogen-activated protein kinase kinase
SEK-1, which functions in parallel to the zinc-finger protein LIN-29 to promote cellular demise.
Linker-cell death is morphologically similar to cell death associated with normal vertebrate
development and polyglutamine-induced neurodegeneration. Our results may therefore provide
molecular inroads to understanding nonapoptotic cell death in metazoan development and disease.
Programmed cell death is essential for meta-zoan development and is required to sculptorgans, eliminate harmful cells, and coun-
ter cell division (1, 2). Apoptosis, an extensively
studied cell death process, requires caspase ac-
tivation and is accompanied by a stereotypical
morphological signature that includes chromatin
compaction, cytoplasmic shrinkage, and no gross
disruption of organelles (3). Mice lacking key
apoptotic effectors such as caspase-3, caspase-9,
Apaf-1, or Bax and Bak have mild defects and
can survive to adulthood (4). Given the preva-
lence of cell death during mouse development
(5), these observations raise the possibility that a
nonapoptotic cell death pathway plays key roles
in animal development. Although genes promot-
ing necrotic cell death have been identified (6),
they are not required for normal development (7).
Indeed, genes dedicated to nonapoptotic devel-
opmental cell death have not been described.
We previously described the programmed
death of the Caenorhabditis elegans linker cell
during male reproductive system development
(8). The linker cell leads the migration of the
male gonad and dies between the fourth larval
stage (L4) and adulthood (9). Linker cell demise
is orchestrated by a cell-autonomous process in-
dependent of all C. elegans caspases and other
known cell death genes (8, 10). Electron mi-
croscopy (EM) of the dying linker cell reveals
nonapoptotic features, including crenellation (in-
dentation) of the nuclear envelope, uncondensed
chromatin, and organelle swelling (Fig. 1C) (8).
However, linker cell death does not require the
unfolded protein response or other stress responses
(tables S1 and S2). Similar morphological fea-
tures are seen during normal developmental death
of neurons in the vertebrate spinal cord and cil-
iary ganglion (11–13), suggesting that linker cell–
type death is morphologically conserved.
To uncover the molecular mechanisms lead-
ing to linker cell death, we performed a genome-
wide RNA interference (RNAi) screen to identify
genes whose inactivation prevents linker cell
death. We fed 18,132 bacterial clones, express-
ing double-stranded RNA (dsRNA) correspond-
ing to 89% of predicted protein-coding C. elegans
genes, individually to RNAi-sensitized males ex-
pressing a lag-2 promoter::green fluorescent
protein (GFP) linker cell reporter (14). The screen
strategy was validated by recovery of the lin-29
gene, previously identified as required for link-
er cell death (8). We recovered five additional
RNAi clones leading to linker cell survival.
Three clones also affect linker cell migration
and may thus affect multiple aspects of linker
cell fate. One of the remaining clones, derived
from the gene pqn-41 (Fig. 2A), caused linker
cell survival in 20% of animals (Fig. 1A) with
no obvious pleiotropic effects (fig. S1) and was
further studied.
To confirm that the clone we identified inac-
tivates pqn-41, we generated a deletion allele,
ns294, in the gene. pqn-41(ns294) animals lack
337 nucleotides, removing portions of intron
17 and exon 18 of the predicted genomic struc-
ture (Fig. 2A). Consistent with our RNAi results,
pqn-41(ns294) adult males possess an inappro-
priately surviving linker cell (Fig. 1, A and B).
Furthermore, in pqn-41(ns294) mutants the linker
cell persists at least 24 hours after the L4-adult
transition (19% survival, n = 79 animals), sug-
gesting that reducing pqn-41 function not only
delays but may block linker cell death. RNAi
against pqn-41 in pqn-41(ns294) animals does
not increase linker cell survival (16% survival,
n = 108 animals), suggesting that ns294 may
be a strong loss-of-function allele. To test whether
pqn-41(ns294) mutants have defects in develop-
mental apoptosis, we scored for surviving pha-
ryngeal cells that normally die apoptotically (15)
and observed none (n = 10 animals). Thus, the
nonapoptotic nature of linker cell death may
reflect distinct molecular machineries.
None of the pqn-41(ns294) surviving cells
exhibit nuclear crenellation (n = 19 animals),
Laboratory of Developmental Genetics, The Rockefeller Uni-
versity, 1230 York Avenue, New York, NY 10065 USA.
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Fig. 1. PQN-41 is required for linker cell death. (A) Linker cell survival 2 to 4 hours after the L4 molt.
Numbers, percentages. Error bars indicate SEM. *P < 0.04; n ≥ 50 animals. Increased survival in rde-1 may
reflect reduced let-7 miRNA function (8). (B) Adult pqn-41(ns294) male with surviving linker cell
(arrow). Scale bar, 10 mm. (C) Electron micrograph of dying linker cell in a wild-type animal. nl, nucleolus.
Arrow indictaes swollen ER, asterisk i dicates mitochondria, and arrowhead indicates nucl ar envelope
crenellation. (D) Electron micrograph of linker cell in (B). Arrows indicate adhesion junctions. Dashed box
is enlarged in fig. S2A. Scale bars in (C) and (D), 2 mm.

































Figure 1-7. Dying linker cells have uncondensed chromatin 
and crenellated nuclei. 
In linker cell death, the nuclear envelope is crenellated, with 
indentations apparent even using Nomarski optics. Reprinted 
from [87].
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of-function blocks linker cell death. Thus, HSF-1 likely functions downstream of or in 
parallel to the regulators described above [85]. A pro-death role for HSF-1 is surprising, 
as HSF-1 is typically responsible for promoting survival in response to stress. In animals 
exposed to a heat shock 4h before death onset, the linker cell survives inappropriately, 
suggesting that the pro-death and pro-survival functions of HSF-1 may compete [85]. 
We hypothesize that HSF-1 is post-translationally modified, and these modifications 
promote either the cell survival or cell death role, depending on context. Which genes 
are responsible for these modifications in LCD is currently unknown, however.
Genetically, HSF-1 functions at the same step as the SET-16 H3K4 histone 
methyltransferase complex, similar to the mammalian MLL3/4 complex. C. elegans 
complex components include SET-16, SWD-2.2, UTX-1, ASH-2, RBBP-5, WDR-5, and 
PIS-1, and mutations or RNAi against any of these components promotes inappropriate 
survival [86].
Genetic, expression, and functional studies suggest that HSF-1 may work by 
transcriptionally activating components of the ubiquitin proteasome system [85]. The 
single C. elegans E1 enzyme, UBA-1, is required for cell death through activity of 
the E2 ubiquitin-conjugating enzyme LET-70, homologous to mammalian UBE2D2. 
LET-70/UBE2D2 appears to act through an E3 ubiquitin ligase complex comprising the 
cullin CUL-3, the ring box protein RBX-1, the BTB domain containing protein BTBD-2, 
and perhaps SIAH-1 [85]. The identities of substrates binding to this E3 complex are 
unknown, but may provide critical clues to how this caspase-independent cell death is 
executed. It is possible, for example, that degradation of a critical substrate through this 
E3 complex is the key to the lethal effects of the pathway. Correspondingly, proteasome 
19S regulatory domain components are required for linker cell death [85].
Molecular components related to those promoting linker cell death have been 
implicated in degeneration and death in other settings. Wallerian degeneration is 
a process by which the distal process of an injured neuronal axon degenerates, 
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leaving the cell body intact. Wallerian degeneration slow (WldS) mice have persistent 
axotomized axons [89] caused by an abnormal protein fusion between an NAD+ 
synthesis protein, NMNAT, and the ubiquitin factor E4B (Ube4b) [90]. Recent work has 
revealed that mutations in dSarm, the Drosophila homolog of C. elegans tir-1 required 
for linker cell death, also suppress Wallerian degeneration in the fly [91]. Likewise, 
murine Sarm promotes Wallerian degeneration in vivo [91]. Overexpression of the SAM-
TIR domains of murine Sarm in cell culture promotes death that appears non-apoptotic, 
as it proceeds in the presence of caspase inhibitors [92].
In wild-type mice, injury to cortical and dorsal root ganglion (DRG) neurons 
causes degeneration of the axotomized axon [91]. In Sarm1-/- neurons, however, the 
axons persist over an 18h period. In vivo, axotomy at the sciatic nerve in wild-type 
animals causes the axons to degenerate and a disintegration of the integrity of the 
neuromuscular junctions (NMJ). In Sarm1-/- animals, the axons persist and remain 
innervated to the NMJs. When the SAM-TIR domains of Sarm1 are overexpressed 
(Sarm1 lacking first 408 amino acids) in DRG cells in culture, the cells die in a non-
apoptotic manner [92]. Pro-apoptotic factors, caspase inhibitors, calpain inhibitors, or 
extracellular calcium chelation do not inhibit this SAM-TIR-induced cell death [92]. In 
primary DRG, mitochondrial depolarization by the protonophore molecule CCCP results 
in axon degeneration and cell death [93]. This induced cell death is non-apoptotic, but 
requires Sarm1 to degenerate and kill the cells, even in the presence of mitochrondrial 
depolarization. The authors designate this cell death as sarmoptosis [93]. It remains 
unclear, however, if this cell death occurs in normal mammalian development, and how 
different it is from LCD.
In the linker cell, TIR-1/Sarm1 regulates expression of the polyQ repeat protein, 
PQN-41 [87]. While PQN-41 function is not well understood, its sequence raises the 
hypothesis that polyQ-expansion neurodegenerative diseases, such as Huntington’s 
disease, may be instances of a developmental program gone awry [94]. Supporting 
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this, in a mouse Huntington’s disease model, dying cells exhibit swollen mitochondria 
and golgi, and crenellated nuclei, strikingly reminiscent of linker cell death [95] 
(Figure 1-8a,b). TUNEL staining is not detected in dying neurons [96]. Crenellated 
nuclei are also found in dying cells of other polyQ disease models and in human 
patients [97-102] (Figure 1-8c-e).
Intersegmental muscles (ISMs) of the moth, Manduca sexta may also prove 
fertile ground for exploring similarities with linker cell death. Wild-type ISM cells that 
die during metamorphosis exhibit non-apoptotic features: chromatin condensation is 
not seen, nor are DNA fragmentation, or membrane blebbing [103]. However, ubiquitin 
expression is induced, similar to linker cell death [104]. Furthermore, an E1 ubiquitin-
activating enzyme, several E2 ubiquitin-conjugating enzymes, and E3 ubiquitin ligases 
are induced [105]. Molecular characterization of these proteins and their targets may 
expose similarities to linker cell death.
1.5. Non-apoptotic cell death in mammalian development
Although non-apoptotic cell death pathways have been described in vertebrate 
cells, including necroptosis, ferroptosis, or pyroptosis, none appear to be required for 
normal development, as elimination of key genes regulating these processes does 
not affect development or developmental cell death [106,107]. Nonetheless, evidence 
that non-apoptotic cell death has important roles in vertebrate development abounds, 
including but not limited to, the formation of the mammalian palate [108] (Figure 1-8f), 
cornification of epidermal keratinocytes [109], and lysosome-mediated mammary gland 
involution after lactation [53]. In the following subsections, I highlight four additional 
salient examples that raise the possibility that non-apoptotic cell death programs may 
indeed be the norm during vertebrate development. Whether such programs back up, 
act in parallel, or function independently of apoptosis is not easy to distinguish, as a 
key test for their non-apoptotic nature is whether they proceed without apoptotic genes- 
18
Figure 1-8. Crenellated nuclei (pseudocolored yellow, red arrows) are prevalent in 
disease models and in normal development. 
(a) In a mouse model of Huntington’s disease, crenellated nuclei are prominent in 
almost all the cells of the striatum [95]. Black arrow, neuronal nuclear inclusion. (b) 
They are also prevalent in dark neurons of a mouse model of Huntington’s disease [96]. 
(c) In brain autopsy samples of a Huntington’s disease patient, crenellated nuclei with 
uncondensed chromatin are present [102]. (d) In a cell line overexpressing a pathogenic 
Ataxin-3, crenellated nuclei were apparent prior to non-apoptotic cell death [99]. (e) In 
the CAG repeat disease dentatorubral-pallidoluysian atrophy, autopsy samples from 
patients have nuclear membrane indentations in some granule cells in the cerebellar 
cortex [100]. Star, intranuclear inclusion. (f) Dying cells from the developing palatal 
shelf display crenellated nuclei [108]. (g) While Caspase-9 null ESCs rarely die after 
UV treatment, those that do display LCD features, including open chromatin, swollen 
organelles, and crenellated nuclear envelope [32]. Ch, chromatin. (h) Degenerating 
motoneurons in Bak knockout mice have crenellated nuclei, and are small and 
atrophied [112]. N, nucleus. m, mitochondria. rer, rough endoplasmic reticulum. Black 
arrow, synapse. Dotted line, soma. (i) Degenerating motoneurons in a wild-type stage 
24 chick spinal cord have indented nuclei [115]. (j) Non-apoptotic dying retinal ganglion 
cells in the same organism have crenellated nuclei after axotomy [117]. (k) Peripherally 
deprived ciliary ganglion neurons in the embryonic chick display highly indented nuclei 
[118]. N, nucleus. (l) Avian motoneurons in culture adopt either an apoptotic morphology, 
or an LCD morphology as shown here, with highly crenellated nuclei, and swollen 
organelles at later timepoints (not shown) [119]. Scale bar = 1 μm. (m) In the presence 
of caspase inhibitors, motoneurons in the chick acquire non-apoptotic morphology [120]. 
n, nucleus. (n) Mouse uterine epithelial cells die shortly after implantation, and these 
cells display irregularly shaped nuclei [125]. (o) Regressing Müllerian duct cells in wild-
type mice have open chromatin, crenellated nuclei, and swollen organelles [130]. MD, 
Müllerian duct epithelial cell. (p) Explant cultures of degenerating Müllerian duct cells 




Figure 4. Ultrastructure of the Nucleus
Examples of the NII (A and B; indicated by large arrows) found within striatal neurons that have many indentations in the nuclear membrane
(small arrows) demonstrated with conventional electron microscopy (osmium/uranyl/lead staining). Typically, more than 90% of neurons within
the mouse striatum have a smooth nuclear profile, and all lack any inclusion (C). At higher magnifications, the NII is seen to be a pale staining
structure quite distinct from the more darkly stained adjacent nucleolus (Nu) and surrounding chromatin. Scale bar for (A)–(C) is 2 m and
for (D) is 200 nm.
cortex beginning at 3.5 weeks and within the striatum neurons. The largest inclusions can be found within the
cerebral cortex, striatum, cerebellum (Purkinje cells),at 4.5 weeks. These NII become ubiquitinated by 5 to 6
weeks and can be detected by ultrastructural analysis and the spinal cord (motor neurons). Interestingly, within
the striatum inclusions are found in the vast majorityat 8 weeks. Morphological changes within the nuclear
membrane are the latest changes to occur, first becom- of neurons but apparently not in the giant cholinergic
interneurons or in the NADPH-diaphorase-containing in-ing apparent at 10 to 12 weeks. NII appear within the
cerebral cortex before they are found in any numbers terneurons (data not shown). We do not know if the
inclusions are exclusively within projection cells withinwithin the striatum, and they increase in sizeand staining
density for both htt and ubiquitin immunoreactivity. The the striatum or if some interneurons contain these struc-
tures. A systematic analysis is currently being performedfrequency and progressive increase in size of NII ap-
pears to vary dramatically between different classes of of the progressive appearance of NII within identified
a
These juvenile HD patients had an onset of disease at 5 years and
14 years of age and died 6 and 7 years later, respectively.
Light Microscopy. Animals were anesthetized with an overdose of
sodium pentobarbitone (Sagatal, 100 mgkg i.p.) and perfused
through the left cardiac ventricle with 35–50 ml of a 2%
paraformaldehydelysineperiodate fixative in phosphate buffer
(pH 7.4). Brains were carefully removed and placed into fixative
for 4–6 h before being transferred to 30% sucrose in 0.1 M Tris
(pH 7.4) for 48 h at 4°C. Brains were mounted in Tissue-Tek
OCT compound (Miles), frozen with powdered solid CO2, and
sectioned in the coronal plane at 40 m on a sledge microtome.
Sections were mounted onto gelatinized glass slides and allowed
to dry overnight. Alternate sections were stained for Nissl
substance with thionin before all sections were rapidly dehy-
drated through ethanols, cleared in Histoclear (National Diag-
nostics), and coverslipped.
Electron Microscopy. Animals were anesthetized as described
above and then perfused through the left cardiac ventricle with
35–50 ml of 4% paraformaldehyde and either 0.5% glutaralde-
hyde or 0.1% glutaraldehyde in 0.1 M Millonig’s phosphate
buffer (pH 7.4). The brain was removed from the skull and
placed in fresh fixative overnight at 4°C. Coronal sections
through the cerebellum, striatum, and cerebral cortex (50–200
m) were cut on an Oxford vibratome (Lancer) and collected in
serial order in 0.1 M phosphate buffer. After being osmicated (30
min in 1% OsO4 in 0.1 M phosphate buffer), the sections were
stained for 15 min in 0.1% uranyl acetate in sodium acetate
buffer at 4°C, dehydrated in ethanols, cleared in propylene oxide,
and embedded in araldite between two sheets of Melanex (ICI).
Semithin (1 m) sections were cut with glass knives and stained
with toluidine blue adjacent to thin sections cut with a diamond
knife on a Reichert Ultracut ultramicrotome. The sections were
collected on mesh grids coated with a thin Formvar film,
counterstained with lead citrate, and viewed in a JEOL 1010
electron microscope.
Terminal Deoxynucelotidyltransferase-Mediated UTP End Labeling
(TUNEL). Ten to 12 sections from mice of the R62 line at 10–17
weeks of age (three mice per age group) were used for terminal
deoxynucleotidyltransferase catalyzed incorporation of either
digoxigenin-11-dUTP or biotin-16-dUTP into the free 3-OH
terminals of fragmented nuclear DNA (Roche Molecular Bio-
chemicals or Oncor). The incorporated digoxigenin-dUTP was
detected with a horseradish peroxidase conjugated anti-
digoxigenin antibody. Incorporated biotin was detected with an
avidin–biotin–peroxidase complex (Vector Laboratories). Sites
of enzymatic activity were visualized with H2O2 and 3,3-
diaminobenzidine as chromagen. Positive controls were sections
through the neocortex, striatum, and subventricular zone be-
neath the cortex of 5- to 7-day-old mice, whereas negative
controls were sections from 14.5- to 17-week-old nontransgenic
littermates.
Results
Ultrastructural Features of Neuronal Cell Death. We have now
studied in great detail R62 mice kept for up to 17 weeks of age.
However, observations similar in nature to those that we are
reporting can also be found in the other two older symptomatic
lines, but not in any of the asymptomatic lines of mice studied for
up to at least 2 years of age (see Materials and Methods for full
details of the mouse lines). Detailed examination throughout the
brains of these mice using both light and transmission electron
microscopy detected degenerating neurons in the anterior cin-
gulate cortex, in the dorsal striatum, and within the vermis of the
cerebellum. We did not find degenerating neurons in any other
areas of the central nervous system, but are currently performing
a detailed investigation using the ultrastructural criteria defined
for degenerating neurons in this study. Degenerating neurons
can be detected by their enhanced affinity for staining with
either toluidine blue or osmium, which delineates both perikarya
and proximal dendrites (Fig. 1). These neurons exhibit nuclear
and cytoplasmic condensation and clumping of chromatin, while
subcellular organelles, including mitochondria, appear to be
intact. H wev r, during th process f deg neration and cellular
darkening, both mitochondria and the Golgi network undergo a
transient swelling before condensation in the final stages of cell
eath. The cellul r plasma me brane is ruffled, giving a scal-
lop d appearanc to the darkened cell. Al degenerating cells
contain a distinctive NII and exhibit extensive invagination of the
nuclear m mbrane. There is no fragmentati n or ‘‘blebbing’’ of
either nucleus or cytoplasm. Adjacent neurons are of normal
appearance (Fig. 1 B and D) despite the presence of a distinct
NII and invariably contain markedly increased amounts of
lipofuscin.
Pathological Changes in the Neuronal Nucleus. We have repeatedly
tried to identify DNA fragmentation within ‘‘dark neurons’’ by
labeling with the terminal deoxynucleotidyltransferase-
mediated dUTP–biotin nick end labeling (TUNEL) method for
the in situ determination of DNA strand breaks (22–24), but we
were unable to find any labeling of these neurons. We can
however routinely demonstrate apoptotic profiles with this
method during the development of both the cortex and striatum
in the early postnatal period (5–7 days postnatal mouse, data not
shown).
Fig. 1. Ultrastructural appearance of neurons undergoing dark cell degen-
eration in the striatum (A) and anterior cingulate cortex (B–D) of 17-week-old
R62 transgenic mice. Note the juxtaposition of neurons containing NII, but
without any of the characteristic features of dark cell degeneration (arrows in
B and D) (magnification 650).
8094  www.pnas.org Turmaine et al.
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Fig. 2. (A) Two granule cell nuclei are shown. An intranuclear inclusion (star) and two strong nuclear membrane indentations (thick arrows) are evident in
one. A slight nuclear membrane indentation (thin arrow) can be seen in the other (317000). (B) A higher magnification view of an intranuclear inclusion
in the nucleus of another granule cell, showing an aggregate of randomly orientated filamentous structures that are approximately 10–20 nm in diameter
(350000). (C) A granule cell nucleus showing an intranuclear inclusion (lower left) (37000). (D) A granule cell nucleus showing two nuclear membrane





Figure 3. Impaired Apoptosis in Caspase 9/ ES Cells and MEFs
(A) Induction of apoptosis of Casp9/ and Casp9/ cells in response to adriamycin, UV, or  irradiation. Left panels: Cells were treated with
various doses of the indicated stimuli and analyzed 40 hr later by Annexin V-FITC and PI costaining and flow cytometry. Solid bars, Casp9/;
open bars, Casp9/. Right panels: Casp9/ (squares) and Casp9/ (circles) ES cells were treated with a single dose of adriamycin (0.3 g/
ml), UV irradiation (80 mJ/cm2), or  irradiation (600 rads) and analyzed at the indicated times by Annexin V and PI staining and flow cytometry.
(B) Electron microscopy of dead wild-type (left) and Casp9/ (right) ES cells. Cells were treated with UV irr diatio (80 mJ/cm2) for 24 hr and
processed for visualization by electron microscopy. Ch, chromatin.
(C) Induction of apoptosis of Casp9/, Casp3/, and Casp9/ primary MEFs. Apoptosis was induced and cells were assayed at the indicated
time points by Annexin V and PI staining and flow cytometry. Left panel: UV irradiation (40 mJ/cm2). Solid bars, untreated (NT); gray bars, 24
hr after treatment; open bars, 48 hr after treatment. Middle panel: Adriamycin (0.3 g/ml; 20 hr); Etoposide (100 M; 20 hr). Solid bars, NT;
gray bars, adriamy in (Adr) ; open bars, etoposide. Right panels: Cells w re transiently transfected with a GFP expression vector only (NT),
or in combination with a TNF-R1 expression vector (TNF-R1). Twenty-four hours posttransfection, the % of viability (the ratio between the %
of fluorescent cells in the analyzed culture compared to the % of fluorescent cells in the GFP transfected cultures) was determined. Results
of a representative experiment are shown, n  3. Solid bars, Casp9/; open bars, Casp9/.
(D) Cell death of E1A/Ras-transformed MEFs; Casp9/ (empty circles) and Casp9/ (filled circles/dashed lines). Transformed MEFs were
treated with increasing amounts of adriamycin (left upper panel) or mTNF- (left lower panel) and harvested 24 hr later. E1A/Ras MEFs were
treated with a single dose of adriamycin (0.2 g/ml; right upper panel) or mTNF- (50 ng/ml; right lower panel) and collected at the indicated
time p ints. Cell death was determine by trypan blue exclusion.
(E) Fluorescence microscopic visualization of DAPI staining of nuclear chromatin from wild-type and Casp9/ transformed MEFs, either
untreated (NT) and attached to the plate, ordead (floating) following 24 hr treatmentwith 0.2 g/ml of adriamycin (Adr) or 50 ng/ml mTNF- (TNF).
dimensional stereologic analysis we cannot be certain of
this.
Type 3B cell death: dilation of perinuclear space and
organelles. Another striking consequence of axotomy
was that, in some RGCs (typically 2–20% of them), the
endoplasmic reticulum and/or Golgi and/or perinuclear
space between the inner and outer nuclear membranes,
were dilated, leaving “empty” spaces devoid of osmophilic
material (Figs. 4, 5)—changes typical of type 3B cell death
(see Discussion section). This finding was observed exclu-
sively in RGCs contralateral to a tectal lesion, at all the
time points studied (24, 48, and 72 hours postlesion). In
some cases, the dilated perinuclear space could be seen to
be continuous with a dilated labyrinthine expanse within
the endoplasmic reticulum (Figs. 4B, 5A), but sometimes
only one or the other of these elements was markedly
dilated. In two type 3B RGCs, the nuclear envelope was
very indistinct, and in places undetectable (Fig. 4C,D), but
in these, the nucleoplasm was abnormally dark, which
may have masked an intact envelope. Mitochondria gen-
erally appeared normal (Fig. 5B). Unlike in apoptosis,
ribosomes remained on RER. The dilation of perinuclear
space and/or organelles occurred without striking changes
to the nucleus itself, although on average the nuclear
diameter did appear to be slightly greater than normal
and, in some cases, there was a minor increase in the
granularity of the nucleoplasm, reflecting presumably a
change in the distribution of the dispersed chromatin.
There was no clumping of chromatin, as occurs in apopto-
sis but not in type 3B cell death (Clarke, 1990). And the
nuclear invagination and slight shrinkage that are de-
scribed above almost never occurred in these cells (a mod-
erate nuclear invagin tion was seen in just one of them;
Fig. 4C).
Lack of ultrastructural evidence for apoptosis. De-
spite the regular occurrence of type 3B cell death among
RGCs, we considered the possibility that apoptosis might
be occurring as well but in different RGCs and searched
carefully in all ultrathin sections examined for morpho-
logic signs of apoptotic RGCs (condensed cytoplasm and
nucleus; clumped chromatin within the nucleus, nuclear,
or cytoplasmic fragmentation, etc.). We found no such
signs of apoptosis.
Glial reactions. Already by E13, there was a pro-
nounced reaction of the Müller cells (the radial glia of the
retina), which contained numerous clumps of debris, pre-
sumably in secondary lysosomes, throughout the inner
part of the retina (Figs. 6, 7). Moreover, the Müller pro-
cesses were frequently in intimate contact with degener-
ating neurons. By E14 (48 hours postlesion), this glial
reaction had increased (Fig. 6). We have not analyzed the
phagocytic process in detail, but it was striking that the
contact between Müller cells and RGCs with dilated or-
ganelles sometimes involved a complex entwining be-
tween the two kinds of cell (Fig. 7A).
Fig. 3. Invaginated nuclei in axotomized retinal ganglion cells at
24 hours (A) or 3 days (B,C) after an embryonic day 12 tectal lesion.
Notice that the invagination ar at the xternal side of the nucleus,
toward the dendritic stem and Golgi apparatus. Note the abundant
endoplasmic reticulum (asterisks) in B. The inner retinal surface is
down. Scale bars  2 m in A–C.
365ULTRASTRUCTURE OF AXOTOMY-INDUCED NEURONAL DEATH
FIG. 5. Electron micrographs showing the ultrastructural morphology of degenerating cells in the ventral horn of the cervical spinal cord of
the chick embryo following treatment with Ac-DEVD-CHO and BAF for 12 h. (A) Typical example of the type of degeneration found in a st 24
normal embryo. Condensation of chromatin (n), aggregated ribosomes (arrows), and increased electron density of the cytoplasm are distinct.
(B–D) St 24 embryos following 12 h of treatment with Ac-DEVD-CHO. n, nucleus. Note that a degenerating neuron is engulfed by a
macrophage-like cell (m) in D (arrows). (E) A st 24 embryo following 12 h of treatment with BAF. Note the many small cells with small nuclei
and slightly electron-dense cytoplasm. (F) Higher magnification of E. n, a nucleus of an apparently healthy cell. n, the nucleus of a small
“degenerating” cell. Scale bars are 2 m.
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the number of -tubulin/peripherin motor axo s was un-
changed (n  3) (Fig. 5K–P), indicating that the number of mo-
tor axons reaching the distal sciatic erve as similar in Bax KO
and WT mice. Although we cannot exclude the possibility that
small, unmyelinated motor axons were not labeled (or not visi-
ble), many of the small unmyelinated, peripherin sensory axons
in the Bax KO were, in fact, detectable in these preparations.
Additionally, the absence of retrograde labeling of small atrophic
MNs after either sciatic nerve or muscle i jection of DiI (Fig.
5H, I) is onsistent with our interpretation that atrophic pinal
MNs in the postnatal Bax KO do ot in ervate target muscles in
the hindlimb.
Development of MNs during the PCD period in B x KO mice
Because the number of Nissl-positive MNs is increased in Bax KO
versus WT mice when examined during the embryonic PCD pe-
riod, we next asked whether these excess MNs are initially able to
innervate their targets. The size of MNs in the E14.5 Bax KO
appears somewhat smaller than in WT embryos (Fig. 6, compare
A, B), and a size–frequency profile is consistent with this impres-
sion (C). This is in striking contrast to the situation in postnatal
animals in which two MN groups (normal-sized and atrophic
MNs) were clearly distinguished (Fig. 5G). A similar
developmental profile was also observed for the size of facial MNs
in the Bax KO mice (data not shown). To examine limb innerva-
tion on E14.5, DiI was placed distal to the plexus region of the
hindlimb bud to orthogradely label limb
erves and retrogradely lab l spinal neu-
rons. Although quantification of axon
numbers was not possible, the Bax KO
mice ap ear to have an increased number
of nerve fibers innervating the limb (Fig. 6,
compare D,F, E,G). For example, when
we examined whole mounts from 13 DiI-
labeled embryos without previous knowl-
edge of genotype (blinded), the three em-
bryos judged t have the greatest amount
(density) of limb innervation were all Bax
KO animals; the remaining 10 embryos
were either heterozygote or wild-type
mice. In higher magnification views of the
tibial nerve just distal to the branching
point, all of the Bax KO mice exhibit a
thicker nerve (Fig. 6, compare E, G). In
fact, measures of the thickness (microme-
ters) of the tibial nerve indicates that it is
significantly larger in the Bax KO (18.7 
5.6 in WT vs 35.9  6.1 in the Bax KO; n 
3; p  0.05; t test). In the spinal cord of
these same embryos, there was intense
and widespread DiI labeling in both the
DRG and spinal motor column, suggest-
ing that virtually all of the motor and
sensory neurons had projected axons to
the limb bud at E14.5 (Fig. 5 H, I ). To-
gether, the embryonic and postnatal re-
sults indicate that, whereas all of the
MNs initially innervate the hindlimb in
the Bax KO embryo, a subset of Bax KO
MNs fail to maintain innervation post-
natally and become atrophied.
To directly examine the retraction of
axons and the atrophy of Bax KO MNs, we
applied a retrograde tracer (Alexa 488-conjugated cholera toxin B
subunits) into the whisker pad of P3 or P6 WT and Bax KO mice,
and cou ted the number of labeled MNs (Fig. 6 J–N). Because the
PCD of facial MNs occurs between E16 and P7, postnatal labeling
of innervating MNs provides a means of assessing the extent of
atrophy and axon retraction by excess Bax KO-rescued MNs. In
Bax KO mice, we found many very small (100 m 2) retro-
gradely labeled MNs (Fig. 6L, inset) on P3 through P8, whereas
by P14 such atrophic neurons could no longer be retrogradely
label (Figs. 6L, 8C). In contrast, labeled atrophic MNs were
never observed at any age in WT mice. To quantify the cellular
atrophy and axon retraction, healthy and atrophic (100 m 2)
retrogradely labeled MNs were counted separately after different
lab ling schedules. In WT mice, there were fewer retrogradely
labe ed facial M s on P7 after tracer injection on either P3 (4 d
survival) or P6 (1 d survival) compared with the number present
on P4 after tracer injection on P3 (Fig. 6N). This reduction be-
tween P3 and P7 most likely reflects the normal postnatal PCD of
facial MNs during this period (Ashwell and Watson, 1983). In
contrast, a similar comparison in the Bax KO indicates that, be-
tween P3 and P7, there is a reduced number of labeled normal
MNs and an increased number of labeled atrophic MNs, resulting
in no net change in the total number of labeled MNs (2190  151
vs 2267  30; n  3). This is consistent with a subpopulation of
MNs becoming atrophic between P3 and P7 in the Bax KO mice.
Many Bax KO facial MNs remain atrophic into adult stages
Figure 4. Electron micrographs of MNs in P2 WT ( A) and Bax KO ( C) lumbar spinal cord. Dotted lines indicate the soma and
proximal dendrites. Synapses indicated by arrows in A and C are enlarged in B and D. Although immature, both axodendritic ( B)
and axosomatic ( D) synapses exhibit postsynaptic densities (arrows) and synaptic vesicles (arrowheads). Despite being atrophic,
the su population of Bax KO-rescued MNs contain mitochondria (m), rough endoplasmic reticulum (rer), and Golgi apparatus (g).
N, MN nuclei.







inherently unnatural settings. I have therefore focused on processes that are genetically 
non-apoptotic, and which also have obvious non-apoptotic features in the developing 
wild-type animal.
1.5.1. Cell death in the vertebrate nervous system
Initial studies of mice harboring lesions in core apoptotic components, including 
Apaf1, the initiator Caspase-9, and the executioner Caspase-3, suggested important 
roles for these genes in nervous system development. Apaf1-/-, Caspase-3-/-, and 
Caspase-9-/- animals exhibited exencephaly associated with neural tube defects, 
and most animals died perinatally or shortly after birth [13,32-35], and presented 
with mitotically active immature neurons [110]. Later studies revealed that genetic 
background was a strong contributor to these defects, and that mice carrying the same 
lesions in other genetic contexts could develop normally to adulthood. For example, 
Caspase-3-/- mice in a C57BL/6J genetic background survive to adulthood, but the same 
mutation in 129X1/SvJ mice induces perinatal lethality [37]. How then does cell death 
still occur? A number of studies suggest that alternative cell death pathways are likely to 
be at least as important as apoptosis in these mutants.
While embryonic stem cells (ESCs) lacking Caspase-9 exhibit resistance to 
pro-apoptotic agents [32], some mutant cells die and exhibit non-apoptotic LCD-like 
morphology, including a crenellated nuclear envelope, uncondensed chromatin, 
and swollen organelles (Figure 1-8g), suggesting that a process akin to linker cell 
death may be at play. Supporting this, death of post-mitotic spinal cord and brain 
stem motoneurons (Figure 1-9a) appears to proceed normally in Caspase-3-/- and 
Caspase-9-/- animals even though TUNEL staining decreases [110], suggesting 
that caspase-activated DNase (CAD), one of the enzymes responsible for cleaving 
chromosomal DNA during apoptosis [111], is not induced. Thus, cells appear to be 
dying in the absence of caspase activation. Indeed, dying cells lacking Caspase-3 or 
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Caspase-9 have different morphologies than wild-type cells, with reduced chromatin 
condensation [110]. Similar studies in Bax-/- animals reveal an increase in cell number, 
but the extra cells are small and atrophied, are not synaptically connected, and 
























Figure 1-9. Non-apoptotic cell death occurs in vertebrate development. 
(a) In the developing mouse embryo, neurons within the brain and spinal cord (blue) 
die. In male mice at E13.5, the Müllerian duct (MD, purple) and the Wolffian duct (WD, 
green) are both present in the immature reproductive system. Signal from the testes 
cause the Müllerian duct to degenerate by E15.5.  (b) Cell death occurs in the inner cell 
mass of the blastocyst (yellow) prior to implantation. Uterine epithelial cells die upon 
implantation of the blastocyst and may be entosed by the trophoblast cells.
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motoneurons, and DRG sensory cell death numbers are normal compared to wild type, 
again suggesting that caspase-independent cell death mechanisms are important in the 
developing nervous system [113].
As in the mouse, motoneurons are normally produced in excess during chick 
spinal cord development, and many subsequently die [114]. Ultrastructurally, these 
dying wild-type cells possess either apoptotic or non-apoptotic morphologies, the 
latter exhibiting dilated organelles, open chromatin, and an irregular nucleus [115,116] 
(Figure 1-8i). Axotomized retinal ganglion cells or peripherally deprived ciliary ganglion 
cells have the same indented nuclear structure [117,118] (Figure 1-8j,k). Interestingly, 
wild-type chick motoneurons in culture can adopt similar morphologies (Figure 1-8l), 
and while these dying cells can be engulfed, they lack cleaved Caspase-3 staining 
or TUNEL staining [119]. In vivo, these motoneurons still die in the presence of the 
Caspase-3 inhibitor Ac-DEVD-CHO or the stronger pan-caspase inhibitor Boc-D-FMK 
(BAF) [120]. Intriguingly, all of the dying cells treated with caspase inhibitors have 
a crenellated nucleus, open chromatin, and swollen organelles [120], all features of 
LCD (Figure 1-8m).
1.5.2. Cell death in the inner cell mass (ICM)
Cell death is an early occurrence in vertebrate development, and is already 
evident in the inner cell mass (ICM), prior to implantation [121] (Figure 1-9b). These cell 
deaths in a wild-type mouse blastocyst are characterized by condensed chromatin and 
loss of nuclear membrane integrity, but also swelling of the endoplasmic reticulum [122]. 
Single mutants of apoptotic factors do not seem to block blastocyst development, 
suggesting that cell death likely proceeds normally [121]. Supporting this notion, when 
hamster or mouse embryos are cultured from the 8-cell stage to the blastocyst stage 
in vitro in the presence of the Caspase-3 inhibitor Ac-DEVD-CHO, no noticeable 
effects on development are observed [123]. Dying cells in the ICM of wild-type bovine 
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blastocysts exhibit a mix of apoptotic and non-apoptotic features [124]. Some dying 
cells have condensed chromatin but weak TUNEL staining, while others have moderate 
TUNEL staining [124]. Furthermore, only low transcript levels of key apoptotic factors, 
including Caspase-3, Caspase-9, Caspase-8 and Fas/FasLG, are detected [124]. Thus, 
caspases, and perhaps other apoptotic proteins, may not be required for cell death in 
the ICM.
1.5.3. Death of uterine epithelial cells during implantation
At the site of implantation, uterine epithelial cells die and are internalized by 
embryonic trophoblast cells [125] (Figure 1-9b). These dying epithelial cells in normal 
development exhibit compacted chromatin, but also swollen organelles and irregular 
nuclear envelopes [125,126] (Figure 1-8n). One set of studies reported activated 
Caspase-3 in TUNEL-positive dying cells in wild-type hamster and mouse uterine 
epithelial cells at the site of implantation [123]. Additionally, inhibiting Caspase-3 with 
N-acetyl-DEVD-CHO in the uterus stopped implantation in both species, suggesting 
that Caspase-3 may be necessary for cell death [123]. However, Caspase-3-/- or 
Apaf1-/- adult female mice are fully fertile [37,38]. Furthermore, a subsequent detailed 
examination of the process revealed that neither cleaved Caspase-3 nor TUNEL 
are detected in dying wild-type epithelial cells immediately adjacent to trophoblast 
cells [127]. Entosis, engulfment of a living cell followed by degradation, has been a 
suggested mechanism, as the small GTPase ROCK, which controls entosis in cell 
culture [128], appears to be required [127]. The ultrastructure of these dying cells was 
not reported, but could be used to distinguish among different alternative cell death 
mechanisms.
1.5.4. Cell death in the Müllerian duct
In developing mammals, sex specification occurs early in embryogenesis. 
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Initially, both sexes form a Wolffian duct (WD), which develops into male urogenital 
structures, and a Müllerian duct (MD), which gives rise to the female reproductive 
tract. In females, the WD degenerates, whereas the MD regresses in males [129] 
(Figure 1-9a). MD regression occurs at day E13.5 [130], and is initiated by the secreted 
TGF-β protein AMH (anti-Müllerian hormone) [131]. In the absence of AMH, the MD 
persists, and results in female organs alongside the male urogenital system. This leads 
to male infertility, as the ectopic female organs physically block sperm release [132].
The morphology of dying wild-type MD epithelial cells in rats, mice, and rabbits, 
is entirely non-apoptotic: chromatin in degenerating cells does not condense, and 
the nuclear envelope is crenellated [130,133,134] (Figure 1-8o). These features are 
highly reminiscent of linker cell death in C. elegans, suggesting that MD degeneration 
proceeds in a similar fashion. Degeneration of female rabbit WD cells is also 
accompanied by crenellated nuclei [134]. MD and WD degeneration can be faithfully 
reproduced in an organ culture system, and dying cells here exhibit open chromatin and 
nuclear crenellation [135] (Figure 1-8p). 
Regressing wild-type MD cells are TUNEL-positive [136], and cleaved Caspase-3 
is detected in some dying cells [132]. However, neither Caspase-3 nor other apoptosis 
mutants are reported to harbor defects in urogenital tract development. There are 
conflicting reports regarding the sterility of Apaf1-/- mutants males; however, not all 
males are infertile [38,39]. Caspase-3-/- male mice in the C57BL/6J genetic background 
are fully fertile [37]. Thus, it is possible that LCD is the main cell death mechanism 
during MD and WD degeneration, with Apaf1 and Caspase-3 either playing minor roles, 
or specifically promoting cell corpse degradation (e.g. [120]).
While the genes directly driving MD epithelial cell death are unknown, some of 
the upstream signaling events have been explored. Wnt7a signaling from MD epithelial 
cells allows surrounding mesenchymal cells to respond to testes-derived AMH [137], 
likely by regulating expression and/or activation of receptors in the mesenchymal 
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cells [138-140]. Receptor engagement leads to activation of SMAD1/5/8 proteins, which 
in turn induce expression of Wnt4, and possibly other Wnts [140]. Possible autocrine 
signaling then leads to the activation of β-catenin, which may dimerize with LEF1/TCF 
to promote regression in the adjacent epithelial cells [136]. β-catenin accumulates 
in the mesenchymal cytoplasm, and is present near the plasma membrane of MD 
epithelial cells [136]. Mesenchyme-specific knockdown of β-catenin prevents MD 
degeneration [132]. While both MD regression and linker cell death in C. elegans 
use β-catenin signaling to initiate cell death, β-catenin appears to function cell non-
autonomously in the MD. 
The matrix metalloproteinase MMP2 may be involved in signaling to initiate 
regression [141]. Mmp2 is expressed at higher levels in the mesenchyme of males, and 
this increased expression is abolished in the absence of AMH [141]. In organ culture, 
blocking MMP2 activity prevents MD degeneration, while activating MMP2 causes 
degeneration, even in the absence of AMH [141]. However, MMP2 mutant mice are 
fertile, suggesting other genes may be involved [142]. Roles for MMPs in linker cell 
death have not been described, but the adjacent gonad is known to secrete these 
proteins [143].
Together, the examples described make a compelling case for the prevalence of 
caspase-independent non-apoptotic cell death during vertebrate development, with LCD 
playing, perhaps, an important role.
1.6. Phagocytosis and degradation of dying cells
After cell death, the dying corpse must be recognized and engulfed by 
neighboring cells or professional phagocytes. Clearance of cells undergoing 
programmed cell death is important during development of multicellular organisms, 
and failure to remove dying cells is implicated in developmental abnormalities [144] 
and autoimmune disease [145]. Studies of the nematode C. elegans uncovered 
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genes required for engulfment and degradation of cells dying by apoptosis [146-151]. 
Homologous genes regulate apoptotic cell clearance in Drosophila and vertebrates, as 
do a number of species-specific genes [152-154].
1.6.1. Recognition and engulfment of apoptotic corpses
In C. elegans, neighboring cells, rather than specialized phagocytes, engulf dying 
cells [155,156]. Two distinct, parallel pathways are responsible for apoptotic corpse 
recognition [146,157]. In pathway A, ced-1/Megf-10, ced-6/Gulp, and ced-7/Abca1 
function at the cell membrane to recognize the cell corpse, likely through phosphatidyl 
serine (PS) exposure [158-160] (Figure 1-10a).  PS is also actively exposed on cells 
dying by necrosis in C. elegans, and requires the same engulfment machinery as 
apoptotic cells, as well as necrotic specific genes [161]. 
In pathway B, ced-2/CrkII, ced-5/Dock180, and ced-12/Elmo function within 
the cytoplasm of the phagocyte to promote activation of ced-10/Rac [162-165] 
generation of membrane curvature to match the shape of the prey.
The curvature-generating mechanism dedicated to apoptotic-cell
engulfment remains unclear. Epsin is an efficient membrane
generator (Ford et al., 2002; Boucrot et al., 2012). We propose that,
during engulfment, EPN-1 induces membrane curvature, whereas
the associating clathrin scaffold and the subsequently attached F-
actin further stabilize the curvature. The cooperative actions of
EPN-1, CHC-1 and F-actin thus result in the continuous extension
of pseudopods along apoptotic-cell surfaces (Fig. 9B).
The CED-1 pathway recruits EPN-1 to phagocytic
cups
During apoptotic-cell engulfment, we observe transient enrichment of
lipid second messenger PtdIns(4,5)P2 to extending pseudopods, and
further discover that PtdIns(4,5)P2 is an important signaling molecule
recruiting EPN-1 to pseudopods. Similarly, during the phagocytosis
of opsonized objects by mammalian phagocytes, PtdIns(4,5)P2 is
transiently enriched to extending pseudopods (Botelho et al., 2004).
As CED-1, CED-6 and DYN-1 are all essential for recruiting EPN-1
to pseudopods, we propose that, as a phagocytic receptor, CED-1
might promote the regional burst of a PtdIns(4,5)P2-synthesis activity
through its mediator DYN-1 and an effector PI-kinase(s) (Fig. 9),
similar to how it promotes PtdIns(3)P synthesis on nascent
phagosomes (Yu et al., 2008; Lu et al., 2012).
Epsins are known to interact with transmembrane receptors
through ubiquitin-mediated or ubiquitylation-independent
interactions (Horvath et al., 2007; Kang et al., 2013). Currently, it
is unknown whether CED-1 is ubiquitylated and whether CED-1
and EPN-1 directly interact. If direct interaction occurs, CED-1 and
PtdIns(4,5)P2 might cooperatively control the transient enrichment
of EPN-1 to the site of engulfment initiation (Fig. 9B).
The CED-1 signaling pathway orchestrates the
remodeling of both the plasma membrane and
cytoskeleton during apoptotic-cell engulfment
Previously, we have identified ‘focal exocytosis’ as a membrane
fusion event stimulated by CED-1 and mediated through DYN-1
for facilitating membrane expansion around apoptotic cells (Yu et
al., 2006). Our current study further reveals F-actin assembly as
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another crucial pseudopod extension event regulated by CED-1. The
similar category of actin-remodeling defects resulted from
inactivating ced-1, ced-6, dyn-1, epn-1 or chc-1, together with the
essential roles of CED-1, CED-6 and DYN-1 in recruiting EPN-1
and CHC-1, indicate that the CED-1 pathway drives EPN-1 and
CHC-1 to regulate specific aspects of actin remodeling underneath
pseudopod membrane.
Rat CED6 was reported to interact with clathrin heavy chain
(Martins-Silva et al., 2006). Recently, Drosophila Ced-6 was found
to act as a clathrin adaptor that mediated yolk uptake in egg
chambers (Jha et al., 2012). During C. elegans apoptotic-cell
engulfment, however, ced-6(–); chc-1(–) and ced-6(–); epn-1(–)
double mutants display quantitatively similar levels of Ced
phenotype as ced-6(–) single mutants (Fig. 4A,B), suggesting that
CED-6 and EPN-1 are unlikely to act as two parallel clathrin
receptors. Rather, we find CED-6 acts upstream of EPN-1 in a linear
pathway (Fig. 4C). Inactivating ced-1, ced-6 or dyn-1 all resulted in
engulfment defects stronger than that of epn-1 or chc-1, supporting
the model in which actin remodeling is one of the two branches
regulated by the CED-1 pathway.
Previously, the two parallel C. elegans engulfment pathways were
proposed to converge at the point of CED-10, primarily based on
epistasis analysis results (Kinchen et al., 2005). However, the same
type of analysis, performed both previously (Mangahas and Zhou,
2005; Yu et al., 2006) and here, indicates that not only do CED-1,
CED-6, CED-7 and DYN-1 act in parallel to CED-10, CED-2, CED-
5 and CED-12, but CHC-1 and EPN-1 also belong to the CED-1, but
not the CED-10, pathway (Fig. 9A). Furthermore, the transient
enrichment of EPN-1 and CHC-1 to phagocytic cups is independent
of CED-5, CED-12 or CED-10. These results indicate that the CED-
1-EPN-1-clathrin pathway regulates actin remodeling in a Rac
GTPase-independent manner (Fig. 9B). Identifying the candidate
protein(s) that links the CED-1 pathway to actin remodeling will
further reveal this Rac-independent mechanism.
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Fig. 9. CHC-1 and EPN-1 promote actin polymerization in response to CED-1 signaling. (A) Two parallel pathways that regulate apoptotic-cell
engulfment. The mammalian homologs of C. elegans proteins are indicated in parentheses. (B) Model depicting how CHC-1 and EPN-1 regulate cytoskeleton
polymerization and promote pseudopod extension. In response to the ‘eat me’ signal, CED-1 initiates a signaling pathway that recruits EPN-1 to the plasma
membrane at the site of engulfment through PtdIns(4,5)P2 and perhaps direct interaction. EPN-1 further recruits CHC-1 to the same site. CHC-1 oligomerizes











Figure 1-10. Phago ytosis of C. el gans apoptotic corpses. 
(a) In C. elegans, two parallel pathways mediate the e gulfme t of poptotic corpses. 
C. elegans proteins in black, and mammalian homologs in blue. (b) Actin (green) is 
polymerized in the engulfing cell to extend pseudopods around the corpse, mediated by 
clathrin and unknown coupling proteins. “Eat-me” signals, such as phosphatidyl serine 
are exposed o  the dyi g cell. Adapted from [168].
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(Figure 1-10a). Genes from these two pathways have also been implicated 
in axon pruning and the diurnal renewal of photoreceptor cells, among other 
processes [166,167].
In WT embryos, engulfment, which begins with the budding of pseudopods 
and ends when the phagocytic cup closes completely, takes on average 7 min [168]. 
Pseudopod extension around embryonic apoptotic corpses relies in part on the 
C. elegans clathrin gene (chc-1) and epsin (epn-1), which is able to induce membrane 
curvature [168] (Figure 1-10a,b). Both genes act downstream of the ced-1 pathway, 
along with the dynamin dyn-1 [149,168].
Many of the genes identified in C. elegans have functional homologs in 
both Drosophila and vertebrates [169-171]. In these other organisms, professional 
phagocytes exist alongside ‘amateur’ phagocytes. For example, in Drosophila, 
macrophage-like plasmatocytes migrate freely within the embryo to engulf foreign 
particles and dying cells [172]. The CD36-like receptor Croquemort is required in 
Drosophila for the engulfment of apoptotic corpses but not bacteria, suggesting that 
different receptors are required for different particles [152].
1.6.2. Degradation of apoptotic corpses
Once a dying corpse is internalized by a neighboring cell or professional 
phagocyte, its compartment is progressively acidified and recycled (Figure 1-11). 
Degradation of a refractile apoptotic embryonic corpse in C. elegans takes 
approximately 40-50 min in wild-type animals [149,173,174]. 
After internalization, a series of membrane composition changes and changes 
in associated proteins results in the progressive acidification of the phagosome and 
eventual degradation of the corpse in C. elegans embryos. Initially, phosphatidylinositol 
3-phosphate (PI3P) is produced on nascent phagosomes by the PI3-kinases piki-1 and 
vps-34 in C. elegans [175]. PI3P is loaded onto the phagosome in a wavelike fashion, 
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which requires the PI3-phosphatase MTM-1 [175]. This allows the recruitment of FYVE-
domain containing proteins such as the sorting nexins SNX-1, SNX-6 and LST-4/SNX-9 
[176]. Mutations in these genes lead to an excess of engulfed but undegraded apoptotic 
corpses. 
Next, early endosomes marked by the small GTPase RAB-5 are recruited and 
fuse to the nascent phagosome [147]. These RAB-5-positive endosomes are recruited 
immediately after phagosome sealing in C. elegans, likely by DYN-1 [147,174]. RAB-5 
to RAB-7 conversion by SAND-1 and CCZ-1 allows the fusion of late endosomes and 
Figure 8.2.
Events occurring during phagosome maturation. The lumen of nascent phagosomes mimics
the extracellular environment and has a neutral pH value. Multiple molecules, such as the
lipid second messenger PtdIns(3)P and small GTPases Rab5 and Rab7, are produced/
recruited on the surface of phagosomes at different stages, driving the stepwise phagosome
maturation process. During phagosome maturation, nascent phagosomes sequentially fuse
with early endosomes, late endosomes, and lysosomes, forming early phagosomes, late
phagosomes, and phagolysosomes, respectively, and gradually acquire the membrane and
luminal properties of these organelles, including a variety of hydrolases. The phagosomal
lumen is continuously acidified owing to the activity of the V-ATPase, until reaching below
5.0, under which the hydrolysas are fully activated and result in the degradation of
phagocytic cargos.
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Figure 1-11. Degradation of internalized apoptotic corpse. 
After an apoptotic corpse is phagocytosed, phosphatidylinositol 4,5-bisphophate 
(PtdIns(4,5)P2) is emoved from the nascent hagosome and replac d wit  
phosphatidylinositol 3-phosphate (PtdIns(3)P). Next, RAB-5-positive early endosomes 
are recruited and fused to the early phagosome. RAB-7-positive late endosomes are 
recruited and fused to the late phagosome, and ventually lysosome  are recruited and 
fused to form the phagolysosome. These membrane compartment fusions acidify the 
phagolysosome, eventually degrading the apoptotic corpse. Adapted from [253].
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eventually lysosomes to the corpse-containing phagosome [148,177]. RAB-7 may 
function downstream at the lysosome-phagosome fusion step, and remains on the 
phagosomal membrane until the corpse is completely degraded [149,150].
RAB-2 promotes the fusion of lysosomes to the phagosome, and also plays a 
separate role in acidification of the phagosome lumen [149,151]. RAB-14 plays similar 
roles to RAB-2, and the two proteins likely function in partially redundant pathways for 
recruiting and tethering lysosomes to phagosomes [150,151]. Proteomic approaches 
in cell culture have revealed more than a dozen Rabs associated with the phagosome, 
suggesting that other, yet-to-be identified, RAB proteins are also involved [178,179].
In mammalian systems, most of the studies of phagosome maturation in 
macrophages have focused on the internalization of opsonized latex beads or bacteria, 
and many of the genes and pathways discussed above are conserved in these 
processes [179]. The core molecules are the same, with roles for PI3-kinase, Rab5 and 
Rab7 well-established [180]. There is reason to suspect that the process and dynamics 
of apoptotic corpse engulfment differs from engulfment of foreign objects, however, 
especially since engulfment and degradation of cells dying by apoptosis does not elicit 
an immune response [181]. 
1.6.3. Engulfment and degradation of non-apoptotic corpses
While the molecular and genetic characterization of some non-apoptotic cell 
death processes has advanced considerably, whether common clearance mechanisms 
are used for apoptotic and non-apoptotic dying cells remains a major open question. It 
has been shown that apoptotic engulfment genes in C. elegans are not responsible for 
engulfment of the linker cell corpse [82], but whether these and other genes function in 
linker cell corpse degradation is unknown. The genes responsible for both the death and 
degradation of the linker cell are the basis of my thesis.
I was interested in how the polyglutamine protein PQN-41C induces cell death, 
30
so I investigated the function PQN-41C by determining the role of its interacting 
partners, which is discussed in Chapter 2. To identify genes necessary for death and 
degradation, I carried out a forward genetic screen and identified the protein networks 
for two small GTPases, and their role in phagosome maturation; these results comprise 
the bulk of my thesis and are discussed in Chapter 3. Lastly, I found that the caspase 
CED-3 has an unknown and surprising role in linker cell corpse degradation, but not 
death, which is discussed in Chapter 4. In Chapter 5, I synthesize these results and 
place them into a broader context of non-apoptotic cell death and degradation, and I 
speculate on how these processes may be conserved in mammalian systems.
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2. PQN-41C interacts with an inhibitor of linker cell death, HPK-1
2.1. Summary
PQN-41C is a polyglutamine protein required for efficient linker cell death. 
PQN-41C is comprised almost entirely of coiled coil domains [87], which can act as 
protein binding platforms [182]. To determine additional binding partners of PQN-41C, 
I carried out a protein interaction screen using a yeast two-hybrid system against a C. 
elegans cDNA library. I recovered 33 possible interacting partners, and I performed 
RNAi against each of these genes to identify putative roles in linker cell death. I focused 
on hpk-1, a gene encoding a homeodomain protein kinase, which appears to function 
as an inhibitor of linker cell death. I performed epistasis experiments with known linker 
cell death genes and found that loss of hpk-1 suppressed the linker cell survival defects 
of known regulators. However, hpk-1 did not suppress defects in hsf-1(lf), suggesting 
that HPK-1 acts upstream or in parallel to HSF-1. Subsequent analysis revealed that 
HSF-1-GFP fails to form stress granules upon heat shock in the absence of hpk-1. 
Additionally, the heat-shock-related linker cell survival defect is suppressed in the 
absence of hpk-1. Together, these results suggest that HPK-1 promotes the heat shock 
function of HSF-1, and inhibition of HPK-1 is required for efficient cell death, which may 
be regulated through PQN-41C.
2.2. PQN-41C interacts with proteins of different functions
Previous work in the lab suggested that the long isoforms of PQN-41, A and B, 
promote cell survival, while the shorter isoform PQN-41C promotes cell demise [87]. 
All of these isoforms share a polyglutamine repeat region, while the A and B isoforms 
have long N-terminal tails with coiled-coil domains [87]. Both coiled-coil domains and 
polyglutamine repeats are thought to act as protein binding platforms [183], raising the 
possibility that the distinct interactomes of each of these PQN-41 isoforms may confer 
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their opposing functions. To try and determine these interactomes, I attempted a yeast 
two-hybrid screen using each of these isoforms as bait, but I failed to see expression 
of LexA-PQN-41A or LexA-PQN-41B (Figure 2-1a). I did see expression of LexA-
PQN-41C, which did not autoactivate under His-Leu-Trp-Ade- conditions (Figure 2-1b), 
so I decided to continue screening using PQN-41C only. 
Using a C. elegans cDNA library from L4 hermaphrodites, I transformed 
9.3x106 colonies, and I recovered 71 candidate clones over a 9-day screening period 
(Table 2-1). These clones represent 38 genes, with gene ontology classifications of 
proteolysis, PQN-domain, ubiquitin-related, DNA-related, and RNA-related, among 
others (Table 2-1). 





























Figure 2-1. Controls for PQN-41C yeast two hybrid screen. 
(a) Total protein from yeast cells expressing LexA-PQN-41B, LexA-PQN-41C, or 
LexA-p53 (positive control) was extracted and probed with an anti-LexA antibody to 
determine protein expression levels. (b) Yeast expressing p53 and large T antigen 
(positive control) or PQN-41C and empty vector (ev) were tested for interaction or self-
activation, respectively, on minimal media plates.
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Table 2-1.  List of PQN-41C interacting proteins and their surviving linker cell 
phenotype upon knockdown. 
Gene No. of Y2H hits Function
RNAi phenotype 
(N) Notes
empty vector 3% (137)
asp-3 1 Proteolysis 6% (95) 1
F32A5.3 1 Proteolysis 4% (91)
K10C2.1 2 Proteolysis 6% (100) 1
F57F5.1 1 Proteolysis n.d. (arrest)
nep-17c 1 Proteolysis 8% (130) 1
pqn-41 2 Coil-coiled domain 18% (96)*** 1
npp-4 2 Coil-coiled domain 11% (127)* 1




pqn-59 9 Coil-coiled domain/ proteolysis 10% (81)
H34I24.3 1 Coil-coiled domain 6% (88)
pqn-85 1 Coil-coiled domain/DNA-related 18% (82)** 2
tag-214 1 Ubiquitin-related n.d. (slow growth)
F52G3.1 1 Ubiquitin-related 6% (82)
sao-1 1 Ubiquitin-related 11% (158)*




asd-1 1 RNA-related 3% (97)
asd-2 2 RNA-related 2% (118) 1
pes-4 1 RNA-related 10% (94)*
chd-7 2 DNA-related 14% (119)* 1
zfp-1 1 DNA-related 16% (101)**
tag-153 7 DNA-related 10% (167)* 2
eef-2a 1 DNA-related n.d. (arrest)
T19D12.2 1 DNA-related 5% (76) a/c isoforms; 1
aco-2 1 33% (79)*** a/c isoforms
aldo-2a 1 15% (95)*
meg-1/2 3 7% (150) 1
M02E1.1a 2 Unknown function 3% (104) 1
hpk-1 4 kinase 0.7% (136)
C18E3.9 1 Unknown function 4% (74)
clec-49/50 1 lectin 3% (144) 1
F57F4.4 1 7% (160) 1
gdi-1a 1 8% (150) 1
yars-1 1 tRNA synthetase 4% (134)
vit-4 1 Yolk protein Didn’t assay
vit-3 1 Yolk protein Didn’t assay
vit-6 1 Yolk protein Didn’t assay
1. cloned targeting region into L4440 from Y2H (Ahringer clone incorrect or non-
existent). 2. cloned from cDNA library (Ahringer clone incorrect or non-existent). 
**: P<0.0001, **: p<0.001, *: p<0.05, Fishers exact test. RNAi clones obtained 
from [243] unless otherwise noted. Strain contains rrf-3 mutation for increased RNAi-
senstivity, him-5 for males, and a GFP linker cell marker.
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two-hybrid screen (Table 2-1), so I tested the other two isoforms for interaction. I found 
that PQN-41A-LexA interacts with PQN-41B and PQN-41C, and that PQN-41C indeed 
interacts with itself (Figure 2-2). This preliminary result suggests that perhaps PQN-41C 
forms dimers or oligomers to drive its cell death function.
2.2.1. Knockdown of some potential interacting partners causes a linker 
cell survival defect
I knocked down each of the candidate interacting partners in an RNAi-sensitized 
background (Table 2-1). Seven genes gave a significant number of surviving linker cells 
upon knockdown, and one gene appeared to accelerate linker cell death or degradation. 



































Figure 2-2. PQN-41C interacts with itself. 
Interactions between the PQN-41 isoforms were tested using a yeast two-hybrid 
assay. LexA-tagged components listed above the interaction spot, and GAD-tagged 
components listed below the interaction spot. LexA was located N-terminally unless 
otherwise noted (labeled as (c)). Left panel shows effect of transformed proteins on 
yeast growth, and right panel shows growth on minimal media, indicating physical 
interaction. p53 + large T antigen included as a positive control.
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These candidates were investigated further and are discussed below.
2.2.1.1. aco-2
Knockdown of the mitochondrial aconitase aco-2 increased the number of 
surviving linker cells (SLCs) to 33% (Table 2-1). In these animals, the linker cell often 
detached from the gonad, so that the gonad itself never completely migrated to the 
tail of the animal (Figure 2-3). The linker cell failed to migrate completely in 18% of 
the animals (N=8/45). The spermatids were also defective, with 98% of spermatids 
appearing to have excessive vacuolization (N=44/45, Figure 2-3). Knockdown of aco-2 
in a pqn-41(ns294) background was additive, suggesting these genes function in the 





Linker cell detaches 




Figure 2-3. Knockdown of aco-2 leads to incompletely migrated gonads and 
vacuolated spermatids. 
L1 synchronized RNAi-sensitized animals were fed bacteria expressing double-
stranded aco-2 RNA. Males were scored 2h after the L4 to adult transition. Image is a 
representative example. Strain contained rrf-3(pk1426) II; him-8(e1489) IV; qIs56 V.
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specifically in the linker cell resulted in a significant increase of SLCs (Table 2-3). The 
migration defect appears to be cell non-autonomous, however (Table 2-3). I obtained 
a temperature sensitive allele or1565ts from Bruce Bowerman’s lab, but these animals 
failed to grow after hatching at 25oC. A more sensitive time course should be developed, 
perhaps shifting to 25oC prior to the commitment to cell death at the L3 or early L4 larval 
stage.
2.2.1.2. zfp-1
Knockdown of the zinc finger protein zfp-1 resulted in 16% SLCs (Table 2-1). I 
obtained a deletion allele of zfp-1, ok554, which skips exons 6 and 7; these exons do 
not include the zinc finger domain or the PQN-41 interacting region, so ok554 may be a 
hypomorphic allele, as confirmed by a weaker SLC defect in these animals (Table 2-4). 
zfp-1 appears to function cell autonomously in linker cell death, as knockdown 
specifically in the linker cell caused a significant increase in the number of SLCs, 
although there was also an increased number of migration defective cells (Table 2-3).
 To determine its genetic interaction with pqn-41, I knocked down zfp-1 in RNAi-
sensitized pqn-41(ns294) animals. Interestingly, the two genes appear to function 
synergistically, together having a defect of 44% surviving linker cells (Table 2-2). 
Table 2-2.  zfp-1 acts synergistically with pqn-41. 
Gene %Surviving linker cells (N) Predicted if additive
empty vector 25% (107)
aco-2 50% (102) 50%
pqn-85 39% (83) 39%
zfp-1 44% (62)* 37%
aldo-2 22% (49) 36%
chd-7 29% (56) 36%
tag-153 12% (42) 33%
* = results indicate synergy. Strains contain pqn-41(ns294), him-5(e1490) for
males and qIs56 linker cell marker.  Animals were scored 0-2h after the L4 to 
adult transition.
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Animals doubly mutated for zfp-1(ok554) and pqn-41(ns294) together developed slowly, 
and had incomplete male tail development. This developmental defect precluded me 
from scoring the SLC phenotype effectively in this background. However, this result 
suggests these genes function together in similar processes during development, as 
well as in LCD.
2.2.1.3. pqn-85
Knockdown of the NIPBL ortholog pqn-85 in an RNAi-sensitized background 
resulted in 18% SLCs (Table 2-1). Decreasing pqn-85 levels in pqn-41(n294); rrf-3 
animals caused an additive increase of SLCs (Table 2-2). Knockdown of this gene 
in a wild-type background, however, only had a 13% SLC defect, and knockdown 
only in the linker cell had no significant increase in the defect compared to empty 
vector control (Table 2-3). I obtained two alleles of pqn-85, tm2338 and tm2334/+. 
Table 2-3.  aco-2, zfp-1, eef-2, and tag-214 function cell autonomously. 
n.d. = not determined, let = lethal, e.v. = empty vector; * p<0.5, Fishers exact test, 
Strains contain rde-1(ne219) for abrogation of systemic RNAi, nsIs387 for RNAi in 
the linker cell only, him-8(e1489) for males, and qIs56 as a linker cell marker. Animals 
were scored 0-2h after the L4 to adult transition. Knockdown of genes in a wild-type 
background (not RNAi-sensitized, no rde-1 mutation) included as reference.





e.v. 3% (157) 11% (47) 0
aco-2 21% (43)* 20% (91)* 1%
pqn-85 13% (53)* 9% (114) 2%
zfp-1 13% (46)* 23% (47)* 9%
aldo-2 8% (51) n.d. n.d.
chd-7 4% (46) 11% (55) 2%
tag-153 n.d. 3% (40) 0
hpk-1 n.d. 5% (70) 0
eef-2 let 20% (54)* n.d.
F57F5.1 let 7% (119) n.d.
tag-214 slow growth 18% (56)* n.d.
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Unfortunately, tm2338 did not have the annotated mutation, and tm2334 animals were 
inviable as homozygous animals. Therefore, I was unable to adequately follow up on 
this gene.
2.2.1.4. chd-7
chd-7 encodes a chromodomain helicase, homologous to mammalian CHD8. 
Mutations in CHD8 are a risk factor for autism [184]. Knockdown of chd-7 in an RNAi-
sensitized background resulted in a 14% surviving linker cell (SLC) defect. I obtained 
four alleles of chd-7, all of which resulted in in-frame deletions of various parts of the 
protein (Table 2-4). The defects ranged from 2% SLC to 12% SLC, but all alleles were 
unlikely to be true null alleles, based on predicted protein translation. Unfortunately, 
knockdown of chd-7 in a wild-type RNAi background or in the linker cell specifically 
did not increase the number of SLCs compared to WT (Table 2-3), suggesting that the 
original RNAi phenotype may have been a false positive. 
To determine if an odd genetic interaction was occurring between chd-7 and 
Table 2-4.  Genetic mutants of Y2H hits do not recapitulate their RNAi phenotype 
in most cases. 
Genotype %SLC (N) Notes
Wild type 3% (157)
zfp-1(ok554) 11% (47) Weak allele; skips exon 6 and 7 which do not include ZnF or interacting region
chd-7(tm6138) 4% (53) In frame deletion of exon 3
chd-7(tm6139) 2% (49) In frame deletion
chd-7(gk290) 12% (50) In frame deletion at C term
chd-7(gk306) 5% (38) In frame deletion at C term
tag-153(ok699) 4% (26) Strong LOF (out of frame deletion)
aco-2(or1565ts)^ n.d. Temp. sensitive allele
hpk-1(pk1393) 6% (87) Putative null
^obtained from Bruce Bowerman; n.d. = not determined. Animals were scored 0-2h after 
the L4 to adult transition. Strains also contain either him-5(e1490) or him-8(e1489) for 
males, and qIs56 or nsIs65 linker cell marker.
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rrf-3, the gene that confers RNAi sensitivity when mutated, I crossed chd-7(gk290) 
and chd-7(gk306) to rrf-3(pk1426), and found that the double mutants had a significant 
number of SLC compared to the chd-7 mutants alone (chd-7(gk290); rrf-3(pk1426): 17% 
(N=46); chd-7(gk306); rrf-3(pk1426): 14% (N=58)). This result suggests that there may 
be an unknown genetic interaction between chd-7 and rrf-3 that is somehow influencing 
linker cell survival. Knocking down chd-7 in a pqn-41(ns294); rrf-3 background did not 
significantly increase the number of SLCs compared to each gene alone (Table 2-2).
2.2.1.5. tag-153
tag-153 encodes a NOT-domain-containing protein, which is typically found 
in negative regulators of transcription [185]. It is homologous to CNOT2 in humans. 
Knockdown of tag-153 in an RNAi-sensitized background resulted in a weak phenotype 
of 10% SLC (Table 2-1). I obtained a strong loss-of-function allele, ok699, which 
encodes a large deletion that results in an out-of-frame coding sequence. This allele 
did not recapitulate the RNAi phenotype, however, and had a SLC defect similar to 
wild type (Table 2-4). Intriguingly, linker-cell-specific knockdown of tag-153 resulted 
in a decreased number of SLC compared to the empty vector control (Table 2-3); 
knockdown of tag-153 in pqn-41(ns294); rrf-3 animals also decreased the number of 
surviving cells by half (Table 2-2). 
2.2.1.6. aldo-2
aldo-2 encodes an aldolase, a glycolytic enzyme. Knockdown in an RNAi 
sensitized background resulted in a 15% SLC defect, but only 8% when knocked 
down in an otherwise wild type background (Tables 2-1, 2-3). Knockdown of aldo-2 in 
pqn-41(ns294); rrf-3 animals did not enhance the pqn-41 phenotype (Table 2-2). aldo-2 
is expressed in many cells in the animal, although I did not see expression within the 
linker cell specifically.
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2.2.1.7. Knockdown of tag-214, F57F5.1, and eef-2 resulted in slow growth 
or larval lethality
Knockdown of tag-214, a gene encoding an E3 ubiquitin ligase similar to RBBP6, 
F57F5.1, a gene encoding an ortholog of cathepsin B, or eef-2, a gene encoding 
the translation elongation factor EF-2, resulted in either larval lethality or slow larval 
development (Table 2-1). Because of this, I was unable to determine the effect on linker 
cell death using whole animal knockdown experiments. Therefore, I knocked down 
each of these genes in a linker-cell-specific manner, and I found that both eef-2 and 
tag-214 had a significant number of surviving cells when knocked down in the inker 
cell (Table 2-3).
2.2.2. Knockdown of some potential interacting partners reduces the 
number of aberrantly surviving cells
Knockdown of two genes, asd-2, which encodes an RNA binding protein similar 
to mammalian QKI, and hpk-1, which encodes a homeodomain protein kinase similar to 
HIPK1/2 in vertebrates, did not have a SLC defect (Table 2-1). Instead, knockdown of 
these genes resulted in a decreased number of dead or dying linker cells, suggesting 
that these genes may be inhibitors of cell death (asd-2: 42% remaining corpses, 
p=0.0011 compared to WT; hpk-1: 17% remaining corpses, p<0.0001 compared to WT, 
Fishers exact test). Because of the weaker phenotype of asd-2, I decided to focus on 
the role of hpk-1 in linker cell death first.
2.3. PQN-41C interacts with the homeodomain protein kinase, HPK-1, an 
inhibitor of linker cell death 
I recovered four independent yeast two-hybrid colonies of hpk-1, with the 
interacting region near the Ser/Thr kinase domain (Figure 2-4). A literature search of 
hpk-1 homologs revealed a putative interaction with the heat shock factor HSF-1, a 
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known linker cell death gene (see Discussion). Therefore, I wanted to determine how 
hpk-1 is involved in linker cell death, as well as its interactions with known linker cell 
death genes, including HSF-1. 
2.3.1. Knockdown of hpk-1 decreases the number of surviving cells
As mentioned above, knockdown of hpk-1 in an RNAi-sensitized background 
decreased the number of SLCs and remaining corpses 2h after the L4 to adult transition 
compared to WT (Table 2-1). Knockdown specifically in the linker cell also caused 
a decrease in the number of surviving cells, compared to the empty vector control 
(Table 2-3). I obtained a putative null of hpk-1, pk1393, which deletes the majority of the 
kinase domain (Figure 2-4). This allele had a similar number of SLCs compared to WT 
(Table 2-4), and was used for further genetic interaction studies.
2.3.2. Knockdown of hpk-1 suppresses the linker cell death defects of 
regulatory genes required for LCD










Figure 2-4. Genetic information for hpk-1. 
hpk-1 has three isoforms, all of which contain a Ser/Thr kinase region. Shown is the 
location of the Y2H interacting fragment (green), the location of the RNAi targeting 
construct (purple), and the out-of-frame deletion caused by pk1393 (yellow).
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I knocked down hpk-1 in strains where those genes were mutated. Knockdown of hpk-1 
in pqn-41(ns294); rrf-3 animals resulted in half the number of SLCs compared to pqn-
41 alone (Figure 2-5). Similar results were seen with the upstream activator of pqn-41, 
sek-1(ag1) animals, and in the Wnt egl-20(n585) (Figure 2-5). 
Next, I wanted to verify these results using genetic double mutants. Because 
hpk-1 and other cell death genes result in male infertility [82,185], I used artificial 
insemination to generate these strains (see Methods). pqn-41(ns294); hpk-1(pk1393) 
double mutants only had a slight decrease in SLCs compared to pqn-41(ns294) alone 
(Table 2-5). This difference in phenotypes between the genetic mutants and the RNAi 















































Figure 2-5. Knockdown of hpk-1 suppresses the surviving linker cell defects of 
known linker cell death regulators. 
Linker cell survival in indicated genotypes. Animals scored 0-2 h after the L4 to adult 
transition. Strains contain lag-2p::GFP linker cell reporter and him-5(e1490). Number of 
animals scored inside bars. Error bars, standard error of the proportion. n.s., p>0.05,  
*, p<0.05, Fisher’s exact test.
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pqn-41. 
Despite multiple attempts, I was unable to generate double sek-1(ag1) 
hpk-1(pk1393) animals, suggesting that these genes are synthetically lethal. Double egl-
20(n585); hpk-1(pk1393) animals recapitulated the RNAi phenotype, with loss of hpk-1 
suppressing the egl-20 phenotype by half (Table 2-5). I also examined bar-1(ga80) 
hpk-1(pk1393) animals and found that hpk-1 enhanced the bar-1 defect to almost 
100% (Table 2-5). Oddly, application of RNAi in bar-1(ga80) animals also enhanced the 
SLC defect (91% SLCs in empty vector RNAi (N=55) compared to 56% SLCs with no 
RNAi application (N=41)), suggesting that lacking bar-1 and undergoing a stress-related 
event at the same time may affect linker cell death.
Knocking down hpk-1 by RNAi did not suppress defects in hsf-1(sy441) or 
let-70(ns770), however, suggesting HPK-1 functions upstream or in parallel to HSF-
1 (Figure 2-5, [187]). Double hsf-1(sy441); hpk-1(pk1393) genetic mutants were 
indistinguishable from hsf-1(sy441) animals as well (Table 2-5). 
2.4. HPK-1 acts upstream or in parallel to HSF-1
The epistasis data between hpk-1 and known linker cell death genes suggested 
that hpk-1 acts upstream or in parallel to hsf-1. Therefore, I investigated the relationship 
Table 2-5.  hpk-1(pk1393) suppresses defects of some linker cell regulatory genes. 
Genotype %SLC (N)
pqn-41(ns294) 20% (44)
pqn-41(ns294); hpk-1(pk1393) 16% (77)
egl-20(n585) 50% (46)
egl-20(n585); hpk-1(pk1393) 24% (90)
bar-1(ga80) 56% (41)
bar-1(ga80) hpk-1(pk1393) 92% (76)
hsf-1(sy441) 25% (49)
hsf-1(sy441); hpk-1(pk1393) 20% (41)
Animals were scored 0-2h after the L4 to adult transition. Strains also contain 
him-5(e1490) for males, and qIs56 linker cell marker.
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between HPK-1 and HSF-1 further with Mohammad Alam, a rotation student at the time. 
2.4.1.  HSF-1 fails to form heat shock granules in the absence of hpk-1
In yeast, the HPK-1 homolog Yak1 phosphorylates Hsf1 to enhance its DNA 
binding activities [188]. We wanted to determine if something similar was occurring in 
C. elegans, so we examined the formation of HSF-1-GFP granules upon heat shock, 
which can be used as a proxy for DNA binding [189]. We found that these granules 
failed to form in hpk-1(pk1393) animals after an 8 min heat shock at 35oC, suggesting 
that HPK-1 is required for HSF-1 granule formation (Figure 2-6).
2.4.2. The linker cell dies appropriately after heat shock in the absence of 
hpk-1
Because of the dual role that HSF-1 plays in both cell survival and cell death, 
linker cell death is sensitive to changes in temperature and stress events immediately 
WT hpk-1(pk1393)
Figure 2-6. HPK-1 is required for HSF-1 granule formation after heat shock.
HSF-1-GFP granule formation was examined in wild-type (left) and hpk-1(pk1393) 
(right) animals. Animals were heat shocked for 8 min at 35oC and examined immediately 
after for formation of nuclear puncta. Inset shows increased magnification of boxed 
nucleus.
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prior to cell death onset [85]. In wild-type animals, a brief heat shock 4h prior to LCD 
resulted in a 13% surviving linker cell defect (N=61), in support of previously published 
results [85]. In hpk-1(pk1393) animals, however, the linker cell dies appropriately after 
heat shock (6% SLC, N=120). This result suggests that HPK-1 is required to drive the 
heat shock response of HSF-1, and its absence allows HSF-1 to carry out its pro-death 
function, even when the heat shock response has been activated.
2.5. Discussion
From a protein interaction screen, I recovered 33 putative interactors of 
PQN-41C. pqn-41 is expressed in many cells within the animal [87]. Therefore, these 
proteins could be interacting with PQN-41C in the linker cell, or in non-death-related 
functions of PQN-41C, such as egg laying (Andrew Schwendeman, unpubl. data). To 
determine which genes function to linker cell death, I knocked down each of the putative 
interacting proteins in an RNAi-sensitized background. I found that knockdown of ten 
of these genes had a significant number of surviving linker cells. Additionally, two of the 
candidate genes caused a decrease in the number of surviving cells and cell corpses 
upon knockdown. 
One immediate question that comes to mind is why were these ten genes 
not recovered from the genome-wide RNAi screen carried out by Elyse Blum and 
Mary Abraham? For five of these genes, the answer is simple: they were either 
misrepresented or missing from the original RNAi screening library. I generated these 
RNAi clones myself. Another possibility is that because the original RNAi screen was 
carried out under the dissecting scope without a close watch on time, some of the 
weaker candidate genes were missed. My subsequent screen was performed under 
high magnification, exactly 2h after the L4 to adult transition. This step is crucial for 
detecting genes with weak phenotypes (<20% surviving linker cells). Lastly, some of the 
genes I recovered could also be false positives, as some of the genetic mutants I tested 
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do not phenocopy the RNAi data.
As a next level of stringency, I wanted to test which of the ten genes I isolated 
functioned cell-autonomously. I integrated an extrachromosomal array carrying 
mig-24p::rde-1 in an rde-1(ne219) background to examine linker cell specificity. This 
strain also allowed me to examine the linker-cell-specific defects of the three genes that 
caused lethality upon RNAi. This next round of screening revealed that aco-2, zfp-1, 
eef-2, and tag-214 function cell autonomously. tag-214 is a particularly intriguing result, 
as it encodes an E3 ubiquitin ligase, and may be an interesting gene to follow up on in 
the future.
From these different tests, I isolated a few candidate genes that may be worthy 
of future study. The aconitase, aco-2, is responsible for the 2-step dehydration/
hydration reaction that converts citrate to isocitrate in the Krebs cycle [190]. The human 
homolog, ACON2, is implicated in human prostate cancer and neurodegenerative 
disorders, and downregulation is observed in Huntington’s mouse models and patients 
[191,192]. Knockdown of aco-2 caused the largest surviving linker cell defect of all the 
genes tested; these animals also had an interesting phenotype where the linker cell 
would detach from the gonad and continue migrating on its own. A major question that 
remains is whether the defect in aco-2 is caused by a general defect in metabolism or 
is more specific to linker cell death. While initially I considered that not having enough 
ATP would be a reason for a cell to die, it is likely that linker cell death is an energy-
dependent process. Perhaps linker cell death cannot be carried out without energy, and 
perhaps a cell dying from energetic failure would adopt a different morphology. Further 
study into the function of metabolism on linker cell death is likely warranted.
Another interesting gene I identified is zfp-1. zfp-1 encodes a protein homologous 
to human AF10, implicated in leukemia as a result of translocation with MLL [193]. 
ZFP-1 contains leucine zippers, zinc fingers, and PHD/LAP domain. In C. elegans, zfp-1 
has been implicated as a common mediator of lifespan regulation through the insulin-
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signaling pathway and after dietary restriction [194]. In linker cell death, zfp-1 had a 
weak defect upon knockdown, but zfp-1 synergistically enhanced the pqn-41(ns294) 
defect. Since pqn-41(ns294) is not a complete null, it would be prudent to test whether 
we also see enhancement in the newly generated pqn-41(ns807) allele, which removes 
the entire 34 kb locus. 
zfp-1(ok554) appeared to be a hypomorphic allele with respect to its linker 
cell defect. When I generated the genetic double mutant between zfp-1(ok554) and 
pqn-41(ns294), however, these animals had extreme developmental defects, including 
defects in egg laying and tail development. The defect in tail development was so 
severe that it precluded me from easily scoring the linker cell death phenotype. These 
phenotypes suggest that zfp-1 and pqn-41 may be working in other parallel in other 
cellular contexts as well.
I recovered two other proteins with polyglutamine (PQN) domains, pqn-85, a 
gene implicated in DNA repair, and pqn-59, which is similar to the ubiquitin-associated 
protein UBAP2. Both of these genes had weak RNAi phenotypes, but it may be 
interesting to create a triple mutant between the three PQN genes to determine 
how they influence each other. I find it intriguing that we have three putative genes 
implicated in linker cell death that all contain polyglutamine repeats, especially given the 
prevalence of these genes in neurodegenerative disorders.
The negative regulator of transcription, TAG-153, had a weak surviving linker cell 
defect upon knockdown by RNAi. The loss-of-function allele, ok699, had no appreciable 
defect, however. Interestingly, knocking down tag-153 in a pqn-41(ns294) background 
suppressed the pqn-41 defects by half. To determine how these genes work together, 
it would be prudent to create a double mutant allele between tag-153(ok699) and 
pqn-41(ns294) or pqn-41(ns807) to see whether this suppression also occurs in the 
genetic double mutants.
The best candidate I recovered and likely the gene that warrants the 
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most attention is the homeodomain protein kinase hpk-1. Knockdown of hpk-1 in 
pqn-41(ns294), egl-20(e585), and sek-1(ag1) animals suppressed their defects by 
half. This result suggests that hpk-1 may function as an inhibitor of linker cell death, 
downstream of these genes. hpk-1 RNAi in hsf-1(sy441) mutants did not affect the 
number of SLCs, suggesting that hpk-1 may function upstream or in parallel to hsf-1. 
Consistent with this, Jennifer Malin found that knockdown of hpk-1 in let-70(ns770) 
animals also does not affect the let-70(ns770) defect [187].
Yeast lacking the hpk-1 homolog, Yak1, have a reduced resistance to heat 
stress [195]. Yak1 phosphorylates Hsf1 in vitro, which enhances its DNA binding 
ability [188]. These results support our finding that HSF-1-GFP fails to form stress 
granules after heat shock when HPK-1 is missing. It should be noted that the result we 
obtained is the opposite reported by [196], although they used knockdown of hpk-1 by 
RNAi rather than a genetic mutant to examine this function.
HSF-1 in the linker cell can function in either a pro-survival, stress-related role 
or a pro-death role [85]. The pro-death role of HSF-1 competes with its pro-survival 
role at the start of linker cell death, likely through post-translational modifications. In 
mammalian systems, sumoylation of HSF-1 inhibits its transcriptional activity [197], and 
in C. elegans, HPK-1 antagonizes sumoylation of HSF-1 in order to positively modulate 
its heat shock response [197]. One hypothesis we had from these results is that 
because sumoylation of HSF-1 negatively affects its transcription of heat-shock-related 
genes, then perhaps sumo-HSF-1 could have a distinct function in its cell death role. 
Additional experiments are needed to test this hypothesis.
In C. elegans, HPK-1 promotes the pro-survival, stress-related role of HSF-1 
during early larval stages [196,198], and perhaps likely also in the linker cell. In the 
absence of HPK-1, the pro-survival function of HSF-1 is weakened, pushing the 
system towards cell death. In fact, hpk-1(pk1393) animals are unable to mate, although 
their spermatids are fully functional. Perhaps in these animals the linker cell is dying 
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prematurely and affecting gonad fusion to the cloaca. This hypothesis could be easily 
tested in the long-term imaging device recently developed by Wolfgang Keil in our lab 
(see Chapter 3).
I first stumbled upon HPK-1 through a protein interaction screen of PQN-41C. 
Knockdown of hpk-1 by RNAi in a pqn-41 loss-of-function background suppressed the 
surviving linker cell defects in pqn-41 animals by half. When I made a double mutant 
between hpk-1(pk1393) and pqn-41(ns294), however, the suppression was weaker. To 
analyze these interactions further, it would be useful to determine if hpk-1(pk1393) is 
able to suppress the defects seen in the complete null of pqn-41. If our model is correct 
(Figure 2-7), knocking out hpk-1 in a complete null background of pqn-41 should reduce 
the defects of pqn-41. Additionally, because pqn-41 is a cold-sensitive protein, and 
hpk-1 plays a role in the heat shock response, it will be useful to determine how the 
double mutant behaves at 15oC and at 25oC.









Figure 2-7. Model for how PQN-41C, HPK-1, and HSF-1 function in linker cell 
death. 
PQN-41C acts upstream of HSF-1, likely promoting its cell death function. PQN-
41C interacts physically with HPK-1, perhaps inhibiting its pro-survival role of HSF-1 
modulation after stress conditions.
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binds HPK-1 at the onset of linker cell death, inhibiting its pro-survival function towards 
HSF-1 (Figure 2-7). One way to test this hypothesis is with an in vitro phosphorylation 
assay. Incubating HPK-1 and HSF-1 together with radioactive phosphate may result 
in some of the phospho-groups transferring to HSF-1. If we now add recombinant 
PQN-41C to this reaction, perhaps phosphate is no longer incorporated. Given that 
these proteins are relatively unstable, this hypothesis may be more difficult to test in 
actuality, but it would be a worthwhile experiment.
In addition to the interplay between PQN-41C, HSF-1, and HPK-1, I also 
observed some other interesting defects while trying to determine the function of hpk-1 
in linker cell death. hpk-1(pk1393); sek-1(ag1) double mutants were synthetically lethal, 
suggesting that these genes may function in parallel in vital cellular processes. I also 
found that bar-1(ga80) hpk-1(pk1393) double mutants have a SLC defect of nearly 
100%. bar-1(ga80) is not a complete null, making interpretation of this data difficult. In 
Xenopus and Drosophila, however, HIPK1 can repress or activate β-catenin targets, 
depending on the developmental context [199,200], suggesting that these genes 
function together in other cellular systems. One hypothesis I had about their function 
in the linker cell is that lacking both genes may alter the linker cell’s stress levels and 
promote the stress-related function of HSF-1, independent of HPK-1. For example, 
bar-1(ga80) animals fed empty vector control RNAi bacteria have linker cell defects of 
91%, compared to 56% in bar-1(ga80) animals under normal, non-RNAi conditions. This 
result suggests that bar-1 animals are ultrasensitive to perturbations in stress activation 
(simply activating the RNAi pathway in this background is enough to nearly inhibit linker 
cell death completely).
Another hypothesis is that HPK-1 phosphorylates BAR-1 and stabilizes it. In ga80 
mutants, this stabilization is crucial for mutated BAR-1 to maintain some of its protein 
levels and carry out partial wild-type function. In the absence of HPK-1, this stabilization 
is lost, and bar-1(ga80) hpk-1(pk1393) double mutants could represent total BAR-1 loss 
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with respect to its linker cell function. This hypothesis is derived from the fact that HIPK2 
stabilizes β-catenin homologs in Xenopus [200], Drosophila [199] and in vitro [199].
The interplay between PQN-41, HPK-1, HSF-1, and BAR-1 represents an 
exciting avenue of future research and may tell us more about the fine-tuning of linker 
cell death onset.
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3. RAB-35 and ARF-6 GTPases mediate engulfment and clearance
following linker cell-type death
3.1. Summary
Following death, the linker cell must be engulfed and degraded. Therefore it is a 
particularly attractive in vivo model for investigating the clearance of a cell that normally 
dies non-apoptotically: the time of linker cell death onset is predictable, the process can 
be followed in live animals, and engulfment events can be dissected genetically.
In this chapter, I show that engulfment and degradation of the linker cell 
differs in mechanics and genetics from apoptotic cell clearance. I demonstrate that, 
unlike apoptotic cell corpses, the linker cell is simultaneously engulfed by two U cell-
descendent phagocytes, resulting in cell splitting. Apoptotic engulfment genes are 
not required for this novel form of engulfment. Rather, I find that the GTPase RAB-35 
is a key coordinator of at least two steps in linker cell degradation. Early on, RAB-
35 localizes to extending phagocyte pseudopods, and prevents premature onset of 
phagocytosis. Once engulfment has occurred, RAB-35 drives degradation of the linker 
cell by promoting recruitment of RAB-5 and then RAB-7 GTPases onto phagosome 
membranes, and subsequent lysosomal fusion and degradation. I demonstrate that 
both activities of RAB-35 require inactivation of another conserved small GTPase, 
ARF-6, which I show functions as a clearance inhibitor. RAB-35 physically interacts 
with the ARF-6 GTPase activating protein CNT-1, providing a plausible mechanism for 
ARF-6 inhibition. Furthermore, while RAB-35 localizes to engulfing-cell and phagosome 
membranes during most of linker cell clearance, ARF-6 only transiently persists at the 
membrane, and its timely removal depends on RAB-35.
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3.2. Linker cell corpse clearance occurs by a novel mechanism
3.2.1. The dying linker cell is simultaneously engulfed by two neighboring 
cells
Linker cell death and clearance occurs during the transition from the fourth larval 
stage to the adult, and can take up to 8 hours to complete [82,201]. To examine this 
process at high spatiotemporal resolution, I used a long-term imaging microfluidic device 
that Wolfgang Keil, a postdoc in the lab, previously developed [198] to simultaneously 
image the linker cell (mig-24p::Venus) and the engulfing cells (lin-48p::mKate2) in live 
animals (Figure 3-1). Animals were loaded into the device, and z-stacks were acquired 
every 8 min for > 20h (Figure 3-1). Animal development and linker cell death kinetics 
were not affected by either imaging or fluorescent reporter identity (Figure 3-1b, Table 







Figure 3-1. Microfluidic device for long-term imaging of linker cell death. 
(a,b) C. elegans male immobilized in a microfluidic chamber (see [198]) at (a) first 
contact between linker cell (green) and engulfing U.l/rp cell (magenta, asterisk), and (b) 
after 10 hours. All males examined in all figures in Chapter 3 carry the male-producing 
him-5(e1490) or him-8(e1489) mutation. Scale bar, 100 μm.
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were noted, with time zero corresponding to the time of first contact between the linker 
cell and the U.lp or U.rp engulfing cells (Figure 3-2a), and are consistent with previous 
reports [82,201].
I found that after first contact, the linker cell migrates so that it becomes 
sandwiched between the U.lp and U.rp cells (Figure 3-2b), whose cell nuclei are 
displaced anterior to the linker cell. Linker cell nuclear crenellation also becomes 
apparent at this time (Figure 3-2c). Remarkably, following linker cell nuclear changes, 
both U.l/rp cells simultaneously attempt to engulf the linker cell (Figure 3-2d, 
Figure 3-3). During this process, which I term competitive phagocytosis, linker cell 
Table 3-1.  Reporter identity does not affect linker cell degradation 
(mean ± SE of proportion).
Genotype % linker cell corpses in 24h adults N
qIs56[LCp::GFP] 12 ± 3.2 100
nsIs65[LCp::Venus] 11 ± 3.1 100
nsIs60[LCp::Venus] 5 ± 2.1 103
arf-6(ns388); nsIs65 64 ± 4.8 101
rab-35(b1013); nsIs65 79 ± 4.0 102
nsIs589[UCp::mKate2]; nsIs65 5 ± 5.0 101
arf-6(ns388); nsIs589; nsIs65 57 ± 6.6 56
rab-35(b1013); nsIs589; nsIs65 54 ± 8.4 35
nsIs653[UCp::mKate2-PH]; nsIs65 1 ± 1.0 104
nsIs60; nsIs622[UCp::mCh-RAB-5] 0 100
nsIs592[UCp::mCh-RAB-7]; nsIs65 8 ± 2.8 91
nsIs586[UCp::CTNS-1-mKate2]; nsIs65 3 ± 1.7 101
nsIs650[LCp::mKate2] 4 ± 2.0 101
nsIs595[UCp::YFP-RAB-35]; nsIs650 2 ± 1.4 101
rab-35(b1013); nsIs595; nsIs650 1 ± 1.0 100
arf-6(tm1447); nsIs595; nsIs650 3 ± 1.7 101
nsIs625[UCp::ARF-6-YFP]; nsIs650 10 ± 3.9 59
arf-6(tm1447); nsIs625; nsIs650 4 ± 2.6 55
rab-35(b1013); nsIs625; nsIs650 51 ± 6.9 53
arf-6(tm1447); rab-35(b1013); nsIs625; nsIs650 43 ± 5.2 90
nsIs636[UCp::ARF-6 (D92N)-YFP]; nsIs650 56 ± 4.9 101
rab-35(b1013); nsIs713[UCp::YFP-RAB-35]; nsIs65 0 53
UCp = lin-48p; LCp = mig-24p, except for qIs56, which is lag-2p. All animals carried a 
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Figure 3-2. Linker cell death and degradation. 
(a) Left: Maximum intensity projection showing linker cell at first contact with U.l/rp 
cells. Right: 3D rendering. Scale bar, 10 μm. (b-j) Stereotypical events during linker cell 
dismantling. Images as in (a), except that in (c,g,h) a single DIC slice is shown instead 
of 3D rendering. Right, time of events in individual animals (blue circles) after first 
contact. X, event did not occur during imaging. Bars, mean ± sd. Arrowhead, linker cell. 
(b) Linker cell between U.l/rp cells (caret) (c) Nuclear crenellation onset. (d) Competitive 
phagocytosis begins. (e) Linker cell rounding (f) Linker cell corpse splits. (g) Onset 
of refractility. (h) End of refractility. (i) Small fragment disappears. (j) Large fragment 
disappears.
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rounding (Figure 3-2e) is followed by splitting of the linker cell into two fragments 
(Figure 3-2f). The larger linker cell remnant contains the nucleus, and is equally likely 
to be found within U.lp or U.rp (8/19 and 11/19, respectively; p=0.5, χ2-test). The cell 
engulfing the nucleus-containing fragment is more likely to be binucleate (17/19; 
p=0.0006, χ2-test), a result of an earlier unrelated U cell descendent fusion event [202], 
suggesting that the larger U.l/rp cell engulfs a larger portion of the linker cell. The larger 
linker cell remnant, but not the smaller, then becomes refractile by DIC microscopy 
(Figure 3-2g-h). The two linker cell fragments are degraded with similar kinetics 
(Figure 3-2i-j). Competitive phagocytosis does not result in extensive leakage of linker 
cell cytoplasm, as I never observed reporter protein outside the cell (N=35).








Figure 3-3. Competitive phagocytosis is dynamic. 
Additional frames of animal shown in Figure 3-2, demonstrating back-and-forth tugging 
events leading to linker cell splitting. Scale bar, 10 μm.
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internalized, I followed linker cell death in animals expressing the mKate2-PH reporter, 
derived from PLC-δ1, which marks the plasma membrane and membranes of open 
phagosomes by binding PI(4,5)P2 [203]. Localization of this reporter around the linker 
cell ceases soon after cell splitting (Figure 3-4), suggesting that linker cell fragmentation 
and U.l/rp internalization are coupled.
The unique mechanics governing linker cell dismantling raise the question of 
whether U cell descendants are specifically equipped for linker cell clearance. To test 
this, I examined animals carrying a mutation in the gene him-4, in which linker cell 
migration is defective, and the cell ends up near the head [82]. In these animals, linker 
cell death occurs fairly reliably, as determined by onset of nuclear crenellation [82]. 
However, while engulfment and degradation by neighboring cells can occur, it is 
inefficient (62 ± 6.9% remaining corpses in 24h adult males, N=50, p<0.0001 compared 
to wild type, Fisher’s exact test). Thus, U.l/rp cells exhibit specialization for linker cell 
clearance.
a













Figure 3-4. mKate2-PH is removed from the plasma membrane immediately after 
splitting, indicating internalization. 
Linker cell splitting correlates with loss of mKate2-PH, an open phagosome marker. 
Scale bar, 10 μm. (a-b) Arrowhead, mKate2-PH plasma membrane marker around linker 
cell prior to cell splitting (c-d) Caret, mKate2-PH plasma membrane marker absent from 
phagosome after cell splitting.
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3.2.2. Apoptotic engulfment genes are not required for linker cell clearance
It was previously reported that linker cell engulfment can occur in animals 
lacking apoptosis engulfment genes [82]; however, whether the cell is eventually 
degraded in these settings was not examined. To look at this in detail, I followed linker 
cell engulfment in animals lacking components of each or both parallel pathways that 
together drive apoptotic cell engulfment. Animals were scored 24h after the L4-to-adult 
transition, when the majority of animals have cleared the linker cell corpse [201]. I 
found that linker cell engulfment is only weakly perturbed by mutations in some known 
engulfment genes (Table 3-2). Furthermore, double mutants between engulfment 
genes in different pathways do not strongly affect linker cell clearance. Consistent 
with this observation, when I expressed MFG-E8-GFP, a phosphatidylserine binding 
protein [204,205], in U cell descendants, I did not observe fluorescence accumulation 
around the linker cell (5 lines, >100 animals scored in total). Nonetheless, I did find that 
mutations in the phagosome maturation gene sand-1 significantly inhibit clearance of 
linker cell debris (Table 3-2).
Thus, while genes promoting cell corpse degradation following engulfment 
are shared between linker cell death and apoptosis, upstream genes required for 
phagocytosis and the initiation of degradation are different. Linker-cell-specific 
engulfment genes remain, therefore, to be discovered.
3.3. A forward genetic screen to identify new factors in engulfment and 
clearance
To identify components of the linker cell engulfment machinery, I sought 
mutants in which linker cell engulfment and/or degradation are defective. To do so, 
I mutagenized hermaphrodites carrying a lag-2p::GFP linker cell reporter and a 
him-5 mutation, which increases the proportion of male progeny (Figure 3-5a). After 
two generations, males were screened for linker cell persistence. It was previously 
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shown that animals defective in linker cell death exhibit gonadal blockage, and can be 
sterile [82]. I therefore directly collected spermatids from mutant males by impaling a 
needle into the gonad, and used these spermatids to artificially inseminate wild-type 
hermaphrodites [206] (Figure 3-5b-d, see Methods for details). Cross progeny were then 
Table 3-2.  Canonical apoptotic engulfment genes play a minor role in linker cell 
corpse removal 
(mean ± SE of proportion).
Genotype Mammalian homolog % linker cell corpses in 24h adults N
WT 12 ± 3.2 100
ced-1(e1735) CD91 14 ± 3.4 103
ced-6(n2095)a Gulp 9 ± 2.9 100
ced-7(n1892) ABCA 7 ± 2.3 120
ced-2(e1752) a CrkII 20 ± 4.0* 102
ced-5(n1812) a Dock180 12 ± 2.9 125
ced-12(k149) Elmo 27 ± 4.5* 96
ced-10(n1993) Rac1 26 ± 4.5* 97
ced-1; ced-5 21 ± 3.2 162
ced-7; ced-10 27 ± 4.5* 98
nuc-1(e1392) DNaseII 31 ± 4.5** 104
cep-1(gk138) p53 12 ± 3.2 103
ced-8(n1891) XK 7 ± 2.5 104
dyn-1(ky51) dynamin 22 ± 4.1 103
ttr-52(tm2003) transthyretin-like 7 ± 2.5 101
ttr-52(tm2078) transthyretin-like 4 ± 1.9 102
psr-1(ok714) phosphatidylserine receptor 7 ± 2.5 103
psr-1(tm469) phosphatidylserine receptor 4 ± 2.6 56
piki-1(ok2346) PI3K 13 ± 3.4 94
unc-108(n3263) Rab2 5 ± 2.3 88
sand-1(or552) Mon1 38 ± 4.9*** 97
sand-1(ok1963) Mon1 58 ± 4.8*** 104
rme-1(b1045)b EHD4 19 ± 6.1 42
scav-1(ok2598) Scarb1 12 ± 5.1 41
scav-2(ok877) CD36 4 ± 2.7 54
scav-3(ok1286) CD36 3 ± 2.1 64
scav-5(ok1606) Scarb1 5 ± 2.9 56
cdh-3(gk178860) cadherin 13 ± 4.5 56
cdh-3(pk87) cadherin 3 ± 2.8 36
ansIs1[lag-2p::GFP, rol-6(+)];bnsIs65[mig-24p::Venus]; him-8; *: p < 0.05, Fisher’s exact 
test; **: p < 0.005, Fisher’s exact test; ***: p < 0.0001, Fisher’s exact test. All animals 
carried a him-5(e1490) mutation and qIs56[lag-2p::GFP] linker cell marker, unless 
otherwise noted.
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used to establish mutant lines.
I screened 15000 genomes, and isolated 181 males for artificial insemination. 
From these, I had 66 successful inseminations (36% success rate), and obtained 
59 mutants lines (some of the successful inseminations only produced male cross-
progeny). 44 of these strains were confirmed under the compound microscope, as 
having some defect in linker cell death or degradation, while the rest were considered to 
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Figure 3-5. Genetic screen for linker cell degradation mutants. 
(a) Genetic screen scheme. (b-d) Artificial insemination procedure. (b) Needle filled with 
buffer plunged into a 24h mutant adult male gonadal cavity. Spermatids automatically 
flow into the needle (arrow). (c) Needle aligned with a wild type hermaphrodite vulva 
(arrowhead). (d) Needle inserted into the vulva and spermatids released. Released 
spermatids fill the hermaphrodite gonadal cavity (arrows).
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I divided each of the remaining strains into five categories: I. weakly surviving, 
II. relatively healthy, III. odd death, IV. delayed death, and V. persistent corpse (see
Appendix for descriptions of classifications and phenotype analysis of the remaining 
mutants). For my thesis work, I focused on the three strongest mutants in the class V, 
and the subsequent analyses are described in this chapter.
3.4. RAB-35 pathway
3.4.1. RME-4/DENND1 promotes linker cell engulfment and degradation
One mutant, ns410, exhibits persistent refractile linker cell corpses, and was 
further studied (Figure 3-6a). Using standard genetic mapping, coupled with whole 



































Figure 3-6. ns410 is a mutation in rme-4. 
(a) DIC image of persistent linker cell corpse (arrowhead) in rme-4(ns410). Scale bar, 
10 μm. (b) Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP 
linker cell reporter and him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals 
scored inside bars. Average of at least three independent lines. Error bars, standard 
error of the proportion or standard error of the mean. n.s., p>0.05, Fisher’s exact test.
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in the DENN domain protein RME-4, homologous to vertebrate DENND1 [204] 
(Figure 3-7). Linker cell degradation is restored to ns410 mutants by expressing a 
fosmid spanning the genomic region of rme-4 (Figure 3-6b). Furthermore, two other 
rme-4 alleles, ns412 (S217N; isolated in my screen) and b1001 (G257D; a previously 
characterized loss-of-function lesion [207]) also promote linker cell degradation defects, 
as does the rme-4(tm1865) deletion allele (Figure 3-8). rme-4(tm1865) mutants exhibit 
a weaker linker cell survival defect, perhaps because the truncated RME-4 protein 









Figure 3-7. rme-4 gene locus. 











































Figure 3-8. Phenotypic analysis of other mutations in rme-4. 
Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker cell 
reporter and him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals scored 
inside bars. Average of at least three independent lines. Error bars, standard error of the 
proportion or standard error of the mean. n.s., p>0.05, Fisher’s exact test.
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exacerbates the defect of animals carrying this allele (Figure 3-8). Taken together, these 
results demonstrate that the rme-4 gene is required for linker cell corpse degradation.
RME-4 is widely expressed and found in the linker cell and in its engulfing cells 
(Figure 3-9). To determine where RME-4 functions, I expressed cDNAs for either the 
rme-4A or rme-4B transcript (Figure 3-7) in either the linker cell or the engulfing cells. 
I found that the longer A isoform restores linker cell degradation when expressed in 
U cell descendants, but not when expressed in the linker cell (Figure 3-6). B isoform 
expression in the engulfing cells has no effect (Figure 3-8). Thus, RME-4A is the active 
isoform driving linker cell engulfment, and it does so by acting in the engulfing cells.
3.4.2. RAB-35 GTPase Is a key linker cell degradation regulator controlled 
by RME-4/DENND1 and TBC-10/TBC1D10A
The RME-4 DENN domain was previously proposed to drive the guanine 
nucleotide exchange reaction (GEF function) of the small GTPase RAB-35 [207,208]. 
The ns410, ns412, and b1001 rme-4 alleles are predicted to cause single amino-acid 
changes within this domain, suggesting that RME-4 could function as GEF during 
linker cell degradation. To test this directly, I examined two rab-35 mutants, tm2058 and 
rme-4p::rme-4A-GFP
DIC
Figure 3-9. rme-4 translational reporter expression. 
Arrowhead, linker cell. Caret, U.lp or U.rp cell. Top: GFP. Bottom: DIC. Scale bar, 10 μm.
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b1013, that carry a small deletion surrounding the start codon, and an early Q69Ochre 
stop mutation, respectively (Figure 3-10a). I found that both lesions inhibit linker cell 
corpse degradation, and persistent corpses resemble those seen in rme-4 mutants 
(Figure 3-10b,c). While rab-35 is broadly expressed (Figure 3-11), I found that linker cell 
degradation is restored to rab-35 mutants by expression of rab-35 cDNA in engulfing 


















































Figure 3-10. Mutations in rab-35 cause a persistent corpse defect. 
(a) rab-35 gene locus. Yellow box, deletion allele tm2058. Pink diamonds, point 
mutations. Red octagon, early stop allele b1013. (b) Linker cell degradation in indicated 
genotypes. Strains contain lag-2p::GFP linker cell reporter and him-5(e1490). UCp, 
lin-48p. LCp, mig-24p. Number of animals scored inside bars. Average of at least three 
independent lines. Error bars, standard error of the proportion or standard error of the 
mean. n.s., p>0.05, Fisher’s exact test. (c) DIC image of persistent linker cell corpse 
(arrowhead) in rab-35(b1013).
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for linker cell degradation.
RAB-35 and other small GTPases cycle between GTP and GDP bound forms. 
If RME-4 functions as a RAB-35 GEF, I expect RAB-35[GTP] to be the active form of 
the protein in linker cell degradation. Indeed, I found that expression of RAB-35(Q69L), 
predicted to lock the protein in the GTP-bound configuration, fully restores linker 
cell degradation to rab-35(b1013) mutants (Figure 3-10b). A GDP-bound mimetic, 
RAB-35(S24N), however, only partially rescues rab-35(b1013) linker cell defects. 
Furthermore, I found that RAB-35(S24N) protein selectively binds RME-4A (but not 
RME-4B) in a yeast two-hybrid assay [204] (Figure 3-12). Thus, RAB-35 functions with 
RME-4 in engulfing cells, and RAB-35[GTP] is likely the relevant active form driving 
linker cell clearance.
I next sought to identify the GTPase activating protein (GAP) completing the 
RAB-35 GTPase cycle. I reasoned as follows: weak RME-4 (GEF) mutations should 
result in some RAB-35[GTP] production, but perhaps not enough for efficient linker cell 
degradation. Combining an rme-4(weak) mutation with a RAB-35 GAP mutation, which 
would block RAB-35[GTP] hydrolysis, could, however, allow sufficient accumulation of 
rab-35p::GFP-rab-35
DIC
Figure 3-11. rab-35 translational reporter expression. 
Arrowhead, linker cell. Caret, U.lp or U.rp cell. Top: GFP. Bottom: DIC. Scale bar, 10 μm.
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RAB-35[GTP] for efficient linker cell degradation. I therefore screened for the effects of 
mutations in C. elegans homologs of the known mammalian Rab35 GAP genes tbc-7/
Tbc1D24, tbc-10/Tbc1D10A, and tbc-13/Tbc1D13 [209]. Mutations or knockdown of 
these genes alone have no effect on linker cell corpse degradation, nor do they rescue 
linker cell degradation defects of animals carrying the strong rme-4(ns410) mutation, in 
which no RAB-35[GTP] is predicted to accumulate (Figure 3-13a). However, combining 
the tbc-10(gk388086) allele with the weak rme-4(tm1865) allele restores normal linker 
cell degradation (Figure 3-13b). Thus, TBC-10 is likely the RAB-35 GAP.
Supporting this notion, while TBC-10 protein is widely expressed 
(Figure 3-13c), specific expression of TBC-10 in U cell descendants of rme-4(tm1865); 
tbc-10(gk388086) double mutants reintroduces the linker cell degradation defect. Similar 
expression of a TBC-10(R225A) protein, containing a lesion in the putative catalytic 
arginine finger, has no effect (Figure 3-13b).
Taken together, these results suggest that RAB-35[GTP] is a key regulator of 













Figure 3-12. RAB-35[GDP] interacts with RME-4A. 
Yeast two-hybrid assay with LexA-RAB-35[S24N] (GDP) as bait, and Gal4-AD (GAD) 
empty vector, GAD-RME-4A, or GAD-RME-4B as prey. Top: histidine present. Bottom: 
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Figure 3-13. TBC-10 is the putative RAB-35 GAP in linker cell corpse removal. 
(a,b) Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker 
cell reporter and him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals scored 
inside bars. Average of at least three independent lines. Error bars, standard error of 
the proportion or standard error of the mean. n.s., p>0.05, Fisher’s exact test. (c) tbc-10 
transcriptional reporter. Arrowhead, linker cell. Caret, U.l/rp cells. Top: GFP. Bottom: 
DIC. Scale bar, 10 μm.
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3.4.3. RAB-35 promotes timely onset of linker cell engulfment and is 
required for subsequent phagosome maturation
To define more specifically the defects associated with loss of RAB-35, I imaged 
rab-35(b1013) mutants using the microfluidic setup, and quantified hallmark linker cell 
death and degradation events over > 24h (Table 3-1). I found no significant differences 
compared to wild-type animals in the onset or duration of developmental milestones 
(e.g. tail-tip retraction or appearance of rays; Figure 3-14a-c), or in appearance of linker 
cell death hallmarks (e.g. nuclear crenellation; Figure 3-14d-i). However, competitive 
phagocytosis of the linker cell begins prematurely in rab-35 mutants (Figure 3-15a), 
initiating before the linker cell has the opportunity to intercalate between the U.l/rp 
cells (Figure 3-15b). While subsequent linker cell splitting occurs at the same time as 
in wild-type animals (Figure 3-14g), formation of the larger refractile corpse is delayed 
(Figure 3-15c), and refractility can last much longer (Figure 3-15d). Mutations in rab-35 
delay degradation of the large fragment, if it occurs at all (Figure 3-15e,f). The smaller 
linker cell fragment is degraded as in the wild type (Figure 3-14h). Thus, RAB-35 plays 
roles in both engulfment initiation and phagosome maturation.
Consistent with a role in engulfment initiation, I found that RAB-35, tagged with 
the fluorescent reporter YFP, localizes to extending pseudopods early on, and remains 
enriched around the larger linker cell-containing phagosome for an extended period of 
time, until late stages of linker cell degradation (Figure 3-16).
Some aspects of phagosome maturation have been previously characterized. 
I therefore sought to address where in this process RAB-35 functions. To do so, I first 
generated animals expressing both YFP-RAB-35 and either mCherry-RAB-5, marking 
early phagosomes, mCherry-RAB-7, marking late phagosomes, or CTNS-1-mKate2, 
marking the phagolysosome (Table 3-1). In wild-type animals, RAB-35 and RAB-
5 transiently co-localized on the phagosome membrane in 5/6 animals examined 
(Figure 3-17a-d). In three of six animals, RAB-5 enrichment was seen in only a single 
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Figure 3-14. Characterization of stereotypical events during linker cell clearance in 
rab-35 and arf-6 mutants.
(a-i) Strains contain linker cell reporter [mig-24p::Venus], U.l/rp cell reporter 
[lin-48p::mKate2], him-5(e1490). Dots, individual events in single animals in hours with 
respect to first contact. X, event did not occur; not factored into statistical analysis. Bars, 
mean ± std. n.s., p>0.05, Student’s t-test.
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a
p = 0.004
c refractile corpse start
p = 0.0005
p < 0.0001

























































































Figure 3-15. RAB-35 plays roles in both engulfment initiation and phagosome 
maturation. 
Strains contain linker cell reporter [mig-24p::Venus], U.l/rp cell reporter 
[lin-48p::mKate2], him-5(e1490). (a) Competitive phagocytosis onset in individual 
animals (circles). Bars, mean ± sd. Student’s t-test. WT, wild-type. (b) Arrowhead, early 
competitive phagocytosis in rab-35(b1013). (c-e) Quantification of linker cell events as 
in (a). X, Event persisting or not observed by end of imaging; not included in statistical 
analysis. (f) Arrowhead, persistent large cell fragment in rab-35(b1013).
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frame over a 20h experiment (images acquired every 8 min), suggesting that RAB-5 can 
move quickly on and off the phagosome membrane. RAB-7 and RAB-35 co-localization 
is more sustained (Figure 3-18a-d, 7/7 animals). Furthermore, as RAB-35 disappears 
from the phagosome membrane, mCherry-RAB-7 fluorescence accumulates within the 
phagosome (Figure 3-18c,d). Such internalization of RAB-7 had not been previously 
reported in other settings. CTNS-1 and RAB-35 exhibit minimal co-localization 
(Figure 3-19), suggesting that RAB-35 is removed from the phagosome membrane once 
lysosomal fusion occurs.
I next examined reporter localization in rab-35(b1013) mutants. I found that 
RAB-5 fails to localize to the phagosome membrane in these animals (Figure 3-17e-g, 
5/7 animals). Similarly, RAB-7 does not accumulate on the phagosome surface, and is 
not taken up into the phagosome (Figure 3-18e-g, 5/5 animals).
These studies, therefore, support the idea that RAB-35 acts early in phagosome 
maturation, and is required for recruiting RAB-5 and RAB-7 for proper degradation to 
ensue.
01h:36m 04h:48m 06h:40m
a YFP-RAB-35 b c
YFP-RAB-35
linker cell
Figure 3-16. RAB-35 localizes to extending pseudopods and remains around the 
phagosome. 
Top: Localization of YFP-RAB-35 within U.l/rp cells. Bottom: YFP-RAB-35 (green), and 





















Figure 3-17. RAB-5 and RAB-35 transiently colocalize around the phagosome. 
(a-d) Localization of YFP-RAB-35 (top) and mCherry-RAB-5 (middle) within the U.l/rp 
cells examined during linker cell (LC) death and degradation in the wild type. Linker cell 
not fluorescently labeled. Caret, site of colocalization. LC, linker cell. (e-g) mCh-RAB-5 
imaged in a rab-35(b1013) animal (top). Bottom: mCh-RAB-5 overlaid on DIC image. 


























Figure 3-18. RAB-7 and RAB-35 colocalize around the phagolysosome. 
(a-d) Localization of YFP-RAB-35 (top) and mCherry-RAB-7 (middle) within the U.l/rp 
cells examined during linker cell (LC) death and degradation in the wild type. Linker 
cell not fluorescently labeled. Caret, site of colocalization. LC, linker cell. Asterisk, 
accumulation within phagosome. (e-g) mCherry-RAB-7 (top) fails to surround linker cell 
in rab-35(b1013) mutant. Linker cell labeled in green. Scale bar, 5 μm.
Figure 3-19. CTNS-1 and RAB-35 have 
different localization patterns. 
(a-c) Localization of YFP-RAB-35 (top) 
and CTNS-1-mKate2 (middle) within the 
U.l/rp cells examined during linker cell 
(LC) death and degradation in the wild 
type. Bottom: merge, YFP-RAB-35, green; 
CTNS-mKate2, magenta. Scale bar, 5 μm. 




3.5.1. The small GTPase ARF-6 blocks linker cell clearance
To delineate the molecular mechanism by which RAB-35 controls linker cell 
engulfment onset and degradation, I pursued studies of another mutant, ns388, isolated 
in the genetic screen. Animals carrying this lesion have similar linker cell defects to 
rab-35 mutants (Figure 3-20a,b), but do not harbor mutations in rab-35, tbc-10, or 
rme-4.
Using whole genome sequencing and standard genetic mapping, I found that 
ns388 animals contain a point mutation predicted to cause a D92N mutation in the 
small GTPase ARF-6 (Figure 3-21). Importantly, and unlike rab-35 mutations, a single 
arf-6(ns388) allele is sufficient to block linker cell degradation. Thus, arf-6(ns388) 
















































Figure 3-20. ns388 is a dominant allele of arf-6. 
(a) Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker 
cell reporter and him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals scored 
inside bars. Average of at least three independent lines. Error bars, standard error of the 
proportion or standard error of the mean. n.s., p>0.05, Fisher’s exact test. (b) DIC image 
of persistent linker cell corpse (arrowhead) in arf-6(ns388) male. Scale bar, 5 μm.
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coding region, and has no ARF-6 expression by Western blot[207], exhibits normal 
linker cell clearance (Figure 3-20a, 3-21), suggesting that arf-6(ns388) is a gain-of-
function and not a dominant-negative allele. To confirm that arf-6 is indeed the relevant 
gene, I generated two independent CRISPR alleles, ns751 and ns752, recreating the 
arf-6(ns388) lesion. Both promote linker cell defects similar to those of arf-6(ns388) 




















Figure 3-21. arf-6 genomic locus and mutant location. 
Yellow box, deletion alleles. Caret, single nucleotide insertion allele ns764. Pink 
diamonds, point mutations.
105107 107
ns751ns752 ns760 ns761 ns762 ns765 ns771 ns763
[I42M; 
P43T]























[D92N] [T44N] [Q67L] [putative nulls]
n.s.
102 104 100 102 101 105 102 101101100
WT
Figure 3-22. CRISPR generated alleles of arf-6. 
Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker cell 
reporter and him-5(e1490). Number of animals scored inside bars. Error bars, standard 
error of the proportion. n.s., p>0.05; *, p<0.05; Fisher’s exact test.
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expression of an arf-6(ns388) cDNA in engulfing cells blocks linker cell clearance 
(Figure 3-20a). Wild-type arf-6 expression in engulfing cells does not affect linker cell 
death, nor does expression of either arf-6(ns388) or arf-6(+) cDNAs in the linker cell 
(Figure 3-20a). 
These results, therefore demonstrate that gain of ARF-6 function blocks linker 
cell clearance, and suggest that ARF-6 normally functions as a linker cell clearance 
inhibitor.
3.5.2. ARF-6(gf) promotes premature competitive phagocytosis onset and 
delays linker cell degradation
To understand how ARF-6(gf) interferes with linker cell clearance, I imaged 
arf-6(ns388) animals in the microfluidic device and followed hallmark linker cell death 
and degradation events (Table 3-1). Except for a slight advance in cuticle shedding, 
no defects in animal development or linker cell killing are seen in arf-6(ns388) mutants 
(Figure 3-14). However, as with rab-35 mutants, premature onset of competitive 
phagocytosis is observed (Figure 3-24a,b), formation of a refractile linker cell 
corpse is delayed (Figure 3-24c), and the period of linker cell refractility is prolonged 
arf-6p::arf-6-GFP b arf-6p::arf-6(ns388)-GFPa
Figure 3-23. Wild-type arf-6 and arf-6(ns388) are broadly expressed. 
(a,b) Arrowhead, linker cell. Caret, U.lp or U.rp cell. Top: GFP; bottom: DIC. Scale bar, 
10 μm. (a) arf-6 translational reporter expression. (b) arf-6(ns388) translational reporter 
expression.
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(Figure 3-24d). Degradation of the large linker cell fragment is greatly delayed, if it 
occurs at all (Figure 3-24e).
The similar defects exhibited by arf-6(ns388) and rab-35 mutants suggests that 
the proteins encoded by these genes may localize in a similar manner. To test this 
idea, I expressed ARF-6-YFP in the U.l/rp cells and followed its localization changes 
during linker cell death and degradation (Figure 3-25a-c). ARF-6-YFP localizes to 
U.l/rp pseudopods (Figure 3-25a), remains enriched on the phagosome membrane 
after cell splitting (Figure 3-25b), and then rapidly translocates to intracellular puncta 
(Figure 3-25c). Importantly, enrichment of mCherry-RAB-5 around the phagosome 


























































































Figure 3-24. arf-6(gf) causes premature competitive phagocytosis and delays large 
fragment degradation. 
(a) Arrowheads, premature competitive phagocytosis in arf-6(ns388). Scale bar, 10 μm. 
(b-e) Quantification of linker cell clearance events in arf-6(ns388). Strains contain linker 
cell reporter [mig-24p::Venus], U.l/rp cell reporter [lin-48p::mKate2], him-5(e1490). Bars, 
mean ± sd. Student’s t-test. WT, wild-type. X, Event persisting or not observed by end of 
imaging; not included in statistical analysis.
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occurs after ARF-6-YFP removal (Figure 3-25d-g, 5/6 animals). As with RAB-7, I also 
observed RAB-5 accumulation in the phagosome interior (Figure 3-25g, 6/6 animals).
Thus, ARF-6 and RAB-35 localize to similar structures surrounding the dying 
















LC LC LC LC
Figure 3-25. ARF-6-YFP localizes to extending pseudopods, the nascent 
phagosome, and then translocates to intracellular puncta before RAB-5 
enrichment. 
(a-c) Top: Localization of ARF-6-YFP within the U.l/rp cells. Caret, ARF-6 on phagosome 
membrane. Arrowhead, ARF-6 in intracellular puncta. Bottom: ARF-6-YFP (green), 
and linker cell (mig-24p::mKate2; magenta). (d-g) Localization of ARF-6-YFP (top) 
and mCherry-RAB-5 (middle). LC, linker cell. Asterisk, accumulation of RAB-5 within 
phagosome. Scale bar, 5 μm.
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3.5.3. ARF-6 function is regulated by CNT-1/ACAP2 and EFA-6/EFA6
To understand the dominant nature of the ARF-6(D92N) lesion, I attempted 
to assess the consequences of locking ARF-6 protein in the GTP or GDP bound 
states [211]. I used CRISPR to generate arf-6 mutants encoding T44N and Q67L 
mutations (Figure 3-22), predicted to accumulate ARF-6[GDP] or ARF-6[GTP] proteins, 
respectively. Neither mutant, however, has linker cell defects, perhaps because they 
destabilize the protein. Consistent with this interpretation, the arf-6(Q67L) allele 
behaves as a null in genetic assays (see below). I did however, serendipitously isolate 
from the CRISPR mutagenesis an arf-6(I42M;P43T) double mutant with linker cell 
clearance defects. Based on an Arf6:Arf6GAP co-crystal protein structure [212], these 
lesions may interfere with GAP binding to ARF-6, and subsequent GTP hydrolysis. 
D92 of Arf6 forms intramolecular hydrogen bonds with R95 (Figure 3-26a). In the D92N 
mutant, these hydrogen bonds are lost (Figure 3-26b), which may result in loss of 
stability of adjacent interactions. Both P43 and I42 of Arf6 form hydrophobic interactions 
with W451 and I462 on the ArfGAP (Figure 3-26c). These interactions are lost in 















ArfGAP Arf6 ArfGAP Arf6(D92N) ArfGAP Arf6 ArfGAP Arf6(I42M;P43T)
Figure 3-26. Mutations in ARF-6 are predicted to disrupt ArfGAP binding. 
(a) Protein structures of human Arf6 (teal) and ArfGAP (blue) from [209]. PDB: 3LVQ. 
Relevant amino acids indicated in white. Yellow dotted line, hydrogen bonds. White 
ladder, hydrophobic interactions. Amino acids shown are conserved in C. elegans 
ARF-6 and CNT-1. (b) D92N mutation mapped onto Arf6. Protein structure information 
as in (a). (c) Different region of Arf6 and ArfGAP. Protein structure information as in (a). 
(d) I42M, P43T mutations mapped onto Arf6.
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phagosome maturation during linker cell clearance, and the mutants I isolated may 
hinder GAP binding.
To test this idea further, I reasoned that mutations in a relevant ARF-6 GAP 
would exhibit linker cell clearance defects, as they would lock ARF-6 in the GTP-bound 
state. From a screen of candidate mutations (Figure 3-27a, Table 3-3), we found that 




























































































Figure 3-27. CNT-1A is the relevant ARF-6 GTPase activating protein (GAP). 
(a,b) Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker 
cell reporter and him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals scored 
inside bars. Average of at least three independent lines. Error bars, standard error of 
the proportion or standard error of the mean. n.s., p>0.05, Fisher’s exact test. (c) Yeast 
two-hybrid assay with LexA-CNT-1A or LexA-CNT-1B as bait, GAD-ARF-6, GAD-ARF-
6(D92N) or GAD-ARF-6(I42M,P43T) as prey. Top: histidine present. Bottom: histidine 
absence. Growth on -His plates indicates physical interaction.
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protein similar to vertebrate Acap2, block linker cell clearance (Figure 3-27a, 3-28a,b). 
Expression of the CNT-1A isoform in U.l/rp cells, but not the linker cell, fully rescues 
linker cell defects of cnt-1 mutants (Figure 3-27b); whereas CNT-1B expression gives 
partial rescue (Figure 3-28c). Rescue is abolished by mutating the catalytic arginine 
of CNT-1A (Figure 3-27b). Importantly, ARF-6 is required for the linker cell defects 
of cnt-1 mutants, as an arf-6(tm1447) loss-of-function mutation restores linker cell 
clearance to cnt-1 mutants (Figure 3-27a). Consistent with the idea that the D92N and 
I42M;P43T mutations disrupt GAP binding, I found that while wild-type ARF-6 interacts 
with CNT-1A (but not CNT-1B) in a yeast two-hybrid assay; both ARF-6(D92N) and 
ARF-6(I42M;P43T) fail to interact with CNT-1A (Figure 3-27c). Thus, ARF-6[GTP] is 
likely the active form of the protein blocking linker cell removal, and CNT-1 is the ARF-6 
GAP for linker cell clearance.
Similar reasoning used to identify TBC-10 as a RAB-35 GAP allowed me 
to identify EFA-6, homologous to the mammalian Arf6 GEF Efa6 [210], as the 
putative ARF-6 GEF for linker cell clearance. While the efa-6(ok3533) deletion allele 
has no linker cell degradation defect, this allele restores linker cell clearance to 
mutants carrying null alleles of cnt-1 (Figure 3-29a; cnt-1(tm2313); efa-6(ok3533): 
14 ±  3.4%, N = 102, p<0.0001 compared to cnt-1(tm2313), Fisher’s exact test). 
Table 3-3.  Other putative ARF-6 GAPs have no linker cell defect 
(mean ± SE of proportion).
Genotype % linker cell corpses in 24h adults N homolog
WT 12 ± 3.2 100
F23H11.4(gk585084) 8 ± 4.3 39 ARAP1-3/ ArfGAP
F23H11.4(gk165637) 13 ± 3.4 96 ARAP1-3/ ArfGAP
git-1(ok1848) 10 ± 3.9 59 GIT1
git-1(gk392605) 15 ± 5.6 41 GIT1
gap-2(ok1001) 10 ± 4.2 52 SynGAP/RasGAP
cnt-2(gm377) 12 ± 3.2 102 ArfGAP
All animals carried a him-5(e1490) mutation and qIs56[lag-2p::GFP] linker cell marker.
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Furthermore, efa-6(ok3533) also blocks the dominant defects of arf-6(ns388) 
and arf-6(ns763[I42M;P43T]) mutants, strengthening our assessment that 
ARF-6 GTP loading is required for the function of these ARF-6 gain-of-function 
proteins (Figure 3-29a,c). While EFA-6 is expressed in the linker cell and U.l/rp cells 
(Figure 3-29b), expression of EFA-6 isoforms in the U.l/rp cells partially restores linker 
cell clearance defects to efa-6(ok3533); arf-6(ns388) double mutants (Figure 3-29c). 
Furthermore, EFA-6 isoforms interact with ARF-6[GDP] in a yeast two-hybrid assay 
(Figure 3-29d).
Taken together, these results suggest that ARF-6 inhibits linker cell phagocytosis 


































Figure 3-28. cnt-1 is ubiquitously expressed, and CNT-1B is not involved in linker 
cell corpse removal. 
(a,b) cnt-1 transcriptional reporter expression. Caret, U.lp or U.rp cell. Arrowhead, linker 
cell. Top: GFP; bottom: DIC. Scale bar, 10 μm. (c) Linker cell degradation in indicated 
genotypes. Strains contain lag-2p::GFP linker cell reporter and him-5(e1490). UCp, 
lin-48p. LCp, mig-24p. Number of animals scored inside bars. Average of at least 
three independent lines. Error bars, standard error of the proportion or standard error 
of the mean. n.s., p>0.05, Fisher’s exact test. #, significantly different from both cnt-






































































































Figure 3-29. EFA-6 is the relevant ARF-6 guanine nucleotide exchange factor. 
(a) Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker 
cell reporter and him-5(e1490). Number of animals scored inside bars. Error bars, 
standard error of the proportion. Fisher’s exact test. (b) efa-6 transcriptional reporter. 
Caret, U.lp or U.rp cell. Arrowhead, linker cell. Top: GFP; bottom: DIC. Scale bar, 
10 μm. (c) Histogram as in (a). UCp = lin-48p. Error bars represent standard error of the 
proportion or standard error of the mean. Average of at least three independent lines. 
#, significantly different from both efa-6(ok3533); arf-6(ns388) and arf-6(ns388). ^, only 
one line out of three show significant rescue. n.s., p>0.05. (d) Yeast two-hybrid assay 
with LexA-ARF-6[T44N] (GDP) as bait, GAD-EFA-6A-D as prey. Top: histidine present. 
Bottom: histidine absence. Growth on -His plates indicates physical interaction.
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3.6. RAB-35 negatively regulates ARF-6 in linker cell corpse clearance 
3.6.1. RAB-35 binds CNT-1A and drives ARF-6 removal from phagosome 
membranes
rab-35(0) and arf-6(gf) mutants exhibit similar linker cell clearance defects. I 
wondered, therefore, whether RAB-35 and ARF-6 proteins act in the same pathway. 
I found that putative null mutations in arf-6 or efa-6 almost fully restore linker cell 
clearance to rab-35 mutants (Figure 3-30, 3-31a). The arf-6[Q67L] CRISPR mutant 
also suppresses rab-35(0) defects (Figure 3-31b), confirming this allele inactivates 
ARF-6 and is not an ARF-6[GTP] mimetic (see above). Linker cell clearance defects 
are restored to rab-35(b1013); arf-6(tm1447) double mutants by expressing wild-
type arf-6 in U.l/rp cells, but not in the linker cell (Figure 3-31c). Furthermore, neither 
mutations in cnt-1 nor the dominant arf-6 allele enhance the linker cell defects of rab-35 










































Figure 3-30. RAB-35 inhibits ARF-6. 
Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker cell 
reporter and him-5(e1490). Number of animals scored inside bars. Error bars, standard 
error of the proportion. Fisher’s exact test. #, significant difference compared to 
rab-35(b1013) and wild type.
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Figure 3-31. RAB-35 and ARF-6 are in the same 
genetic pathway. 
(a-e) Linker cell degradation in indicated genotypes. 
Strains contain lag-2p::GFP linker cell reporter and 
him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals scored inside bars. 
Average of at least three independent lines. Error bars, standard error of the proportion 
or standard error of the mean. n.s., p>0.05, Fisher’s exact test. ΔG2 = deletion of 
glycine2, necessary for myristoylation. #, (a) significantly different from single mutants, 
(c) significantly different from both rab-35(b1013); arf-6(tm1447) and rab-35(b1013), 
or (e) significantly different from both arf-6 (tm1447) and arf-6(ns388). ^, only 2/4 lines 
showed significant rescue. 
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restores linker cell clearance to arf-6(ns388) mutants (Figure 3-30a). Taken together, 
these results suggest that RAB-35 normally functions to inactivate ARF-6.
To understand how RAB-35 inhibits ARF-6, I first imaged mKate2-RAB-35 and 
ARF-6-YFP localization in the same animal. Consistent with the other imaging studies, 
the two proteins initially co-localize to extending U.l/rp cell pseudopods (Figure 3-32a,b). 
RAB-35 then accumulates on the phagosome membrane, while ARF-6 enrichment 
fades (Figure 3-32c,d, 8/9 animals). Next, I examined ARF-6-YFP dynamics in 
rab-35(b1013) animals (Figure 3-32e-h). Remarkably, I found that ARF-6-YFP remains 
eARF-6-YFP























Figure 3-32. RAB-35 
removes ARF-6 from 
phagosome membranes. 
(a-d) Localization of ARF-
6-YFP (top) and mKate2-
RAB-35 (middle) within the 
U.l/rp cells examined during 
linker cell (LC) death and 
degradation in the wild type. 
Bottom: merge, ARF-6-YFP, 
green; mKate2-RAB-35, 
magenta. Scale bar, 
5 μm. (e-h) ARF-6-YFP 
localization in rab-35(b1013) 
mutant. LC labeled in 
magenta. Scale bar, 5 μm. 
(i-k) ARF-6(D92N)-YFP 
localization in otherwise wild-
type animals. LC labeled in 
magenta. Scale bar, 5 μm.
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on the membrane longer than in wild type animals (Figure 3-32g,h, 5/6 animals; 
ARF-6-YFP removed 4.6 ± 0.9h after first contact in wild type animals vs 15.4 ± 9.7 h 
in rab-35(b1013) where the corpse persists, p=0.023, Student’s t-test). Furthermore, in 
wild-type animals, ARF-6(D92N) remains enriched on phagosome membranes longer 
than ARF-6-YFP (Figure 3-32i-k, 4/4 animals; 19.1 ± 11.4h after first contact, p=0.01 
compared to WT, Student’s t-test).
These results raise the possibility that RAB-35 promotes linker cell clearance, 
at least in part, by facilitating ARF-6 removal from the phagosome. Consistent with this 
notion, an ARF-6(D92N) gain-of-function protein is more effective in blocking linker cell 
clearance than ARF-6(D92N) lacking a myristoyl group addition sequence, required for 
membrane localization [214] (Figure 3-31e).
To determine whether ARF-6 localization is regulated by direct binding to RAB-
35, I assessed their interactions in a yeast two-hybrid system. While I did not detect 
any interactions between these two proteins, I found that RAB-35[GTP], the active form 
of RAB-35, binds CNT-1A (and not CNT-1B) (Figure 3-33). Thus, RAB-35 may recruit 






















Figure 3-33. RAB-35 interacts with the ARF-6 GAP, CNT-1A. 
Yeast two-hybrid assay with LexA-RAB-35[S24N] (GDP) or LexA-RAB-35[Q67L] (GTP) 
as bait, Gal4-AD (GAD)empty vector, GAD-CNT-1A, or GAD-CNT-1B as prey. Top: 
histidine present. Bottom: histidine absence. Growth on -His plates indicates physical 
interaction.
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3.6.2. The RAB-35/ARF-6 module is not required for apoptotic cell 
clearance
Given the roles of RAB-35 and ARF-6 in the clearance of a cell dying by LCD, 
I wondered whether these proteins play similar roles in apoptotic cell clearance. To 
test this, I counted the number of persisting apoptotic cells in 3-fold embryos, after 
nearly all developmental cell death has taken place. In him-5 mutant control animals, 
I counted 0.10 ± 0.30 persisting refractile corpses on average (N=21). In arf-6(ns388) 
mutants, 0.47 ± 0.60 corpses were observed (N=21, p=0.0131, Student’s t-test). 
rab-35(b1013) mutants exhibited 0.81 ± 0.92 corpses, on average (N=21, p=0.0018, 
Student’s t-test). These small defects pale in comparison to defects exhibited by 
mutants defective in canonical apoptotic engulfment genes (e.g. ced-7; ced-10 double 
mutant: 16.8 ± 4.2 corpses, N = 11). Furthermore, rme-4 mutant embryos I tested 
have no clearance defects (ns410: 0.14 ± 0.36 apoptotic corpses, N=14; ns412: 
0.13 ± 0.33 apoptotic corpses, N=24). I also examined whether rab-35 mutations exhibit 
genetic interactions with canonical apoptosis engulfment genes in linker cell death, but 
found no such interactions (Table 3-4).
Our results, therefore, demonstrate that the RAB-35/ARF-6 module plays specific 
roles in dismantling the linker cell that are not shared with clearance of apoptotic cells in 
C. elegans.
3.7. Discussion
3.7.1. A New Engulfment and Degradation Pathway for Non-Apoptotic 
Dying Cells
In this section, I demonstrate that the clearance machinery promoting the 
removal of the linker cell, which dies by LCD, differs from that used to clear apoptotic 
cells in C. elegans. These studies uncover a protein network promoting linker cell 
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engulfment and degradation (Figure 3-34a). I find that RAB-35 and ARF-6 play key 
early roles, controlling the sequential loading of phagosome maturation factors onto 
the phagosome membrane (Figure 3-34b). These data are consistent with a model in 
which RAB-35[GTP] promotes elimination of dying cells by blocking the activity of an 
inhibitor of the process, ARF-6[GTP]. These studies are the first to implicate a RAB-35/
ARF-6 module in the engulfment and degradation of dying cells, define in detail multiple 
accessory factors, identify the relevant targets (e.g. RAB-7) and, importantly, explore the 
functions of these proteins in vivo in a living multicellular animal.
Although I identifed the LCD corpse engulfment pathway in C. elegans, a number 
of studies in other systems raise the possibility that this process may be conserved. 
Table 3-4.  Mutations in the canonical apoptotic engulfment genes ced-1 and ced-5 
do not enhance mutations in rab-35. 
(mean ± SE of proportion).
Genotype % linker cell corpses in 24h adults N
WT 12 ± 3.2 100
ced-1(e1735) 14 ± 3.4 103
ced-5(n1812)a 12 ± 2.9 125
rab-35(b1013) 74 ± 4.2 105
rab-35(tm2058) 69 ± 4.6 99
sand-1(ok1963) 58 ± 4.8 104
ced-1; rab-35(b1013) 77 ± 4.2 101
ced-5; rab-35(b1013) 63 ± 4.8 101
ced-1; ced-5; rab-35(b1013) 62 ± 4.8 103
ced-1; rab-35(tm2058) 56 ± 4.9 102
ced-5; rab-35(tm2058) 58 ± 4.9 102
ced-1; ced-5; rab-35(tm2058) 63 ± 4.7 104
sand-1; rab-35(b1013)b 95 ± 2.7 63
a = nsIs1[lag-2p::GFP, rol-6(+)]. b = animals scored at 36h post L4-adult transition to 
account for slow growth of double mutant. All animals carried a him-5(e1490) mutation 
and a GFP linker cell marker.
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Figure 3-34. A model for control of linker cell degradation by the RAB-35/ARF-6 
module. 
(a) RAB-35:GTP promotes linker cell degradation by interacting with the ARF-6 GAP 
CNT-1. CNT-1 is required for turning ARF-6 off and removing it from the membrane. 
ARF-6:GTP inhibits linker cell degradation. GAP, GTPase activating protein. GEF, 
guanine nucleotide exchange factor. (b) 1. ARF-6 and RAB-35 surround the nascent 
phagosome. 2. RAB-35 recruits CNT-1. 3. CNT-1 turns off ARF-6, removing it from the 
phagosome membrane. RAB-35 remains on the membrane. 4. RAB-5 is recruited. 
5. RAB-7 recruitment and RAB-5 loss. 6. RAB-35 is largely gone from the membrane













































For example, in Drosophila, nurse cell death is thought to be caspase independent, 
and knockdown of RAB-35 results in persistent nurse cell nuclei [72]. While the role of 
RAB-35 was not further investigated, the involvement of this protein in a non-apoptotic 
setting is intriguing. Furthermore, concerted activities of RAB-35 and ARF-6 in other 
contexts have been described, including neurite outgrowth, cytokinesis, oligodendrocyte 
differentiation, maturation of recycling endosomes, and FcγR-mediated uptake of 
bacteria by macrophage [215-219]. In some of these cases, interactions between 
RAB-35 and putative ARF-6 GAPs are seen [220]. Additionally, ARF-6 is known to 
function in endocytosis of yolk proteins in C. elegans [221]. There it works with RAB-10 
in a similar regulatory cascade as the one we have uncovered.
3.7.2. New Ways to Generate ARF[GTP] Mimics
My genetic analysis of linker cell engulfment yielded important reagents, likely 
to be of utility in studying ARF-family proteins. I found that a Q67L mutation in ARF-6, 
which is predicted to mimic the GTP-bound state of the protein, behaves instead 
as a functional null in our assay. This modification, effective in the context of other 
GTPases, may, therefore, result in protein instability, or loss of active conformation. 
However, I found that the ARF-6(D92N) mutant protein, or a protein carrying two 
lesions, ARF-6(I42M;P43T), appear to mimic ARF-6[GTP], and if anything, enhance 
protein stability. Based on the published structure of Arf6 binding to the ArfGAP ASAP3 
[212], the D92N mutation is adjacent to a residue that coordinates to a key valine in 
the ArfGAP, whereas the I42M,P43T double mutations modify residues that directly 
coordinate to known GAP catalysis residues [212]. I propose that these lesions could 
keep the protein locked in the GTP-bound state, because they prevent GAP protein 
binding. This interpretation is bolstered by the protein interaction studies. I propose that 
introducing similar lesions into other ARF proteins, and perhaps into other GTPases, 
could allow for the development of new GTP-bound mimetics of these proteins.
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3.7.3. Competitive Phagocytosis
In addition to unique molecular components, I found that the mechanics of 
linker cell engulfment are very different from engulfment of apoptotic cells. The 
imaging studies reveal a process of competitive phagocytosis, where two phagocytes 
compete to engulf portions of the linker cell, resulting in cell splitting. RAB-35 acting 
through ARF-6 prevents premature activation of this engulfment process. As with 
the molecular constitutes of linker cell engulfment and degradation, I believe that the 
process of competitive phagocytosis may also be conserved. In macrophage-less 
mice, for example, mesenchymal cells engulf dying neighbors during digit formation, 
and occasionally two mesenchymal cells can be seen engulfing the same dying cell in 
transmission electron microscopy images [222]. Consistent with this process involving 
new engulfment regulators, mesenchymal cells do not express the CED-7 homolog 
ABC1 [222]. Similarly, in developing rat cerebellum, more than one non-professional 
phagocyte can be seen engulfing a dying cell [223]. A related process has been 
documented during germ cell development in C. elegans. Primordial germ cells extend 
cytoplasm-containing lobes into the adjacent endoderm, and the lobe is excised from 
the remaining cell, in a process reminiscent of competitive phagocytosis [224].
The need for engulfment by more than one cell could be related to the size of 
the dying cell. For example, when macrophages attempt to engulf a particle that is too 
large, engulfment is stalled [225,226]. Engulfment by two or more cells could solve 
this problem. However, in this case, cytoplasmic spillage must be avoided. The new 
engulfment process I describe here accomplishes exactly that.
A process reminiscent of competitive phagocytosis can also be seen when 
cultured human peripheral blood monocytes engulf a C. albicans pathogen [227]. 
Similarly, cultured mouse monocytes simultaneously engulf a Leishmania parasite [227]. 
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One cell engulfs the flagellum, while the other engulfs the posterior pole. In this context, 
roles for RAB-35 in pathogen clearance [178,215,220] are especially intriguing, and 
may suggest underlying mechanisms similar to linker cell clearance.
In summary, I demonstrate that engulfment and degradation of a cell that dies 
by LCD requires mechanics and machinery different from that used for apoptotic cell 
engulfment and degradation, and identify a molecular pathway governing this novel form 
of cell clearance. Given the conservation of LCD, I propose that this ancillary process 
may be conserved as well.
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4. CED-3 is required for linker cell corpse degradation but not death
The linker cell dies independently of all known cell death genes, including 
members of the apoptotic pathway [82,83]. Knowing this, I was quite surprised when 
Holly Johnsen, a graduate student in Bob Horvitz’s lab at MIT, came up to me at a 
meeting to let me know that she had seen ced-3 transcripts in the linker cell while 
examining the role of caspase of other cells in the tail. I rechecked the surviving linker 
cell defects, and confirmed that the cells are still dying by the strict morphological 
defects to which we adhere. Interestingly, I noticed that ced-3 and ced-4 mutants 
instead had an increased number of cell corpses, suggesting that perhaps these genes 
are involved in corpse degradation, but not death. 
4.1. CED-3 and CED-4 are required for efficient degradation
I reexamined the genes involved in apoptosis and found that the linker cell still 
dies, as evidenced by a crenellated nuclear envelope (Table 4-1). Instead, linker cell 
corpses in ced-3 and ced-4 animals persist, while corpses in ced-9 or egl-1 animals 
are largely cleared (Figure 4-1). To examine this further, I imaged ced-3 animals using 
the microfluidic set up. I found no difference in development events compared to wild- 
Table 4-1.  The linker cell dies in the absence of apoptotic genes. 






a = nsIs1[lag-2p::GFP, rol-6(+)]. All animals carried a him-
5(e1490) mutation and a GFP linker cell marker.
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type animals (e.g. tail tip retraction onset, Figure 4-2a-c). I also found no difference in 
onset of nuclear crenellation, suggesting that the death kinetics are similar between 
ced-3 animals and wild-type animals (Figure 4-2e). I did notice, however, that ced-3 
animals lagged in most aspects of corpse degradation. There was a delay in linker cell 
corpse rounding, which sometimes never occurred (Figure 4-3a). This result suggests 
that ced-3 corpses may have a delay in engulfment, which is corroborated by the 
observation that cell splitting is delayed in these animals (Figure 4-3b). There was also a 
delay in the formation and the duration of the refractile corpse (Figure 4-3c,d). Both the 
small fragment and the large fragment persisted longer than in wild type (Figure 4-3e,f), 
although the duration of the small fragment was unchanged (Figure 4-2f).
While there is a delay in phagocytosis, ced-3 corpses are terminally engulfed 24h 

































100 102 114 102 97 104
p < 0.0001
p = 0.0111
Figure 4-1. Linker cell corpses in ced-3 and ced-4 mutant animals are not 
degraded. 
Linker cell degradation in indicated genotypes. Strains contain either lag-2p::GFP linker 
cell reporter or nsIs1[lag-2p::GFP, rol-6(+)] (denoted by ^) and him-5(e1490). Number of 
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Figure 4-2. ced-3 mutations do not affect male developmental events. 
(a-f) Strains contain linker cell reporter [mig-24p::Venus], U.l/rp cell reporter 
[lin-48p::mKate2], and him-5(e1490) for males. Dots, individual events in single animals 
in hours with respect to first contact. X, event did not occur and was not factored into 
statistical analysis. Bars, mean ± std. n.s., p>0.05, Student’s t-test. Wild type (WT) same 
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p = 0.0414 p = 0.0031
p = 0.0016 p < 0.0001
Figure 4-3. ced-3 mutations affect the majority of linker cell corpse degradation 
events. 
(a-f) details as in Figure 4-2.
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are fertile, suggesting no interference between a lingering unengulfed linker cell and 
spermatid release [5]. 
To further bolster the hypothesis that CED-3 is involved in degradation rather 
than killing, I created ced-3; pqn-41(ns294) double mutants and found that loss-of-
function mutations in ced-3 did not enhance the surviving linker cell defects of pqn-41 
animals (Table 4-3).
4.2. ced-3 and ced-4 act in the linker cell
Since corpses persist in both ced-3 and ced-4 mutants, I wanted to determine 
where these genes are expressed and where they function.
4.2.1. ced-3 expresses in the linker cell as it dies, but not as it migrates
I examined two transcriptional reporters, nsIs25[ced-3p::GFP] and 
nsEx4944[ced-3p::mCherry]. In both cases, I saw expression of fluorescent protein in 
the linker cell once it reached the cloaca, but not as it was migrating (Figure 4-4a,b). 
I noticed that expression in the linker cell was much fainter than other cells dying 
by apoptosis in the male tail (Figure 4-4a,b), suggesting that ced-3 is not induced 
as strongly when required only for cell clearance. I also obtained bcIs109, a ced-3 
translational reporter, and found GFP puncta in the nucleus of the dying linker cell, 
consistent with a role in nuclear degradation (Figure 4-4c). I did not see expression in 
the U.l/rp cells from any of the reporters.
4.2.2. ced-4 is expressed in the linker cell
I created a ced-4 transcriptional reporter and noticed expression in both the dying 
(Figure 4-5a) and migrating linker cell (Figure 4-5b). I also saw off-target overexpression 
artifacts in the intestine (Figure 4-5b). Nonetheless, perhaps this low-level expression in 
the migrating cell explains why ced-3 must be transcriptionally induced, to prevent being 
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Table 4-2. Linker cell corpses in degradation mutants are terminally engulfed. 
Table 4-3.  ced-3(lf) does not enhance the surviving linker cell defects of pqn-
41(ns294).









ced-3(n2452); rab-35(tm2058) 98 102
ced-3(n2452); rab-35(b1013) 100 107
ced-3(n717); rab-35(tm2058) 99 72
ced-3(n717); rab-35(b1013) 99 76
All animals carried a him-5(e1490) mutation, a GFP linker cell marker, and an 
mCherry U.l/rp cells marker.
Genotype %SLC (N) 2h adults
Wild type 3% (157)
pqn-41(ns294) 20% (44)
pqn-41(ns294); ced-3(n717) 24% (50)
pqn-41(ns294); ced-3(n2452) 20% (114)





Figure 4-4. ced-3 is expressed in the dying 
linker cell. 
(a-c) Caret, cells dying by apoptosis. 
Arrowhead, linker cell. (a,b) ced-3 
transcriptional reporter expression. (c) ced-3 
translational reporter expression and 
localization.
a ced-4p::mKate2 b ced-4p::mKate2
Figure 4-5. ced-4 is expressed in the 
dying and migrating linker cell. 
ced-4 transcriptional reporter in (a) linker 
cell (arrowhead) at cloaca and (b) linker 
cell (arrowhead) migrating. Top: mKate2; 
bottom: DIC.
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activated by CED-4 prematurely. Together, these results suggest that CED-4 is present 
in the migrating linker cell, and ced-3 is transcriptionally induced upon death initiation to 
begin its degradation function.
4.2.3. ced-4 functions in the linker cell, not the engulfing cell
Since both ced-3 and ced-4 are expressed in the linker cell, but not in the U.l/rp 
cells, I wanted to confirm that these proteins function within the linker cell. Because 
expression of ced-3 ectopically in the linker cell may cause apoptotic cell death, I 
examined ced-4 function instead. I expressed ced-4 cDNA under a linker-cell-specific 
promoter (mig-24p) and a U.l/rp-promoter (lin-48p), and checked for rescue of the 
ced-4(n1162) defect. I found that expression in the linker cell, but not the engulfing cells 































Figure 4-6. CED-4 functions in the dying linker cell. 
Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker cell 
reporter and him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals scored 
inside bars. Average of at least three independent lines. Error bars, standard error of 
the proportion or standard error of the mean. n.s., p>0.05, Fisher’s exact test.
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4.3. Interactions between RAB-35/ARF-6 module and caspase
In the previous chapter, I described a RAB-35/ARF-6 module that is required for 
corpse degradation in the U.l/rp cells, and how it is necessary for proper phagosome 
maturation. CED-3 is also required in the linker cell to aid in its engulfment and degrade 
components of the nucleus. Because both are involved in some aspect of corpse 
degradation, I wanted to determine if and how these pathways interact.
4.3.1. ced-3 is still expressed when rab-35 and arf-6 are mutated
I wanted to determine if ced-3 expression is affected when the RAB-35 or 
ARF-6 pathways are disrupted. To test this, I crossed the ced-3 transcriptional reporter 
into rab-35(b1013) and arf-6(ns388) animals. In both cases, ced-3 is still expressed 
(Figure 4-7). This result is consistent with the idea that ced-3 is induced after cell death, 
but upstream of phagosome maturation.
4.3.2. ced-3 likely functions upstream of rab-35
To determine if there are any genetic interactions between the pathways, I 
created double mutants between ced-3, and rab-35 and its GAP, tbc-10. I found no 
synergistic interactions (Figure 4-8), but these corpses more closely resembled ced-3 
corpses, suggesting it functions upstream of rab-35. I also wanted to determine if 
a ced-3p::GFP in rab-35(b1013) ced-3p::GFP in arf-6(ns388)b
Figure 4-7. ced-3 is still expressed in rab-35 and arf-6 mutants. 
ced-3 transcriptional reporter in (a) rab-35(b1013) and (b) arf-6(ns388) animals. 
Arrowhead, linker cell.
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recruitment of YFP-RAB-35 is defective in ced-3 mutant animals using the microfluidic 
long-term imaging set up and imaging over the duration of linker cell clearance. I was 
unable to detect any consistent differences in YFP-RAB-35 localization or intensity 
between WT and ced-3, suggesting that RAB-35 function is unperturbed in ced-3 
animals.
4.3.3. ced-3 and arf-6(gf) are synergistic
Intriguingly, I found that ced-3 and arf-6 pathways interact. Double mutants 
between arf-6(gf) and ced-3(lf) are synergistic, while null mutations in arf-6 do not affect 
the phenotype of ced-3 animals (Figure 4-9).
As noted in Chapter 3, ARF-6-YFP localizes to either the dorsal or the 
ventral side of the engulfing cell. In ced-3 animals, the intensity of ARF-6-YFP when 













































Figure 4-8. ced-3 and rab-35 do not genetically interact. 
Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker cell 
reporter and him-5(e1490). Number of animals scored inside bars. Error bars, standard 
error of the proportion. n.s., p>0.05, Fisher’s exact test.
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localized to the ventral side of the cell, or to both the ventral and dorsal sides was 
unaffected (Figure 4-10). Intriguingly, when ARF-6-YFP localized to the dorsal side 
alone, both the intensity and duration was reduced in ced-3 animals (Figure 4-11). 
Perhaps this result may have something to do with the role of ced-3 in engulfment 
receptor presentation, and may hint at an additional function of ARF-6 in wild-type 
animals.
4.4. Discussion
I found that the caspase CED-3 and its upstream activator CED-4 are required 
for linker cell corpse degradation, perhaps having a role in engulfment receptor 
presentation and nuclear degradation. Neither of the proteins are required for death, 
as the linker cell corpse displays nuclear crenellation and is eventually engulfed in the 
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p < 0.05
Figure 4-9. ced-3 and arf-6 pathways interact. 
Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker cell 
reporter and him-5(e1490). Number of animals scored inside bars. Error bars, standard 
error of the proportion. n.s., p>0.05, Fisher’s exact test.
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I noticed that the majority of corpses in ced-3 animals were small, consisting 
solely of a crenellated nucleus with little cytoplasm remaining. Based on the long-term 
imaging studies, I know that this small cell is the larger fragment, where the cytoplasm 
has been removed, and only the nucleus remains. Perhaps CED-3 is responsible for 
presentation of engulfment receptors and degradation of the nucleus, but not nuclear 
envelope changes or bulk cytoplasmic degradation. Further investigation is necessary 
to determine how CED-3 is affecting cell splitting and cell engulfment. Intriguingly, the 
ced-3 linker cell corpse morphology is reminiscent to that of dying motoneurons in the 
absence of the pro-apoptotic Bax [112]. Those cells are also small with shriveled nuclei 
and do not maintain synaptic connections, suggesting they are dead, but not degraded. 



















Figure 4-10. ARF-6-YFP intensity is unaffected when localized only on the ventral 
arm of the pseudopod or on both arms in ced-3 mutants. 
The intensity of ARF-6-YFP around the linker cell during linker cell death and 
degradation was monitored in the microfluidic device over at least 20 h. Total intensity 
values were plotted as a function of time. Wild type (WT) localization (ventral/posterior 
localization) in blue, ventral/posterior localization in ced-3(n2452) in light pink, and 
dorsal+ventral localization in ced-3(n2452) in dark pink.
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clear the corpse debris.  
A role of ced-3 in degradation rather than killing is also supported from its known 
targets. The majority of caspase targets identified could actually be required mostly 
for corpse cleanup, instead of death. For example, in apoptosis in C. elegans, CED-3 
cleaves DCR-1 to convert it from an RNase to a DNase and degrade DNA in dying cells 
[228]. In mammalian cells, effector caspases activate a DNase to degrade the DNA as 
well [111]. While bulk cleavage of DNA would presumably lead to cell death, the primary 
function could actually be nuclear clearance after phagocytosis. Determining the exact 
timing of death, caspase activation, DNA degradation, and corpse removal will be key in 
determining the primary, likely extremely nuanced function of caspase in dying cells.
The ability of caspases to carry out nuanced cell function is well-documented. 
Controlled expression of caspase either by levels or location can have a wide variety 
of consequences in development. For example, in C. elegans, CED-3 is known 
to cleave LIN-14, LIN-28, and DISL-2, which are key regulators of developmental 
WT
ced-3

















Figure 4-11. ARF-6-YFP intensity and duration is affected when localized only on 
the dorsal arm of the pseudopod in ced-3 mutants. 
The intensity of ARF-6-YFP around the linker cell during linker cell death and 
degradation was monitored in the microfluidic device over at least 20 h. Total 
intensity values were plotted as a function of time. Wild type (WT) localization (dorsal 
localization) in blue, dorsal localization in ced-3(n2452) animals in pink.
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timing [229,230]. These cleavage events allow for robust development of the 
worm. In Drosophila, controlled activation of caspase is required for proper sperm 
development [231]. Based on these examples, the idea that caspase is a bulk killing 
machine is likely incorrect, but that its activation in cell death, degradation, and other 
proteolytic events is likely distinct and very well-controlled.
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5. Discussion and future directions
5.1. A model for linker cell death and degradation
During my graduate studies, I discovered components required for both linker cell 
death and degradation. I found that HPK-1, a homeodomain protein kinase, interacts 
with the polyglutamine protein PQN-41C. This interaction may disrupt the positive 
interactions between HPK-1 and the heat shock function of HSF-1, perhaps allowing 
HSF-1 to undertake its linker cell killing role. After linker cell death, I found that the 
U.l/rp cells simultaneously engulf the dying cell, eventually leading to cell splitting and 
internalization. Precocious competitive phagocytosis occurs in animals lacking the small 
GTPase rab-35, or in a gain-of-function mutant of arf-6. In these animals, phagosome 
maturation fails to proceed, although engulfment itself is unaffected. Linker cell corpse 
degradation also requires the caspase ced-3 from within the linker cell for efficient 
removal. 
The linker cell requires both external (i.e. RAB-35) and internal (i.e. CED-3) 
proteins for proper corpse elimination. Perhaps these extra layers of degradation ensure 
that the linker cell is properly cleared, as removal of the linker cell from the gonadal 
tube is absolutely essential for male fertility. Multiple avenues of corpse removal would 
therefore be prudent to guaranteeing male fertility and propagation of genetic material.
One of the few pro-survival factors targeted by CED-3 in C. elegans is 
CNT-1 [232]. In apoptosis, CNT-1 interacts with Akt signaling to promote cell survival, 
and cleavage of CNT-1 by CED-3 removes this function [228]. It is quite interesting that 
I also found a role for CNT-1, although in a different context. In linker cell phagosome 
maturation, CNT-1 is required to turn off ARF-6 through recruitment by RAB-35. Given 
that ced-3 and arf-6(gf) genetically interact, one might suspect that CNT-1 is the link. 
A few pieces of evidence dispute this, however. First, CNT-1 acts in the engulfing cell, 
while CED-4, and by proxy, CED-3, act in the linker cell. Second, using CRISPR, I 
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removed the CED-3 cleavage site in the endogenous cnt-1 locus, and I found no effect 
on linker cell degradation, suggesting that CED-3 cleavage of CNT-1 is dispensable for 
linker cell corpse removal.
The use of caspase to degrade the linker cell, but not to kill it, shows the fine line 
between death and degradation, and how difficult it may be to distinguish between these 
phenotypes. In linker cell death, however, I think caspase is involved in downstream 
degradation events, because persistent linker cell corpses in ced-3 mutant animals 
have lost a majority of their cytoplasmic volume and are much smaller than typical 
surviving cells. In addition, the nuclear envelope is crenellated. This phenotype has 
been confirmed by scientists in external laboratories, and is even the case in quadruple 
caspase mutants [83]. 
Instead ced-3 mutant animals have difficulty with internalization of the cell 
corpse, as evidenced by the delay in cell splitting. They also have trouble in digesting 
the fragments after internalization, especially the larger nuclear fragment. While these 
animals also have a delay in removal of the small, cytoplasmic piece, the actual duration 
of this piece is unaffected. This means that it takes longer for the animal to generate 
the smaller fragment, but this piece is degraded efficiently once it is. Intriguingly, 
ced-3 persistent linker cell corpses resemble dying motoneurons in the absence of 
apoptosis [112]. Perhaps these cells are dying by LCD and are then being degraded via 
caspase activation. Another alternative is that both cell death forms are used to kill and 
degrade the cell of interest, depending on developmental stage, signaling pathways, 
and the local environment.
5.2. A new function of caspase and an alternative explanation of published 
results
Caspase-dependent apoptosis does not account for many cell death events that 
occur during animal development. Indeed, mice homozygous for knockout alleles of key 
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apoptotic genes, including caspase-3, caspase-9, Apaf1, or Bax and Bak, can survive 
to adulthood [33,36,233], a surprising observation given the prevalence of cell death in 
murine development. Inactivation of apoptosis genes also only weakly interferes with 
degenerative disease progression [234]. LCD, a non-apoptotic cell death process, is 
prevalent in vertebrates [235] and may account for a significant fraction of cell deaths 
that take place during development and in disease.
From our studies, it is apparent that caspase is instead needed for bulk cell 
degradation, as well as a more specific function in engulfment. Perhaps some of 
present apoptotic data could also be explained by this alternative function of caspases. 
For example, in Bax-Bak- mice, cell death between the digits is greatly delayed [38]. 
However, since the morphology of these dying cells was not examined by electron 
microscopy, one could imagine a scenario where caspase activation is needed only 
after LCD has commenced in these cells.
Indeed, in collaboration with Sarit Larisch and Dana Mamriev at the 
University of Haifa, we noticed that mouse embryonic fibroblasts (MEFs) display 
LCD-like morphology only 8 min after treatment with the cell-death-inducing drug 
staurosporine (STS) (M. Alam, unpubl. data). In HeLa cells treated with STS, the 
initiator caspase-9 is activated 30 min after treatment, and the effector caspase-3 is 
induced 3h after treatment [236]. Caspase-3 activation peaks 12h after STS treatment 
in human corneal endothelial cells, and the cells adopt apoptotic morphology 12h after 
treatment [237]. These results suggest that LCD could be the main killing function, with 
caspase responsible for clearing cellular debris.
The LCD-like crenellations still occur in treated MEF cells with mutated apoptotic 
genes (D. Mamriev, M. Alam, unpubl. data). We also noticed induction of components 
of the ubiquitin proteasome system 30 min after treatment (L. Kutscher, D. Mamriev, 
unpubl. data). While the research is still early, this system mimics what we see with the 
death of the linker cell. 
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Perhaps there are other pathways that were initially thought to be exclusively 
apoptotic that instead rely on apoptotic genes for efficient corpse clearance, and not for 
death. Given the diversity of non-apoptotic functions for caspase [238], then perhaps it 
is not so far-fetched that caspase has a nuanced role in cell death. 
5.2.1. Suggestions for classifying cell death in vivo
How then should we classify apoptosis versus LCD, especially given that 
molecules between the two may be shared but have distinct functions? First, I would 
argue that ultrastructural morphology is important for identifying the relevant pathway. 
LCD and apoptosis have distinct morphology by electron microscopy (EM), and this 
could be used as a first step in identifying the cell death process at play. As EM methods 
require specialized training and equipment, it may not always be available. Perhaps in 
this case, nuclear morphology is the best indication of LCD vs. apoptotic. Expression 
of fluorescently tagged lamin in cells dying by LCD revealed that the crenellations are 
visible with light microscopy (M. Alam, unpubl. data). 
The presence of cleaved caspase-3 should no longer be considered a proxy 
for apoptosis, given the role of CED-3 in corpse clearance of cells dying by LCD. 
Determining exactly how to differentiate between these cell death pathways will 
hopefully become clearer as we learn more about the relative contributions each makes 
to eliminate a dying cell.
5.2.2. LCD and apoptosis as parallel pathways?
One possibility is that LCD drives cell death in development, while caspases 
perform a cell degradation role. Another possibility is that the two pathways work in 
parallel, each functioning in certain developmental stages and contexts. Perhaps LCD 
is the main cell death program in vertebrate systems, especially since mutations in 
apoptotic genes only affect certain tissues. Finding the molecules conserved across 
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species will be crucial in testing these hypotheses. Many of the LCD genes isolated so 
far, including the ones described in this thesis, may be nematode-specific, as most of 
the upstream regulatory genes isolated tell the linker cell exactly when and where to die. 
The key will be identifying the genes targeted by the ubiquitin proteasome system, and 
determining if those molecules are conserved across systems.
5.3. Future directions
While my graduate work revealed a substantial amount about the genes and 
mechanisms involved in linker cell death and degradation, many pertinent questions 
remain. Discussed below are some that I consider most pressing in relation to my work.
5.3.1. Linker cell death future questions 
Chapter two of my thesis focused on the role of PQN-41C interacting proteins 
in cell death. I recovered many interesting candidate genes that warrant additional 
investigation, including the aconitase aco-2, the zinc finger protein zfp-1, two additional 
polyglutamine-containing genes pqn-59 and pqn-85, and the cell death inhibitor hpk-1. 
I am especially interested in how these interactions with PQN-41C contribute to cell 
death, especially since neurodegenerative diseases associated with polyglutamine 
expansion proteins may result from a developmental cell death program gone awry [94].
5.3.1.1. Does PQN-41C bind HPK-1 to prevent it from activating HSF-1?
I isolated the homeodomain protein kinase HPK-1 as an interacting partner of 
PQN-41C. Genetic experiments placed HPK-1 with HSF-1, and additional preliminary 
experiments showed that loss of hpk-1 affects HSF-1 heat shock function and abrogates 
the heat-related cell death defect of the linker cell. A positive regulatory interaction 
between HPK-1 and HSF-1 in modulating the stress response is bolstered by previously 
published data in C. elegans [186,196,197] and other organisms [188,239]. 
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Because loss of hpk-1 allows cell death to occur more robustly, I hypothesized 
that HPK-1 normally promotes the stress-related, pro-survival role of HSF-1, and that 
an interaction with PQN-41C is necessary to disrupt this interaction. This would then 
allow HSF-1 to function in its pro-death capacity instead. However, it seems necessary 
for HPK-1 to function prior to death, as loss of hpk-1 affects male fertility. Further work 
should directly test this hypothesis. Ideally, this would be tested biochemically, as 
discussed in Chapter 2. Another, perhaps simpler way to test this hypothesis, would 
be to mutate putative Ser/Thr phosphorylation residues to alanines on HSF-1 and test 
for rescue in hsf-1(sy441) animals. By doing this as a single copy insertion under the 
endogenous promoter, one could test these residues for their role in both the heat shock 
response globally, as well as their role in linker cell death specifically. 
5.3.1.2. How does HPK-1 regulate HSF-1 in its heat shock role?
One added benefit to the above method is that we could simultaneously identify 
amino acid residues necessary for both functions of HSF-1 in a single experiment. 
In other systems, HPK-1 inhibits the ability of HSF-1 to become sumoylated, which 
bolsters its heat shock response [196]. Alternatively, in response to increased levels 
of reactive oxygen species (ROS), the HPK-1 homolog, HIPK2, is desumoylated, 
which drives downstream gene expression changes [239]. Perhaps in linker cell 
death, when HPK-1 is inhibited, HSF-1 becomes sumoylated, pushing HSF-1 towards 
its cell death role. Identifying sumoylation sites computationally and attempting to 
rescue hsf-1(sy441) with lysine to alanine mutations at these residues may help 
identify putative sumoylation sites on HSF-1. The role of sumoylation in modifying and 
modulating HSF-1 and HPK-1 in linker cell death definitely deserves closer inspection. 
Adding to the intrigue, Jennifer Malin identified the E3 sumo-conjugating enzyme 
UBC-9 as a putative substrate of the E3 ligase BTBD-2 in linker cell death. Perhaps 
selective removal of a sumoylation-promoting enzyme is required to kill the linker cell. 
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Identifying the post-translation modifications necessary to modulate the different roles 
of HSF-1 is crucial to fully understanding the interactions between these proteins, and 
learning how the cell decides between life and death.
5.3.2. Linker cell degradation future questions
Chapters 3 and 4 of my thesis focused on the events that occur after linker cell 
death, namely how is the dying linker cell cleared from the organism. I discovered a 
core genetic network involving the two small GTPases ARF-6 and RAB-35, whose 
interplay is required for proper phagosome maturation and cell degradation. I also 
discovered that caspase is required in the linker cell to be properly engulfed by the 
U.l/rp cells and for the nucleus of the linker cell to be properly degraded. While I 
uncovered quite a bit about the dismantling of the cell corpse, some questions remain 
and are discussed below.
5.3.2.1. How is the cell specificity of ARF-6 and RAB-35 function conferred?
One puzzling piece remaining is the fact that the U.l/rp cells seem specifically 
equipped to dismantle the linker cell, yet both arf-6, rab-35, and many of their regulators 
are expressed throughout the entire animal. Overall, animals harboring mutations in 
these genes do not have major issues in viability, although these genes have additional 
endocytic and membrane trafficking functions [207,210]. Perhaps one aspect of 
specificity could be downstream effectors of these genes that have yet to be identified, 
which equip the U.l/rp cells with specialized phagocytosis and degradation functions. 
5.3.2.2. How is the dying linker cell corpse recognized?
Both RAB-35 and ARF-6 have roles in phagocytosis onset and phagosome 
maturation. It is still unknown, however, what the exact signaling molecules and 
engulfment receptors displayed on the linker cell membrane are. We know that 
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canonical apoptotic genes are not involved, and PS exposure was also not readily 
detected. I think the linker cell is emitting a “find me” signal though, as I occasionally 
witnessed dying cells that had a slight migration defect, where the U.l/rp cells extended 
processes and appeared to pull the linker cell into its proper place. At the same time, 
it also must have highly regulated “eat me” and “don’t eat me” signals, as competitive 
phagocytosis and internalization should not take place before the linker cell is 
completely sandwiched between the two engulfing cells and the gonad contents are 
protected. What these signals are should be a future area of active investigation.
What is the best way to go about finding these molecules? I would suggest 
revisiting my forward genetic screen, but this time carrying out the screen in animals 
carrying both a U.l/rp marker (nsIs589) and a linker cell marker (nsIs65). I would 
suggest picking off young adult males with intact linker cells under low magnification 
(dissecting microscope), but then immediately mounting these males on a slide for 
examination under high magnification (compound microscope). By doing so, it will be 
easier to identify surviving cells based on DIC morphology, and perhaps also cells that 
remain sandwiched but unengulfed within the U.l/rp cells (but still display a crenellated 
nuclear envelope, indicating death). After recovery, I would suggest isolating each male 
with a single wild-type hermaphrodite for 24h, to ensure that these males are infertile 
(because a surviving or unengulfed linker cell will block spermatid exit). Only then would 
I suggest attempting the artificial insemination (AI) procedure with these 24h old males, 
noting also whether the linker cell is still around prior to AI. By more carefully conducting 
the forward genetic screen can we find genes specifically involved in death or dying cell 
recognition.
5.3.2.3. What other genes are involved in corpse degradation?
We discovered that RAB-35 seems to be required to remove ARF-6 from the 
nascent phagosome, and RAB-35 also has downstream functions involving RAB-5 
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and RAB-7 recruitment. Based on sand-1; rab-35 double mutants, which have nearly 
all cell corpses remaining even 36h after the L4 to adult transition, I think that RAB-35 
is required in parallel to sand-1, at the RAB-5 to RAB-7 transition. This hypothesis is 
bolstered additionally by the fact that while in the majority of rab-35(b1013) animals, 
mCh-RAB-5 was never recruited to the phagosome, there was one animal where 
mCh-RAB-5 persisted around the phagosome for nearly the entire experiment, 
suggesting that RAB-35 is necessary for its removal. This is especially surprising for 
RAB-5, as it is usually only enriched around the phagosome for a single frame in wild-
type animals. For mCh-RAB-7 localization in rab-35 mutant animals, I never saw such 
persistent localization, despite screening more animals.
To pinpoint the ARF-6-independent function of RAB-35 more precisely, I 
should examine mCh-RAB-5 and mCh-RAB-7 localization in persistent cell corpses in 
arf-6(tm1447); rab-35(b1013) double mutant animals. These animals have a small but 
significant increase in the number of cell corpses compared to wild type, so that such 
analysis would be possible. If my above idea is true, I should see persistent mCh-RAB-5 
recruitment around these lingering corpses, and never see mCh-RAB-7 recruitment.
5.3.2.4. What are the target proteins of CED-3?
I also determined that CED-3 is required for proper corpse degradation, 
especially of the nucleus-containing fragment, and perhaps also plays a role in timely 
engulfment. The latter could be investigated using the genetic screen I described, but 
the former could be investigated by a candidate screen. As previously mentioned, in 
apoptosis in the C. elegans embryo, CED-3 is required to convert the RNase DCR-1 
to a DNase tDCR-1 to efficiently remove DNA from the dying cell [224]. To investigate 
whether something similar could be occurring here, I tested a mutant of dcr-1. While the 
research is still preliminary, there was a slight delay in corpse removal at 2h after the L4 
to adult transition. The nuclease nuc-1, also a CED-3 target, has a small but significant 
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corpse removal defect at 24h. Perhaps a nuc-1; dcr-1 double mutant would resemble 
the ced-3 mutant animals and hint at the role of CED-3 in removing nuclear DNA from a 
dead cell. 
5.4. Concluding remarks
The studies described here suggest how linker cell death may be inhibited when 
opposing cell survival signals are present. Additional studies are needed to determine 
the exact molecular mechanism by which this inhibition occurs, but may provide much 
needed clues to understanding how the HSF-1 switch is controlled in linker cell death. 
These studies also provide clear mechanistic insight to how the linker cell corpse is 
removed and degraded following cell death, which is controlled by two small GTPases, 
RAB-35 and ARF-6, and their regulators. RAB-35 and ARF-6 have been previously 
implicated in phagocytosis of pathogens, suggesting that the insights provided here 
are well-conserved in many modes of phagocytosis. The finding that CED-3 is involved 
in cell degradation and not cell death perhaps answers the question as to why many 
mouse models of apoptotic knockout genes are viable: those genes are involved in the 
degradation of cells that are dying by LCD. Investigating the role of LCD in mammalian 
development is thus an urgent and exciting avenue of research in the near future.
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6. Materials and Methods
6.1. Reagents
6.1.1. C. elegans strains
C. elegans strains were raised at 20oC on nematode growth medium (NGM) 
seeded with OP50 bacteria [240], unless otherwise indicated. Wild-type animals were 
of the Bristol N2 strain. All strains have one of two mutations that generate a high 
incidence of male progeny, him-8(e1489) IV or him-5(e1490) V. Mutants recovered 
by EMS mutagenesis were outcrossed five times before use. Transgenic lines were 
generated by injection of plasmid DNA mixes into the hermaphrodite gonad. Integrated 
transgenic strains were generated with UV/trioxalen treatment [241] (Sigma, T6137) and 
were outcrossed at least four times before imaging experiments. Most strains also had 
one of three integrated linker cell markers qIs56[lag-2p::GFP] V, nsIs65[mig-24p::Venus] 
X, or nsIs650[mig-24p::mKate2] X. Other alleles and transgenes are as follows:
LGI: chd-7(tm6138), chd-7(tm6139), chd-7(gk290), chd-7(gk306), rab-2(n3263), 
ced-1(e1735), cep-1(gk138), dpy-5(e907)
LGII: rrf-3(pk1426), pqn-85(tm2334), pqn-85(tm2338), hsf-1(sy441), 
cnt-1(gk899634), cnt-1(tm2313) 
LGIII: zfp-1(ok554), rab-35(b1013), rab-35(tm2058), tbc-10(gk388086), 
unc-119(ed3), ttr-52(tm2003), ttr-52(tm2078), F23H11.4(gk585084), 
F23H11.4(gk165637), cnt-2(gm377), ced-9(n1950), ced-4(n1162)
LGIV: pqn-41(ns294), pqn-41(ns807), egl-20(n585), arf-6(tm1447), arf-
6(ns388), arf-6(ns751[D92N]), arf-6(ns752[D92N]), arf-6(ns753), arf-6(ns760[T44N]), 
arf-6(ns761[T44N]), arf-6(ns762[T44N]), arf-6(ns763[I42M;P43T]), arf-6(ns765[Q67L]), 
arf-6(ns771[Q67L]), arf-6(ns753), arf-6(ns764), arf-6(ns767), arf-6(ns769), 
sand-1(or552), sand-1(ok1963), efa-6(ok3533), ced-10(n1993), ced-5(n1812), 
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psr-1(ok714), psr-1(tm469), ced-3(n717), ced-3(n2452)
LGV: rde-1(ne219), egl-1(n1084n3082)
LGX: hpk-1(pk1393), sek-1(ag1), bar-1(ga80), rme-4(ns410), rme-4(ns412), 
rme-4(b1001), rme-4(tm1865), tbc-13(ok1812), piki-1(ok2346), him-4(e1267), 
git-1(ok1848), git-1(gk392605), gap-2(ok1001)
6.1.2. Transgenes generated or used in present study
Transgene Constructs
nsIs387 UV/TMP integration of nsEx3148[mig-24p::rde-1-SL2-mCherry + lag-2p::mCherry]
drSi13 II hsf-1p::hsf-1-GFP::unc-54 3'UTR + Cbr-unc-119(+) single copy insertion [189]
nsIs653
UV/TMP integration of nsEx5304[pLMK10[lin-




rme-4 fosmid (WRM0615bE09) 10 ng/ul + lin-48p::mCh 
(25 ng/ul) + pBluescript (65 ng/ul)
nsEx4721,-22,-16 pLMK11[lin-48p::rme-4a cDNA-SL2-mCh](20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx4559,-60,4748
pLMK12[mig-24p::rme-4a cDNA](20 ng/ul) + odr-
1p::RFP(+) (20 ng/ul) + pEB30[lag-2p::mCh] (25 ng/ul) + 
pBluescript (35 ng/ul)
nsEx4669,-64,4742 pLMK13[lin-48p::rme-4b cDNA-SL2-mCh](20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
pwIs268 rme-4 translational reporter, gift from B. Grant [207]
nsEx4658,-66,-91 pLMK14[lin-48p::rab-35 cDNA-SL2-mCh](20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx4654,-89,-90
pLMK15[mig-24p::rab-35 cDNA](20 ng/ul) + odr-
1p::RFP(+) (20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35 
ng/ul)
nsEx4813,-16,-47
pLMK16[mig-24p::rab-35(Q69L) cDNA](20 ng/ul) + odr-





pLMK17[mig-24p::rab-35(S24N) cDNA](20 ng/ul) + odr-
1p::RFP(+) (20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35 
ng/ul)
pwIs357 rab-35 translational reporter, gift from B. Grant [207]
nsEx4741,-49,-86, 
4937,-81,-82
pLMK18[lin-48p::tbc-10 cDNA-SL2-mCh](20 ng/ul) + odr-
1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx5703,-04,-05 pLMK19[lin-48p::tbc-10(R225A) cDNA-SL2-mCh](20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsIs493 UV/TMP integration of sEx10170[rCes R06B10.5::GFP + pCeh361]. Strain BC10170 from CGC.
nsIs595 V
UV/TMP integration of nsEx5132[pLMK20[lin-48p::YFP-
RAB-35 cDNA] (10 ng/ul)+ unc-119(+) (25 ng/ul) + 
pBluescript (65 ng/ul)]
nsIs713
UV/TMP integration of [pLMK21[lin-48p::mKate2-RAB-35 
cDNA] (10 ng/ul)+ unc-119(+) (25 ng/ul) + pBluescript (65 
ng/ul)]
nsIs60 mig-24p::Venus + unc-119(+), a gift from M. Abraham
nsIs622 X
UV/TMP integration of nsEx4724[pLMK22[lin-
48p::mCherry-RAB-5 cDNA] (1 ng/ul)+ unc-119(+) (25 ng/
ul) + pBluescript (74 ng/ul)]
nsIs592 V
UV/TMP integration of nsEx5610[pLMK23[lin-
48p::mCherry-RAB-7 cDNA] (1 ng/ul)+ unc-119(+) (25 ng/
ul) + pBluescript (74 ng/ul)]
nsIs586 V
UV/TMP integration of nsEx5798[pLMK24[lin-48p::CTNS-




pLMK25[lin-48p::arf-6 cDNA-SL2-mCh](20 ng/ul) + odr-
1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx4657,-60, 
4753,-85,-50
pLMK26[lin-48p::arf-6(D92N) cDNA-SL2-mCh](20 ng/ul) + 
odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx4825,-44,-45, 
4815,-46,-49
pLMK27[mig-24p::arf-6 cDNA](20 ng/ul) + odr-1p::RFP(+) 
(20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35 ng/ul)
nsEx4787,-94, 4814
pLMK28[mig-24p::arf-6(D92N) cDNA](20 ng/ul) + odr-
1p::RFP(+) (20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35 
ng/ul)
nsEx4595 pLMK29[arf-6p::arf-6 genomic DNA-GFP-unc-54 3'UTR] (10 ng/ul) + unc-119(+) (25 ng/ul) + pBluescript (65 ng/ul)
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nsEx4602
pLMK30[arf-6p::arf-6(ns388) genomic DNA-GFP-unc-54 




pLMK31[lin-48p::arf-6(ΔG2) cDNA-SL2-mCh](20 ng/ul) + 
odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx4954,-67,5696 pLMK32[lin-48p::arf-6(ΔG2, D92N) cDNA-SL2-mCh](20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx5694,-95 pLMK33[lin-48p::cnt-1a cDNA-SL2-mCh](20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx4951,-52,-5692
pLMK34[mig-24p::cnt-1a cDNA](20 ng/ul) + odr-
1p::RFP(+) (20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35 
ng/ul)
nsEx5740,-42,-58 pLMK35[lin-48p::cnt-1a(R490A) cDNA-SL2-mCh](20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx5741,-44,-60 pLMK36[lin-48p::cnt-1b cDNA-SL2-mCh](20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx4938,-49,-50
pLMK37[mig-24p::cnt-1b cDNA](20 ng/ul) + odr-
1p::RFP(+) (20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35 
ng/ul)
nsEx5757 pLMK38[cnt-1p::GFP] (10 ng/ul) + unc-119(+) (25 ng/ul) + pBluescript (65 ng/ul)
nsEx5743,-56,-59 pLMK39[lin-48p::efa-6a cDNA-SL2-mCh](20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx5133,-51,-52 pLMK40[lin-48p::efa-6b cDNA-SL2-mCh](20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx5139,-47,-5140 pLMK41[lin-48p::efa-6c cDNA-SL2-mCh](20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx5134,-35,-40 pLMK42[lin-48p::efa-6d cDNA-SL2-mCh](20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
nsEx5100 pLMK43[efa-6p::GFP] (25 ng/ul) + unc-119(+) (25 ng/ul) + pBluescript (50 ng/ul)
nsIs625
UV/TMP integration of nsEx5136[pLMK44[lin-48p::ARF-6-
YFP cDNA] (10 ng/ul)+ unc-119(+) (25 ng/ul) + pBluescript 
(65 ng/ul)]
nsIs636
UV/TMP integration of nsEx5130[pLMK45[lin-48p::ARF-





pLMK64[lin-48p::MFGe8-GFP] (10 ng/ul) + unc-119(+) (25 
ng/ul) + pBluescript (65 ng/ul), gift from Z. Zhou [151]
nsIs25 ced-3p::GFP, rol-6(+), gift from C. Maurer
nsEx4944,-5 pPG08[ced-3p::mCherry], a gift from P. Ghose (10 ng/ul) + unc-119(+) (25 ng/ul) + pBluescript (65 ng/ul)]
bcIs109 ced-3p::ced-3-GFP, rol-6(+), gift from B. Conradt
nsEx5307 pLMK65[ced-4p::mKate2] (25 ng/ul) + unc-119(+) (25 ng/ul) + pBluescript (50 ng/ul)]
nsEx5627,-8,-9,
pLMK66[mig-24p::ced-4a cDNA] (20 ng/ul) + odr-
1p::RFP(+) (20 ng/ul) + pEB30 (20 ng/ul) + pBluescript (40 
ng/ul)
nsEx5619,-20,-81 pLMK67[lin-48p::ced-4a cDNA-SL2-mCh] (20 ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)
6.1.3. Additional Plasmids generated or used in present study
Plasmid Details










pLMK56 LexA-RAB-35(S24N), [GDP], Y2H





pLMK62 arf-6[D92N] CRISPR targeting vector, pDD162 backbone
pLMK63 arf-6[T44N] CRISPR targeting vector, pDD162 backbone
pLMK64 arf-6[Q67L] CRISPR targeting vector, pDD162 backbone
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6.2. C. elegans methods
6.2.1. Forward genetic screen and artificial insemination
Young L4 hermaphrodites containing qIs56 [lag-2p::GFP] and him-5(e1490) 
were mutagenized with 75 mM ethylmethanesulfonate (EMS, Sigma M0880) for 4h at 
20oC. Animals were synchronized twice by bleaching, and male animals were enriched 
by passing through a 40 μm cell strainer (BD Falcon) passively for 20 min [242]. Male 
animals fit more readily through the mesh than hermaphrodites and were enriched to 
~88%. Animals were then scored under a fluorescent dissecting microscope (Leica) for 
presence of a linker cell by GFP 24h after the L4 to adult transition. GFP-expressing 
animals were isolated away from hermaphrodites for 24h after that to accumulate 
spermatids within the gonad. Mutant males were immobilized on a dried agar pad under 
immersion oil, and spermatids removed with a needle containing SM buffer (50 mM 
HEPES, pH 7, 50 mM NaCl, 25 mM KCl, 5 mM CaCl2, 1 mM MgSO4, 1 mg/ml BSA) 
[206]. An N2 hermaphrodite with a single row of eggs was then immobilized on the 
same dried agar pad and gently injected with the collected sperm through the vulva. We 
typically tried to insert all spermatids into a single hermaphrodite. GFP+ heterozygous 
progeny were collected, allowed to self fertilize, and linker cell persistence confirmed 
under a dissecting microscope.
6.2.2. Gene identification
A combination of Hawaiian Snip-SNP mapping [243] and whole genome 
sequencing [244] was used to identify rme-4(ns410), rme-4(ns412), and arf-6(ns388) 
using output from galign [245]. rme-4 was confirmed by fosmid rescue using 
WRM0615bE09, and arf-6 identification was confirmed by mutant cDNA expression and 
CRISPR alleles.
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6.2.3. Linker cell survival and corpse persistence assays
Linker cell death was scored as previously described [87]. Briefly, unstarved 
gravid hermaphrodites were bleached to isolate embryos, which were allowed to 
hatch overnight in M9. Synchronized L1 animals were released on 9-cm NGM plates 
seeded with OP50 or HT115 E. coli containing the RNAi construct of interest on IPTG-
RNAi plates. Male animals were isolated onto a new plate prior to the L4-to-adult 
transition based on full retraction of the male tail tip with rays visible under the unshed 
L4 cuticle. 2h or 24h later, these animals were mounted onto 2% agarose-water pads, 
anaesthetized in 25 mM sodium azide, and examined on an Axioplan 2 fluorescence 
microscope (Zeiss) with a 63x/1.4NA objective (Zeiss) and Nomarski optics. The linker 
cell was identified by location, morphology, and fluorescence from reporter transgenes. 
Cells were then scored as surviving, dead, or gone based on DIC morphology and 
fluorescence. For heat shock experiments, animals were subjected to brief heat shock 
4h prior to the L4 to adult transition [85].
6.2.4. Germline transformation and rescue experiments
Plasmid mixes containing the plasmid of interest, co-injection markers, and 
pBluescript were injected into both gonads of young adult hermaphrodites [246]. 
Injected animals were singled onto NGM plates and allowed to grow for two 
generations. Transformed animals based on co-injection markers were picked onto 
single plates, and screened for stable inheritance of the extrachromosomal array. Only 
lines from different P0 injected hermaphrodites were considered independent. For cell-
specific rescue experiments, animals expressing mCherry in either the linker cell or the 
U.l/rp cells were picked to a new plate at the early L4 stage, before linker cell death, to 
avoid bias. Isolated animals were then staged based on tail morphology under a white 
light microscope for appropriate linker cell scoring.
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6.2.5. RNAi assay
pL4440 RNAi plasmids containing coding sequence to genes of interest were 
isolated from the Ahringer Library [247] (Source BioScience) and the coding sequence 
was confirmed by sequencing. Additional targeting plasmids were generated by cloning 
in the Y2H hit to the pL4440 vector. All plasmids were grown at 37oC in HT115 bacteria, 
which have a plasmid containing an inducible promoter driving T7 RNA polymerase. 
The bacteria were plated on NGM plates that had been supplemented with the antibiotic 
carbomycin and IPTG. One day later, synchronized L1 animals were plated on the RNAi 
plates and grown for two days before assaying for linker cell corpse persistence.
6.2.6. Apoptotic corpse assay
Strain and vectors used in assay were from the DUALHybrid Kit (Dualsystem 
Biotech). Bait cDNA was cloned into the pLexA plasmid and prey cDNA was cloned into 
pGAD vectors. These plasmids were cotransformed into NMY51 yeast strain using the 
lithium acetate method described in the DualHybrid manual. Selection was performed 
on SD plates lacking the amino acids leucine, tryptophan, and histidine.
6.3. Molecular biology methods
6.3.1. Yeast two-hybrid screen
Strain and vectors used in assay were from the DUALHybrid Kit (Dualsystem 
Biotech). Bait cDNA was cloned into the pLexA plasmid and prey cDNA was cloned 
into pGAD vectors, or a C. elegans cDNA library tagged to GAD was used as bait, in 
the case of the screen. These plasmids were cotransformed into NMY51 yeast strain 
using the lithium acetate method described in the DualHybrid manual. Selection was 
performed on SD plates lacking at least the amino acids leucine, tryptophan, and 
histidine, and occasionally adenine, where noted. 
126
6.3.2. Generation of arf-6 alleles using CRISPR-Cas9 genome editing
Alleles of arf-6 were generated using the co-CRISPR-based genome editing 
method as previously described [248]. pDD162 was used as a vector backbone, and 
the following sgRNA sequences were added for each individual CRISPR attempt 
(D92N: 5’ CTAAAAACCTGTCTCTATCAG 3’; T44N:  5’ TCAGTGACCACAATGACGA 
3’; Q67L 5’ CTTCAGGACGTCGGCGGAC 3’) to generate arf-6 targeting vectors. A 
dpy-10 sgRNA-pDD162-based vector was also generated (5’ GCTACCATAGGCAC 
CACGAG 3’). Single-stranded repair oligos were PAGE purified and ordered from 
Sigma (D92N: 5’ aggaaaaaaaccaatttttccgcatttttcgcctaaaaacCTGTCTCTATtAGCaG 
CGTCCATCACAAAAATGAGCGCCTGAGTTCCTGTGTAATAATGTC 3’; T44N:  5’ 
agCAATTCTGTACAAACTGAAGCTCGGGCAATCAGTGACCACAATTCCGAacGT 
GGGCTTCAATGTGGAGACTGTCACGTATAAAAATATCAAATTCAACGT 3’; Q67L 5’ 
ggcctaaaaacccccaaaaaccccaatttttcttcagGACGTCGGCGGACttGACAAAATTCGAC 
CCCTCTGGCGACATTATTACACAGGAACTCAGGCGCT 3’, dpy-10(cn64): 5’ CACTT 
GAACTTCAATACGGCAAGATGAGAATGACTGGAAACCGTACCGCATGCGGTG 
CCTATGGTAGCGGAGCTTCACATGGCTTCAGACCAACAGCCTAT 3’ [248]. N2 
animals were injected with the following mix: 50 ng/μl dpy-10 sgRNA, 50 ng/μl arf-6 
targeting vector, 20 ng/μl dpy-10(cn64) repair oligo, 20 ng/μl arf-6 repair oligo in 1x 
injection buffer (20mM potassium phosphate, 3mM potassium citrate, 2% PEG, pH 7.5). 
F1 animals with Dpy or Rol phenotypes were picked to individual plates, indicating 
a CRISPR-based editing event had occurred. F1 animals were allowed to lay eggs, 
and then genotyped for successful co-conversion of the arf-6 locus using PCR and 
restriction enzyme screening or Cel1 digestion of heteroduplex DNA [249]. Non-Rol, 
non-Dpy F2 animals were then singled and homozygosed for the arf-6 mutation.
6.3.3. Plasmid construction
Plasmids containing lin-48p, mig-24p, or transcriptional reporters were cloned 
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using multi-piece one-step cloning into a modified pPD95.75 backbone lacking GFP. 
For CRISPR-related vectors, plasmids were generated using a site-directed plasmid 
mutagenesis protocol on pDD162 [250,251]. Yeast vectors were generated using 
traditional cloning from either a pLexA-N-terminus vector or a pGAL4AD-N-terminus 
vector (Dualsystems Biotech), and single amino acid change variants were generated 
using QuikChange (Agilent).
6.4. Cell biology methods
6.4.1. Long-term imaging and movie generation
Early L4 male animals were imaged in a microfluidic device described in detail 
in [201]. Animals were fed a constant flow of NA22 bacteria in S medium, supplemented 
with kanamycin (50 ng/μl) to prevent bacterial overgrowth. Animals were immobilized 
and imaged every 8 minutes for at least 20h. Mutant animals were typically imaged 
for > 30h. Exposure time and light intensity was held constant across strains when the 
same integrated transgene was imaged. Occasionally tail development was perturbed 
by the flow of medium and repeated immobilization procedures, and these animals were 
not included in subsequent analyses.
6.4.2. Deconvolution
Images were cropped to a region of interest surrounding the linker cell. We 
measured the point-spread function (PSF) of our optical setup using red (580/605nm) 
and green (505/515nm) fluorescent 200nm beads (ThermoFisher Scientific). Using 
these PSFs, we deconvolved the cropped fluorescence z-stacks using the classic 
maximum likelihood estimation (CMLE) algorithm with standard parameters (refractive 
index of imaging medium: 1.338) in the Huygens Essential software (Huygens Essential 
3.7.1) by Scientific Volume Imaging (SVI).
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6.4.3. Image Analysis
Image analysis was performed using custom-written Matlab R2016b (Mathworks) 
scripts by Wolfgang Keil. To overlay imaging frames, I straightened each three-
dimensional image stack using a previously published algorithm [201,252] based on 
a manually selected worm backbone in the DIC channel. To correct for small residual 
animal movements during multi-channel acquisition, obvious landmarks visible in the 
fluorescence channels, such as the cloaca, fluorescently labeled cells in the animal’s 
tail, or vesicles within the U-cell descendants were then manually aligned to the DIC 
channel in each frame. Time-lapse movies were generated by centering all straightened, 
aligned images on the linker cell and cropping the entire movie to an appropriate size. 
6.4.4. Protein structures
The co-crystal structure of human Arf6 with the ArfGAP ASAP3 (PDB 3LVQ) 
was examined in Pymol (The PyMOL Molecular Graphics System, Version 1.2r3pre, 
Schrödinger, LLC.) in silico mutagenesis for D92N and I42M;P43T was performed and 
hydrophilic interactions tested within Pymol. Key residues in ASAP3 are conserved in 
C. elegans CNT-1, and those for Arf6 are conserved in C. elegans ARF-6.
6.5. Data analysis
Statistical analysis was performed using GraphPad Prism. Statistical parameters 
including mean ± standard error of the proportion, mean ± SEM, and N are reported in 
the main text, figures and figure legends. Data is judged to be statistically significant 
when p < 0.05 by Fisher’s exact test, χ2-test, or student’s t-test, where appropriate.
When comparing a transgenic line to the parental strain, a minimum of three 
independent lines was scored. Approximately 100 animals from each of these lines were 
examined for linker cell defects, and compared to the parental strain using a Fisher’s 
exact test to determine significance. For ease of presentation, I pooled the lines from 
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a given experiment and displayed them on the relevant figure using mean ± SEM (N = 
3, 4, or 5 lines). If only a subset of the three lines showed significance using a Fisher’s 
exact test, I indicated this on the figure and figure legend.
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7. Appendix: A list of mutants from the genetic screen.
Category explanations:
I. weakly surviving: Animals have a small but significant increase in the number of 
surviving cells.
II. relatively healthy: There are no surviving cells by our strict classifications, but the
cells look pretty good overall. May represent a timing defect.
III. odd death: Cells are still dying, but are doing so in an atypical manner. May
represent an aberration in engulfment or degradation.
IV. delayed death: There is an increase in the number of cell corpses at 2h after the
adult molt, but not at 24h.
V. persistent corpse: There is an increase in the number of cell corpses at both 2h 
and 24h after the molt.
FP. may represent a false positive.
Strain/Allele Category % SLCs % RH %GFP 2h %GFP 24h Notes
Wild-type 
(OS238) 3% 6% 40% (157) 12% (100)
ns414 I 26% 51% (35) 29% (14)
ns417 I 17% 9% 63% (35) 33% (50) Likelyon LGV
ns575 I 15% 17% 60% (53) 20% (55)
ns570 I 13% 17% 64% (47) 19% (58)
ns427 I 11% 0 39% (28) 7% (30)
ns578 I 10% 14% 52% (50) 12% (51)
ns425 II 0 36% 80% (36) 20% (45)
ns574 II 7% 25% 52% (56) 18% (39)
ns389 II 5% 21% 83% (58) 51% (53) Likelyon LGIII
ns428 II 3% 23% 50% (26) n.d.
ns426 III 0 n.d. 71% (21) 11% (37) 33% OD
ns587 III 2% 4% 46% (46) 10% (29) 24% OD
ns485 III 0 9% 45% (47) 20% (35) 15% OD
ns580 III 2% 2% 59% (46) 5% (56) 16% OD
ns573 III 0 25% 70% (38) 9% (43) 25% OD
ns579 III 9% n.d. 47% (34) n.d. 18% OD
ns594 III 2% 12% 41% (49) 11% (44) 8% OD
ns435 IV 0 6% 78% (18) 24% (59)
ns483 IV 0 0 74% (38) 19% (37) 29% OD
ns581 IV 9% 2% 84% (45) 13% (38)
ns416 IV 3% 3% 73% (37) 20% (25) 11% OD
ns544 IV 12% 8% 65% (49) 29% (42)
ns431 IV 14% 8% 61% (49) 2% (45)
ns432 IV 4% 4% 56% (45) 21% (43)
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ns545 IV 8% 6% 59% (49) 20% (13)
ns598 IV 7% 7% 74% (43) 12% (5) Likelycol-108
ns388 V 2% 0 95% (37) 60% (38) arf-6
ns412 V 3% 2% 88% (42) 57% (28) rme-4
ns576 V 12% 21% 85% (33) 30% (46)
ns410 V 0% 13% 95% (41) 67% (33) rme-4
ns430 V 0 9% 61% (46) 30% (54)
ns434 V 4% 8% 52% (50) 27% (26)
ns421 FP 2% 14% 55% (42) 13% (38)
ns429 FP 2% 12% 52% (50) 11% (134)
ns586 FP 2% 11% 40% (53) 16% (70)
ns568 FP 2% 10% 56% (62) 12% (50)
ns577 FP 2% 13% 53% (50) 9% (34)
ns584 FP 0 5% 57% (37) 17% (35)
ns411 FP 0 0 38% (21) 21% (24)
ns566 FP 8% 9% 41% (46) 8% (52)
ns419 FP 9% 0 40% (23) 6% (18)
ns418 FP 8% 0 33% (24) 40% (10)
ns433 FP 7% 9% 38% (45) 10% (42)
ns415 FP? 0 n.d. 38% (45) 11% (45) 11% OD
ns575 FP 7% 10% 54% (41) 21% (39) 9% OD
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